MIM	Preferred_Title	Abbreviation
100100	PRUNE BELLY SYNDROME; PBS	 PBS
100300	ADAMS-OLIVER SYNDROME 1; AOS1	 AOS1
100800	ACHONDROPLASIA; ACH	 ACH
101000	NEUROFIBROMATOSIS, TYPE II; NF2	 NF2
101200	APERT SYNDROME	
101400	SAETHRE-CHOTZEN SYNDROME; SCS	 SCS
101600	PFEIFFER SYNDROME	
101800	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1	 ACRDYS1
101900	ACROKERATOSIS VERRUCIFORMIS; AKV	 AKV
102200	PITUITARY ADENOMA 1, MULTIPLE TYPES; PITA1	 PITA1
102370	ACROMICRIC DYSPLASIA; ACMICD	 ACMICD
102500	HAJDU-CHENEY SYNDROME; HJCYS	 HJCYS
102530	SPERMATOGENIC FAILURE 6; SPGF6	 SPGF6
102700	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	
102900	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES	
103050	ADENYLOSUCCINASE DEFICIENCY; ADSLD	 ADSLD
103100	ADIE PUPIL	
103285	ADULT SYNDROME	
103470	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS	
103500	TIETZ ALBINISM-DEAFNESS SYNDROME; TADS	 TADS
103580	PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A	 PHP1A
103780	ALCOHOL DEPENDENCE	
103900	HYPERALDOSTERONISM, FAMILIAL, TYPE I; HALD1	 HALD1
104100	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	 PPKCA1
104200	ALPORT SYNDROME 3, AUTOSOMAL DOMINANT; ATS3	 ATS3
104290	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	 AHC1
104300	ALZHEIMER DISEASE; AD	 AD
104310	ALZHEIMER DISEASE 2; AD2	 AD2
104500	AMELOGENESIS IMPERFECTA, TYPE IB; AI1B	 AI1B
104530	AMELOGENESIS IMPERFECTA, TYPE IA; AI1A	 AI1A
105120	AMYLOIDOSIS, FINNISH TYPE	
105150	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED	
105200	AMYLOIDOSIS, FAMILIAL VISCERAL	
105210	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	
105250	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	 PLCA1
105400	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1	 ALS1
105500	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	
105550	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1; FTDALS1	 FTDALS1
105650	DIAMOND-BLACKFAN ANEMIA 1; DBA1	 DBA1
105830	ANGELMAN SYNDROME; AS	 AS
106100	ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	 HAE1
106180	ANGIOTENSIN I-CONVERTING ENZYME; ACE	 ACE
106190	ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD	 ANHD
106210	ANIRIDIA 1; AN1	 AN1
106260	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE; AEC	 AEC
106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1	 SPDA1
106600	TOOTH AGENESIS, SELECTIVE, 1; STHAG1	 STHAG1
106700	TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1	 TAPVR1
107250	ANTERIOR SEGMENT DYSGENESIS 1; ASGD1	 ASGD1
107480	TOWNES-BROCKS SYNDROME 1; TBS1	 TBS1
107600	APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC	 ACC
107680	APOLIPOPROTEIN A-I; APOA1	 APOA1
107730	APOLIPOPROTEIN B; APOB	 APOB
107970	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1	 ARVD1
108120	ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	 DA1A
108145	ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5	 DA5
108300	STICKLER SYNDROME, TYPE I; STL1	 STL1
108500	EPISODIC ATAXIA, TYPE 2; EA2	 EA2
108720	ATELOSTEOGENESIS, TYPE I; AO1	 AO1
108721	ATELOSTEOGENESIS, TYPE III; AO3	 AO3
108770	ATRIAL STANDSTILL 1; ATRST1	 ATRST1
108900	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7	 ASD7
108985	SVEINSSON CHORIORETINAL ATROPHY; SCRA	 SCRA
109100	AUTOIMMUNE DISEASE	
109150	MACHADO-JOSEPH DISEASE; MJD	 MJD
109270	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	 SLC4A1
109400	BASAL CELL NEVUS SYNDROME; BCNS	 BCNS
109730	AORTIC VALVE DISEASE 1; AOVD1	 AOVD1
109800	BLADDER CANCER	
110100	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES	 BPES
110450	BLOOD GROUP, COLTON SYSTEM; CO	 CO
110500	BLOOD GROUP, DIEGO SYSTEM; DI	 DI
110800	BLOOD GROUP, I SYSTEM; Ii	 Ii
111100	FUCOSYLTRANSFERASE 3; FUT3	 FUT3
111150	BLOOD GROUP--LUTHERAN INHIBITOR; INLU	 INLU
111250	BLOOD GROUP SYSTEM, LANDSTEINER-WIENER; LW	 LW
111300	BLOOD GROUP, MN; MN	 MN
111600	BLOOD GROUP, LANGEREIS SYSTEM; LAN	 LAN
111740	BLOOD GROUP, Ss; Ss	 Ss
112010	BLOOD GROUP--WALDNER TYPE; WD	 WD
112050	BLOOD GROUP--WRIGHT ANTIGEN; WR	 WR
112240	COLE-CARPENTER SYNDROME 1; CLCRP1	 CLCRP1
112250	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	 DMSMFH
112310	BOOMERANG DYSPLASIA	
112410	HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB	 HTNB
112500	BRACHYDACTYLY, TYPE A1; BDA1	 BDA1
112600	BRACHYDACTYLY, TYPE A2; BDA2	 BDA2
113000	BRACHYDACTYLY, TYPE B1; BDB1	 BDB1
113100	BRACHYDACTYLY, TYPE C; BDC	 BDC
113200	BRACHYDACTYLY, TYPE D; BDD	 BDD
113300	BRACHYDACTYLY, TYPE E1; BDE1	 BDE1
113500	BRACHYOLMIA TYPE 3; BCYM3	 BCYM3
113620	BRANCHIOOCULOFACIAL SYNDROME; BOFS	 BOFS
113650	BRANCHIOOTORENAL SYNDROME 1; BOR1	 BOR1
113750	ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	 OCA6
113800	EPIDERMOLYTIC HYPERKERATOSIS; EHK	 EHK
113900	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A	 PFHB1A
113970	BURKITT LYMPHOMA; BL	 BL
114000	CAFFEY DISEASE	
114290	CAMPOMELIC DYSPLASIA	
114300	ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	 DA3
114480	BREAST CANCER	
114500	COLORECTAL CANCER; CRC	 CRC
114550	HEPATOCELLULAR CARCINOMA	
115080	CARDIAC CONDUCTION DEFECT	
115150	CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	 CFC1
115195	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2	 CMH2
115196	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3	 CMH3
115197	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	 CMH4
115200	CARDIOMYOPATHY, DILATED, 1A; CMD1A	 CMD1A
115210	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1	 RCM1
115300	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT; HCVAD	 HCVAD
115310	PARAGANGLIOMAS 4; PGL4	 PGL4
115430	CARPAL TUNNEL SYNDROME; CTS1	 CTS1
115700	CATARACT 4, MULTIPLE TYPES; CTRCT4	 CTRCT4
115900	CATARACT 42; CTRCT42	 CTRCT42
116100	CATARACT 20, MULTIPLE TYPES; CTRCT20	 CTRCT20
116200	CATARACT 1, MULTIPLE TYPES; CTRCT1	 CTRCT1
116300	CATARACT 30, MULTIPLE TYPES; CTRCT30	 CTRCT30
116400	CATARACT 41; CTRCT41	 CTRCT41
116600	CATARACT 6, MULTIPLE TYPES; CTRCT6	 CTRCT6
116700	CATARACT 13 WITH ADULT i PHENOTYPE; CTRCT13	 CTRCT13
116790	CATECHOL-O-METHYLTRANSFERASE; COMT	 COMT
116800	CATARACT 5, MULTIPLE TYPES; CTRCT5	 CTRCT5
116920	LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD	 LAD
117000	CENTRAL CORE DISEASE OF MUSCLE; CCD	 CCD
117300	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2	
117360	SPINOCEREBELLAR ATAXIA 29; SCA29	 SCA29
117550	SOTOS SYNDROME 1; SOTOS1	 SOTOS1
117650	CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	 CCMS
118100	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	 KFS1
118200	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	 CMT1B
118210	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1	 CMT2A1
118220	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A	 CMT1A
118300	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS	
118400	CHERUBISM	
118450	ALAGILLE SYNDROME 1; ALGS1	 ALGS1
118600	CHONDROCALCINOSIS 2; CCAL2	 CCAL2
118700	CHOREA, BENIGN HEREDITARY; BHC	 BHC
118800	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1	 PNKD1
119300	VAN DER WOUDE SYNDROME 1; VWS1	 VWS1
119500	POPLITEAL PTERYGIUM SYNDROME; PPS	 PPS
119540	CLEFT PALATE, ISOLATED; CPI	 CPI
119580	BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	 BCDS1
119600	CLEIDOCRANIAL DYSPLASIA; CCD	 CCD
119800	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF	 CCF
119900	DIGITAL CLUBBING, ISOLATED CONGENITAL	
120100	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1	 FCAS1
120140	COLLAGEN, TYPE II, ALPHA-1; COL2A1	 COL2A1
120200	COLOBOMA, OCULAR, AUTOSOMAL DOMINANT	
120330	PAPILLORENAL SYNDROME; PAPRS	 PAPRS
120430	COLOBOMA OF OPTIC NERVE	
120433	COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	 COB1
120435	LYNCH SYNDROME I	
120790	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF	
120920	CD46 ANTIGEN; CD46	 CD46
120970	CONE-ROD DYSTROPHY 2; CORD2	 CORD2
121050	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9	 DA9
121200	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1	 BFNS1
121201	SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2	 BFNS2
121300	COPROPORPHYRIA, HEREDITARY; HCP	 HCP
121800	SCHNYDER CORNEAL DYSTROPHY; SCCD	 SCCD
121820	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD	 EBMD
121850	CORNEAL DYSTROPHY, FLECK	
121900	CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1	 CDGG1
122100	CORNEAL DYSTROPHY, MEESMANN; MECD	 MECD
122200	CORNEAL DYSTROPHY, LATTICE TYPE I; LCD1	 LCD1
122400	EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED	 ERED
122470	CORNELIA DE LANGE SYNDROME 1; CDLS1	 CDLS1
122600	SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5	 SCDO5
122700	COUMARIN RESISTANCE	
122860	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	 CDD
122880	CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	 CDHS
123000	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD	 CMDD
123100	CRANIOSYNOSTOSIS 1; CRS1	 CRS1
123150	JACKSON-WEISS SYNDROME; JWS	 JWS
123320	CREATINE PHOSPHOKINASE, ELEVATED SERUM	
123400	CREUTZFELDT-JAKOB DISEASE; CJD	 CJD
123500	CROUZON SYNDROME	
123700	CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	 ADCL1
123790	BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	 BSTVS
124000	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1	 MC3DN1
124200	DARIER-WHITE DISEASE; DAR	 DAR
124480	DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD	 DDOD
124500	VOHWINKEL SYNDROME; VOWNKL	 VOWNKL
124900	DEAFNESS, AUTOSOMAL DOMINANT 1; DFNA1	 DFNA1
125250	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	
125310	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1	 CADASIL1
125350	FAILURE OF TOOTH ERUPTION, PRIMARY; PFE	 PFE
125370	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA	 DRPLA
125420	DENTIN DYSPLASIA, TYPE II; DTDP2	 DTDP2
125490	DENTINOGENESIS IMPERFECTA 1; DGI1	 DGI1
125500	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III	
125595	DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	 DPR
125630	VIBRATORY URTICARIA; VBU	 VBU
125700	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	
125800	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	
125850	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1	 MODY1
125851	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2	 MODY2
125852	DIABETES MELLITUS, INSULIN-DEPENDENT, 2	
125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM	 NIDDM
126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS	 MS
126600	DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD	 DHRD
126700	BASAL LAMINAR DRUSEN	
127000	KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	 KCS2
127300	LERI-WEILL DYSCHONDROSTEOSIS; LWD	 LWD
127400	DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DSH	 DSH
127700	DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1	 DYX1
127750	DEMENTIA, LEWY BODY; DLB	 DLB
128100	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1	 DYT1
128101	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	 DYT4
128200	EPISODIC KINESIGENIC DYSKINESIA 1; EKD1	 EKD1
128230	DYSTONIA, DOPA-RESPONSIVE; DRD	 DRD
128235	DYSTONIA 12; DYT12	 DYT12
129200	BASAN SYNDROME	
129400	RAPP-HODGKIN SYNDROME; RHS	 RHS
129490	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT; ECTD10A	 ECTD10A
129500	CLOUSTON SYNDROME	
129600	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1	 ECTOL1
130000	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1; EDSCL1	 EDSCL1
130010	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	 EDSCL2
130050	EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	 EDSVASC
130060	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	 EDSARTH1
130070	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	 EDSSPD1
130080	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	 EDSPD1
130600	ELLIPTOCYTOSIS 2; EL2	 EL2
130650	BECKWITH-WIEDEMANN SYNDROME; BWS	 BWS
130720	LATERAL MENINGOCELE SYNDROME; LMNS	 LMNS
130900	AMELOGENESIS IMPERFECTA, TYPE IIIA; AI3A	 AI3A
131100	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1	 MEN1
131300	CAMURATI-ENGELMANN DISEASE; CAEND	 CAEND
131440	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	
131705	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN	 TBDN
131750	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB	 DDEB
131760	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	 EBSDM
131800	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	
131850	EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	
131900	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	
131950	EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE; EBSOG	 EBSOG
131960	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBSMP	 EBSMP
132000	EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS	
132400	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1	 EDM1
132450	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS; EDMMD	 EDMMD
132600	PILOMATRIXOMA	
132700	CYLINDROMATOSIS, FAMILIAL	
132800	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE	 MSSE
132810	EPOXIDE HYDROLASE 1, MICROSOMAL; EPHX1	 EPHX1
132900	AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4	 AAT4
133020	ERYTHERMALGIA, PRIMARY	
133100	ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1	 ECYT1
133190	SPINOCEREBELLAR ATAXIA 34; SCA34	 SCA34
133200	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1; EKVP1	 EKVP1
133239	ESOPHAGEAL CANCER	
133540	COCKAYNE SYNDROME B; CSB	 CSB
133700	EXOSTOSES, MULTIPLE, TYPE I	
133701	EXOSTOSES, MULTIPLE, TYPE II	
133780	EXUDATIVE VITREORETINOPATHY 1; EVR1	 EVR1
134500	FACTOR VIII DEFICIENCY	
134570	FACTOR XIII, A1 SUBUNIT; F13A1	 F13A1
134580	FACTOR XIII, B SUBUNIT; F13B	 F13B
134610	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	
134820	FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA	 FGA
135100	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	 FOP
135150	BIRT-HOGG-DUBE SYNDROME; BHD	 BHD
135290	DESMOID DISEASE, HEREDITARY	
135300	FIBROMATOSIS, GINGIVAL, 1; GINGF1	 GINGF1
135500	ZIMMERMANN-LABAND SYNDROME 1; ZLS1	 ZLS1
135700	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	 CFEOM1
135750	LAURIN-SANDROW SYNDROME; LSS	 LSS
135900	COFFIN-SIRIS SYNDROME 1; CSS1	 CSS1
136000	ADERMATOGLYPHIA; ADERM	 ADERM
136120	FISH-EYE DISEASE; FED	 FED
136520	FOVEAL HYPOPLASIA 1; FVH1	 FVH1
136680	FRASIER SYNDROME	
136760	FRONTONASAL DYSPLASIA 1; FND1	 FND1
136800	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1	 FECD1
136820	FUCOSIDASE, ALPHA-L, 2; FUCA2	 FUCA2
136880	FUNDUS ALBIPUNCTATUS	
136900	SORSBY FUNDUS DYSTROPHY; SFD	 SFD
137192	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3	 GABRB3
137200	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN	 NMAN
137215	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC	 HDGC
137245	LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TYPE	
137440	GERSTMANN-STRAUSSLER DISEASE; GSD	 GSD
137550	MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	 CMNS
137600	ANTERIOR SEGMENT DYSGENESIS 4; ASGD4	 ASGD4
137750	GLAUCOMA 1, OPEN ANGLE, A; GLC1A	 GLC1A
137760	GLAUCOMA, PRIMARY OPEN ANGLE; POAG	 POAG
137800	GLIOMA SUSCEPTIBILITY 1; GLM1	 GLM1
137920	RENAL CYSTS AND DIABETES SYNDROME; RCAD	 RCAD
137940	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	 HLTRS
138000	GLOMUVENOUS MALFORMATIONS; GVM	 GVM
138500	HYPERGLYCINURIA	
138800	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1	 MNG1
139090	GRAY PLATELET SYNDROME; GPS	 GPS
139210	MYHRE SYNDROME; MYHRS	 MYHRS
139300	AROMATASE EXCESS SYNDROME; AEXS	 AEXS
139320	GNAS COMPLEX LOCUS; GNAS	 GNAS
139393	GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS	 GBS
140000	HAND-FOOT-GENITAL SYNDROME; HFG	 HFG
140350	HAWKINSINURIA	
140600	OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2	 OS2
140700	HEINZ BODY ANEMIAS	
141200	HEMATURIA, BENIGN FAMILIAL; BFH	 BFH
141500	MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1	 FHM1
141800	HEMOGLOBIN--ALPHA LOCUS 1; HBA1	 HBA1
141900	HEMOGLOBIN--BETA LOCUS; HBB	 HBB
142330	HEPATIC ADENOMAS, FAMILIAL	
142335	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5	 HBFQTL5
142623	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	 HSCR1
142669	BEUKES HIP DYSPLASIA; BHD	 BHD
142680	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	
142690	ACNE INVERSA, FAMILIAL, 1; ACNINV1	 ACNINV1
142900	HOLT-ORAM SYNDROME; HOS	 HOS
142910	3-HYDROXY-3-METHYLGLUTARYL-CoA REDUCTASE; HMGCR	 HMGCR
142945	HOLOPROSENCEPHALY 3; HPE3	 HPE3
142946	HOLOPROSENCEPHALY 4; HPE4	 HPE4
142984	HOMEOBOX D10; HOXD10	 HOXD10
143095	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD	 SEDCJD
143100	HUNTINGTON DISEASE; HD	 HD
143200	WAGNER VITREORETINOPATHY; WGVRP	 WGVRP
143400	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2	 CAKUT2
143470	HYPERALPHALIPOPROTEINEMIA 1; HALP1	 HALP1
143500	GILBERT SYNDROME	
143860	HYPERCHLORHIDROSIS, ISOLATED; HYCHL	 HYCHL
143870	HYPERCALCIURIA, ABSORPTIVE, 2; HCA2	 HCA2
143880	HYPERCALCEMIA, INFANTILE, 1; HCINF1	 HCINF1
143890	HYPERCHOLESTEROLEMIA, FAMILIAL	
144010	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B	
144200	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK	 EPPK
144650	HYPERLIPOPROTEINEMIA, TYPE V	
144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC	 RCC
144750	ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	
144755	HYPEROSTOSIS CRANIALIS INTERNA; HCIN	 HCIN
145000	HYPERPARATHYROIDISM 1; HRPT1	 HRPT1
145001	HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2	 HRPT2
145250	HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE; FPHH	 FPHH
145410	OPITZ GBBB SYNDROME, TYPE II; GBBB2	 GBBB2
145500	HYPERTENSION, ESSENTIAL	
145600	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1	 MHS1
145650	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH	 PRTH
145680	HYPERTHYROXINEMIA, DYSTRANSTHYRETINEMIC; DTTRH	 DTTRH
145750	HYPERTRIGLYCERIDEMIA, FAMILIAL	
145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	
145980	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1	 HHC1
145981	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2	 HHC2
146000	HYPOCHONDROPLASIA; HCH	 HCH
146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7	 HH7
146200	HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	 FIH
146255	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR	 HDR
146300	HYPOPHOSPHATASIA, ADULT	
146500	MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	 MSA1
146510	PALLISTER-HALL SYNDROME; PHS	 PHS
146520	HYPOTRICHOSIS 2; HYPT2	 HYPT2
146550	HYPOTRICHOSIS 4; HYPT4	 HYPT4
146590	ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM	 IHCM
146700	ICHTHYOSIS VULGARIS	
146800	ICHTHYOSIS BULLOSA OF SIEMENS; IBS	 IBS
147050	IgE RESPONSIVENESS, ATOPIC; IGER	 IGER
147060	HYPER-IgE RECURRENT INFECTION SYNDROME 1, AUTOSOMAL DOMINANT; HIES1	 HIES1
147250	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	 SMMCI
147470	INSULIN-LIKE GROWTH FACTOR II; IGF2	 IGF2
147480	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	 ICP1
147750	IVIC SYNDROME	
147891	ISCHIOCOXOPODOPATELLAR SYNDROME; ICPPS	 ICPPS
147920	KABUKI SYNDROME 1; KABUK1	 KABUK1
147950	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2	 HH2
148000	KAPOSI SARCOMA, SUSCEPTIBILITY TO	
148190	KERATITIS, HEREDITARY	
148200	KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	 KEFH
148210	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT	
148300	KERATOCONUS 1; KTCN1	 KTCN1
148350	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	
148370	KERATOLYTIC WINTER ERYTHEMA; KWE	 KWE
148500	TYLOSIS WITH ESOPHAGEAL CANCER; TOC	 TOC
148600	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A	 PPKP1A
148700	PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1	 PPKS1
148820	WAARDENBURG SYNDROME, TYPE 3; WS3	 WS3
149000	KLIPPEL-TRENAUNAY-WEBER SYNDROME	
149100	KNUCKLE PADS	
149200	KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	
149400	HYPEREKPLEXIA 1; HKPX1	 HKPX1
149700	LACRIMAL DUCT DEFECT; LCDD	 LCDD
149730	LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	 LADD
150230	TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2	 TRPS2
150250	LARSEN SYNDROME; LRS	 LRS
150400	TOOTH AGENESIS, SELECTIVE, 4; STHAG4	 STHAG4
150600	LEGG-CALVE-PERTHES DISEASE; LCPD	 LCPD
150699	LEIOMYOMA, UTERINE; UL	 UL
150800	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC	 HLRCC
151050	LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM; LMHD	 LMHD
151100	LEOPARD SYNDROME 1; LPRD1	 LPRD1
151210	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT	 PLSDT
151400	LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL	 CLL
151430	B-CELL CLL/LYMPHOMA 2; BCL2	 BCL2
151600	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3	 NDNC3
151623	LI-FRAUMENI SYNDROME; LFS	 LFS
151660	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2	 FPLD2
152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	 SLE
152790	LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; LHCGR	 LHCGR
152950	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	 MCLMR
153100	LYMPHATIC MALFORMATION 1; LMPHM1	 LMPHM1
153400	LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	 LPHDST
153670	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	 BSSA2
153700	MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	 VMD2
153800	MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2	 ARMD2
154020	HYPOMAGNESEMIA 2, RENAL; HOMG2	 HOMG2
154230	46,XY SEX REVERSAL 4; SRXY4	 SRXY4
154500	TREACHER COLLINS SYNDROME 1; TCS1	 TCS1
154700	MARFAN SYNDROME; MFS	 MFS
154780	MARSHALL SYNDROME; MRSHS	 MRSHS
154800	MASTOCYTOSIS, CUTANEOUS; MASTC	 MASTC
155100	MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	 MATINS
155240	THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC	 MTC
155255	MEDULLOBLASTOMA; MDB	 MDB
155310	VISCERAL MYOPATHY; VSCM	 VSCM
155601	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2	 CMM2
155755	MELANOMA-ASTROCYTOMA SYNDROME	
156200	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1	 MRD1
156240	MESOTHELIOMA, MALIGNANT; MESOM	 MESOM
156250	METACHONDROMATOSIS; METCDS	 METCDS
156400	METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE; MCDJ	 MCDJ
156500	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS	 MCDS
156510	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB	 MDMHB
156530	METATROPIC DYSPLASIA	
156550	KNIEST DYSPLASIA	
156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	 CSCSC1
157140	MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT	 MAPT
157170	HOLOPROSENCEPHALY 2; HPE2	 HPE2
157600	MIRROR MOVEMENTS 1; MRMV1	 MRMV1
157640	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	 PEOA1
157800	CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	 CSCF
158000	MONILETHRIX; MNLIX	 MNLIX
158300	ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7	 DA7
158320	MUIR-TORRE SYNDROME; MRTES	 MRTES
158330	MULLERIAN APLASIA AND HYPERANDROGENISM	
158350	COWDEN SYNDROME 1; CWS1	 CWS1
158580	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A	 HMN7A
158590	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	 HMN2A
158600	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	 SMALED1
158810	BETHLEM MYOPATHY 1; BTHLM1	 BTHLM1
158900	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1	 FSHD1
158901	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2	 FSHD2
159550	ATAXIA-PANCYTOPENIA SYNDROME; ATXPC	 ATXPC
159555	LYSINE-SPECIFIC METHYLTRANSFERASE 2A; KMT2A	 KMT2A
159900	DYSTONIA 11, MYOCLONIC; DYT11	 DYT11
159950	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME	 SMAPME
160120	EPISODIC ATAXIA, TYPE 1; EA1	 EA1
160150	MYOPATHY, CENTRONUCLEAR, 1; CNM1	 CNM1
160500	MYOPATHY, DISTAL, 1; MPD1	 MPD1
160565	MYOPATHY, TUBULAR AGGREGATE, 1; TAM1	 TAM1
160800	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	
160900	MYOTONIC DYSTROPHY 1; DM1	 DM1
160980	CARNEY COMPLEX, TYPE 1; CNC1	 CNC1
161000	NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME; NFJS	 NFJS
161200	NAIL-PATELLA SYNDROME; NPS	 NPS
161400	NARCOLEPSY 1; NRCLP1	 NRCLP1
161800	NEMALINE MYOPATHY 3; NEM3	 NEM3
162000	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	 HNFJ1
162091	SCHWANNOMATOSIS 1; SWNTS1	 SWNTS1
162100	AMYOTROPHY, HEREDITARY NEURALGIC; HNA	 HNA
162200	NEUROFIBROMATOSIS, TYPE I; NF1	 NF1
162210	NEUROFIBROMATOSIS, FAMILIAL SPINAL	
162300	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	 MEN2B
162350	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	 CLN4B
162400	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	 HSAN1A
162500	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	 HNPP
162800	CYCLIC NEUTROPENIA	
162830	NEUTROPHILIA, HEREDITARY	
162900	NEVUS, EPIDERMAL	
163000	CAPILLARY MALFORMATIONS, CONGENITAL; CMC	 CMC
163200	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	 SFM
163500	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2	 CSNBAD2
163729	NITRIC OXIDE SYNTHASE 3; NOS3	 NOS3
163800	SICK SINUS SYNDROME 2; SSS2	 SSS2
163950	NOONAN SYNDROME 1; NS1	 NS1
164200	OCULODENTODIGITAL DYSPLASIA; ODDD	 ODDD
164280	FEINGOLD SYNDROME 1; FGLDS1	 FGLDS1
164400	SPINOCEREBELLAR ATAXIA 1; SCA1	 SCA1
164500	SPINOCEREBELLAR ATAXIA 7; SCA7	 SCA7
165300	OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3	 OPA3
165500	OPTIC ATROPHY 1; OPA1	 OPA1
165550	OPTIC NERVE HYPOPLASIA, BILATERAL	
165720	OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1	 OS1
165800	SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	 SSOAOD
166000	ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE	
166200	OSTEOGENESIS IMPERFECTA, TYPE I; OI1	 OI1
166210	OSTEOGENESIS IMPERFECTA, TYPE II; OI2	 OI2
166220	OSTEOGENESIS IMPERFECTA, TYPE IV; OI4	 OI4
166250	OSTEOGLOPHONIC DYSPLASIA; OGD	 OGD
166260	GNATHODIAPHYSEAL DYSPLASIA; GDD	 GDD
166300	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	 MCTO
166350	OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	 POH
166600	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2	 OPTA2
166700	BUSCHKE-OLLENDORFF SYNDROME; BOS	 BOS
166710	OSTEOPOROSIS	
166760	OTITIS MEDIA, SUSCEPTIBILITY TO; OMS	 OMS
166780	OTOFACIOCERVICAL SYNDROME 1; OTFCS	 OTFCS
166900	OVALOCYTOSIS, SOUTHEAST ASIAN; SAO	 SAO
167000	OVARIAN CANCER	
167030	NEPHROLITHIASIS, CALCIUM OXALATE; CAON	 CAON
167200	PACHYONYCHIA CONGENITA 1; PC1	 PC1
167210	PACHYONYCHIA CONGENITA 2; PC2	 PC2
167250	PAGET DISEASE OF BONE 3; PDB3	 PDB3
167320	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1	 IBMPFD1
167400	PAROXYSMAL EXTREME PAIN DISORDER	
167800	PANCREATITIS, HEREDITARY; PCTT	 PCTT
168000	PARAGANGLIOMAS 1; PGL1	 PGL1
168300	PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC	 PMC
168400	PARASTREMMATIC DWARFISM	
168500	PARIETAL FORAMINA 1; PFM1	 PFM1
168550	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD	 PFMCCD
168600	PARKINSON DISEASE, LATE-ONSET; PD	 PD
168601	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	 PARK1
168605	PERRY SYNDROME	
168820	PARAOXONASE 1; PON1	 PON1
169100	CHAR SYNDROME; CHAR	 CHAR
169150	MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	 MDPT1
169400	PELGER-HUET ANOMALY; PHA	 PHA
169500	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	 ADLD
169600	BENIGN CHRONIC PEMPHIGUS; BCPM	 BCPM
170100	PROLIDASE DEFICIENCY	
170390	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	
170400	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1	 HOKPP1
170500	HYPERKALEMIC PERIODIC PARALYSIS; HYPP	 HYPP
170650	PERIODONTITIS, AGGRESSIVE, 1	
171300	PHEOCHROMOCYTOMA	
171400	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	 MEN2A
172460	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1; MTHFD1	 MTHFD1
172700	PICK DISEASE OF BRAIN	
172800	PIEBALD TRAIT; PBT	 PBT
172870	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA	 PPCRA
173100	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2	 IGHD2
173200	PITYRIASIS RUBRA PILARIS; PRP	 PRP
173470	INTEGRIN, BETA-3; ITGB3	 ITGB3
173600	PNEUMOTHORAX, PRIMARY SPONTANEOUS	
173610	SELECTIN P; SELP	 SELP
173650	KINDLER SYNDROME; KNDLRS	 KNDLRS
173900	POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD1	 PKD1
174000	MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	 MCKD1
174050	POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	 PCLD1
174200	POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	 PAPA1
174300	OROFACIODIGITAL SYNDROME V; OFD5	 OFD5
174500	POLYDACTYLY, PREAXIAL II; PPD2	 PPD2
174700	POLYDACTYLY, PREAXIAL IV	
174800	MCCUNE-ALBRIGHT SYNDROME; MAS	 MAS
174810	FAMILIAL EXPANSILE OSTEOLYSIS; FEO	 FEO
174900	JUVENILE POLYPOSIS SYNDROME; JPS	 JPS
175050	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	 JPHT
175100	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	 FAP1
175200	PEUTZ-JEGHERS SYNDROME; PJS	 PJS
175700	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS	 GCPS
175780	PORENCEPHALY 1; POREN1	 POREN1
175800	POROKERATOSIS 1, MULTIPLE TYPES; POROK1	 POROK1
175900	POROKERATOSIS 3, MULTIPLE TYPES; POROK3	 POROK3
176000	PORPHYRIA, ACUTE INTERMITTENT; AIP	 AIP
176100	PORPHYRIA CUTANEA TARDA	
176200	PORPHYRIA VARIEGATA	
176305	PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	
176400	PRECOCIOUS PUBERTY, CENTRAL, 1; CPPB1	 CPPB1
176410	PRECOCIOUS PUBERTY, MALE-LIMITED	
176430	PREMATURE CHROMATID SEPARATION TRAIT; PCS	 PCS
176450	CURRARINO SYNDROME	
176500	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1	
176670	HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS	 HGPS
176807	PROSTATE CANCER	
176860	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3	 THPH3
176920	PROTEUS SYNDROME	
177000	PROTOPORPHYRIA, ERYTHROPOIETIC, 1; EPP1	 EPP1
177170	PSEUDOACHONDROPLASIA; PSACH	 PSACH
177200	LIDDLE SYNDROME 1; LIDLS1	 LIDLS1
177650	EXFOLIATION SYNDROME; XFS	 XFS
177700	GLAUCOMA 1, OPEN ANGLE, P; GLC1P	 GLC1P
177735	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A	 PHA1A
177820	PSEUDO-VON WILLEBRAND DISEASE; VWDP	 VWDP
177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1	 PSORS1
178110	ARTHROGRYPOSIS, DISTAL, TYPE 8; DA8	 DA8
178500	PULMONARY FIBROSIS, IDIOPATHIC; IPF	 IPF
178600	PULMONARY HYPERTENSION, PRIMARY, 1; PPH1	 PPH1
179620	RAPH BLOOD GROUP SYSTEM	
179800	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	
179850	DOWLING-DEGOS DISEASE 1; DDD1	 DDD1
180000	RETINAL ARTERIES, TORTUOSITY OF; RATOR	 RATOR
180100	RETINITIS PIGMENTOSA 1; RP1	 RP1
180104	RETINITIS PIGMENTOSA 9; RP9	 RP9
180200	RETINOBLASTOMA; RB1	 RB1
180295	RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2	 RMSE2
180300	RHEUMATOID ARTHRITIS; RA	 RA
180500	AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	 RIEG1
180550	RING DERMOID OF CORNEA; RDC	 RDC
180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1	 DRS1
180750	ROBINOW-SORAUF SYNDROME	
180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	
180849	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	 RSTS1
180860	SILVER-RUSSELL SYNDROME; SRS	 SRS
180920	APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG	 ALSG
181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	 SS1
181030	SALIVARY GLAND ADENOMA, PLEOMORPHIC	
181270	SCALP-EAR-NIPPLE SYNDROME; SENS	 SENS
181350	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2	 EDMD2
181400	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK	 SCPNK
181405	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	 SPSMA
181430	SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM	 SPMM
181500	SCHIZOPHRENIA; SCZD	 SCZD
182000	KERATOSIS, SEBORRHEIC	
182100	FUCOSYLTRANSFERASE 2; FUT2	 FUT2
182170	ANEMIA, SIDEROBLASTIC, 4; SIDBA4	 SIDBA4
182212	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	 SGS
182230	SEPTOOPTIC DYSPLASIA	
182250	SINGLETON-MERTEN SYNDROME 1; SGMRT1	 SGMRT1
182290	SMITH-MAGENIS SYNDROME; SMS	 SMS
182410	SNEDDON SYNDROME	
182600	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A	 SPG3A
182601	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4	 SPG4
182900	SPHEROCYTOSIS, TYPE 1; SPH1	 SPH1
182920	MYOPATHY, SPHEROID BODY	
182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	 NTD
182980	SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE; SMAFK	 SMAFK
183086	SPINOCEREBELLAR ATAXIA 6; SCA6	 SCA6
183090	SPINOCEREBELLAR ATAXIA 2; SCA2	 SCA2
183900	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC	 SEDC
184095	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	
184250	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK	 SEMDSTWK
184252	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK	 SMDK
184255	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	 SMDCF
184450	STUTTERING, FAMILIAL PERSISTENT, 1; STUT1	 STUT1
184460	STAPES ANKYLOSIS WITH BROAD THUMBS AND TOES	
184500	STEATOCYSTOMA MULTIPLEX	
184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA	 OSMEDA
184900	STIFF SKIN SYNDROME; SSKS	 SSKS
185000	OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHST	 OHST
185020	CRYOHYDROCYTOSIS; CHC	 CHC
185070	STORMORKEN SYNDROME; STRMK	 STRMK
185300	STURGE-WEBER SYNDROME; SWS	 SWS
185500	SUPRAVALVULAR AORTIC STENOSIS; SVAS	 SVAS
185800	SYMPHALANGISM, PROXIMAL, 1A; SYM1A	 SYM1A
186000	SYNPOLYDACTYLY 1; SPD1	 SPD1
186100	SYNDACTYLY, TYPE III	
186200	SYNDACTYLY, TYPE IV; SDTY4	 SDTY4
186300	SYNDACTYLY, TYPE V; SDTY5	 SDTY5
186500	MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1	 SYNS1
186550	LIEBENBERG SYNDROME; LBNBG	 LBNBG
186570	TARSAL-CARPAL COALITION SYNDROME; TCC	 TCC
186580	BLAU SYNDROME; BLAUS	 BLAUS
187270	TELOMERASE REVERSE TRANSCRIPTASE; TERT	 TERT
187300	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1; HHT1	 HHT1
187500	TETRALOGY OF FALLOT; TOF	 TOF
187600	THANATOPHORIC DYSPLASIA, TYPE I; TD1	 TD1
187601	THANATOPHORIC DYSPLASIA, TYPE II; TD2	 TD2
187800	BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	 BDPLT16
187900	BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	 BDPLT17
187950	THROMBOCYTHEMIA 1; THCYT1	 THCYT1
188000	THROMBOCYTOPENIA 2; THC2	 THC2
188050	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1	 THPH1
188055	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2	 THPH2
188400	DIGEORGE SYNDROME; DGS	 DGS
188470	THYROID CANCER, NONMEDULLARY, 2; NMTC2	 NMTC2
188550	THYROID CANCER, NONMEDULLARY, 1; NMTC1	 NMTC1
188570	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH	 GRTH
188580	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	 TTPP1
188740	TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY; THYP	 THYP
189500	WITKOP SYNDROME	
190300	TREMOR, HEREDITARY ESSENTIAL, 1; ETM1	 ETM1
190330	TRICHOMEGALY; TCMGLY	 TCMGLY
190350	TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1	 TRPS1
190351	TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	 TRPS3
190440	TRIGONOCEPHALY 1; TRIGNO1	 TRIGNO1
190900	TRITANOPIA	
191100	TUBEROUS SCLEROSIS 1; TSC1	 TSC1
191170	TUMOR PROTEIN p53; TP53	 TP53
191480	UNCOMBABLE HAIR SYNDROME 1; UHS1	 UHS1
191830	RENAL HYPODYSPLASIA/APLASIA 1; RHDA1	 RHDA1
191900	MUCKLE-WELLS SYNDROME; MWS	 MWS
192315	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	 RVCL
192350	VATER/VACTERL ASSOCIATION	
192430	VELOCARDIOFACIAL SYNDROME	
192500	LONG QT SYNDROME 1; LQT1	 LQT1
192600	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1	 CMH1
192950	VERTICAL TALUS, CONGENITAL; CVT	 CVT
193100	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR	 ADHR
193200	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6; VAMAS6	 VAMAS6
193220	VITREORETINOCHOROIDOPATHY; VRCP	 VRCP
193230	VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	 SVD
193235	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI	 VRNI
193300	VON HIPPEL-LINDAU SYNDROME; VHL	 VHL
193400	VON WILLEBRAND DISEASE, TYPE 1; VWD1	 VWD1
193500	WAARDENBURG SYNDROME, TYPE 1; WS1	 WS1
193510	WAARDENBURG SYNDROME, TYPE 2A; WS2A	 WS2A
193520	WATSON SYNDROME; WTSN	 WTSN
193530	WEYERS ACROFACIAL DYSOSTOSIS; WAD	 WAD
193700	ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A	 DA2A
194050	WILLIAMS-BEUREN SYNDROME; WBS	 WBS
194070	WILMS TUMOR 1; WT1	 WT1
194080	DENYS-DRASH SYNDROME; DDS	 DDS
194200	WOLFF-PARKINSON-WHITE SYNDROME	
194300	WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH	 ADWH
194380	DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	 DHS1
200100	ABETALIPOPROTEINEMIA; ABL	 ABL
200110	ABLEPHARON-MACROSTOMIA SYNDROME; AMS	 AMS
200150	CHOREOACANTHOCYTOSIS; CHAC	 CHAC
200500	ACHEIROPODY; ACHP	 ACHP
200600	ACHONDROGENESIS, TYPE IA; ACG1A	 ACG1A
200610	ACHONDROGENESIS, TYPE II; ACG2	 ACG2
200700	CHONDRODYSPLASIA, GREBE TYPE	
200990	ACROCALLOSAL SYNDROME; ACLS	 ACLS
201000	CARPENTER SYNDROME 1; CRPT1	 CRPT1
201100	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ	 AEZ
201250	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE; AMDH	 AMDH
201300	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A	 HSAN2A
201400	ACTH DEFICIENCY, ISOLATED; IAD	 IAD
201450	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD	 ACADMD
201470	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD	 ACADSD
201475	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD	 ACADVLD
201710	LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH	 LCAH
201750	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	 ABS1
201810	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY	
201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	
202010	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	
202110	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	
202200	GLUCOCORTICOID DEFICIENCY 1; GCCD1	 GCCD1
202300	ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC	 ADCC
202370	PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	 PBD2B
202400	AFIBRINOGENEMIA, CONGENITAL	
202650	AGNATHIA-OTOCEPHALY COMPLEX; AGOTC	 AGOTC
202700	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1	 SCN1
203100	ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	 OCA1A
203200	ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	 OCA2
203290	ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3	 OCA3
203300	HERMANSKY-PUDLAK SYNDROME 1; HPS1	 HPS1
203400	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	
203450	ALEXANDER DISEASE; ALXDRD	 ALXDRD
203500	ALKAPTONURIA; AKU	 AKU
203650	ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1	 APMR1
203655	ALOPECIA UNIVERSALIS CONGENITA; ALUNC	 ALUNC
203700	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A	 MTDPS4A
203750	ALPHA-METHYLACETOACETIC ACIDURIA	
203780	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE; ATS2	 ATS2
203800	ALSTROM SYNDROME; ALMS	 ALMS
204000	LEBER CONGENITAL AMAUROSIS 1; LCA1	 LCA1
204100	LEBER CONGENITAL AMAUROSIS 2; LCA2	 LCA2
204200	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	 CLN3
204300	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A	 CLN4A
204500	CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2	 CLN2
204650	AMELOGENESIS IMPERFECTA, TYPE IC; AI1C	 AI1C
204690	AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	 AI1G
204700	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1	 AI2A1
204750	2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	 AMOXAD
204870	CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD	 GDLD
205100	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	 ALS2
205400	TANGIER DISEASE; TGD	 TGD
205950	ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY; SIDBA2	 SIDBA2
206100	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	 AHMIO1
206200	IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA	 IRIDA
206500	ANENCEPHALY; ANPH	 ANPH
206700	GILLESPIE SYNDROME; GLSP	 GLSP
206800	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4	 NDNC4
206900	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3	 MCOPS3
206920	MICROPHTHALMIA WITH LIMB ANOMALIES; MLA	 MLA
207410	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	 ABS2
207750	APOLIPOPROTEIN C-II DEFICIENCY	
207800	ARGININEMIA	
207900	ARGININOSUCCINIC ACIDURIA	
208000	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	 GACI1
208050	ARTERIAL TORTUOSITY SYNDROME; ATORS	 ATORS
208085	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1	 ARCS1
208150	FETAL AKINESIA DEFORMATION SEQUENCE; FADS	 FADS
208230	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC	 PPAC
208250	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP	 CACP
208400	ASPARTYLGLUCOSAMINURIA; AGU	 AGU
208530	RIGHT ATRIAL ISOMERISM; RAI	 RAI
208540	RENAL-HEPATIC-PANCREATIC DYSPLASIA 1; RHPD1	 RHPD1
208550	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	
208900	ATAXIA-TELANGIECTASIA; AT	 AT
208920	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	 EAOH
209300	ATRANSFERRINEMIA	
209500	ATRICHIA WITH PAPULAR LESIONS; APL	 APL
209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	 CCHS
209885	BARBER-SAY SYNDROME; BBRSAY	 BBRSAY
209900	BARDET-BIEDL SYNDROME 1; BBS1	 BBS1
209920	BARE LYMPHOCYTE SYNDROME, TYPE II	
209950	IMMUNODEFICIENCY 27A; IMD27A	 IMD27A
210000	BEHR SYNDROME; BEHRS	 BEHRS
210200	3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	 MCC1D
210210	3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	 MCC2D
210250	SITOSTEROLEMIA	
210370	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	 BCD
210600	SECKEL SYNDROME 1; SCKL1	 SCKL1
210720	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	 MOPD2
210750	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6	 SHEP6
210900	BLOOM SYNDROME; BLM	 BLM
211180	BOWEN-CONRADI SYNDROME; BWCNS	 BWCNS
211380	ELSAHY-WATERS SYNDROME; ESWS	 ESWS
211400	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1	 BESC1
211500	FAZIO-LONDE DISEASE	
211530	BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	 BVVLS1
211600	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1	 PFIC1
211750	C SYNDROME	
211800	CALCIFICATION OF JOINTS AND ARTERIES; CALJA	 CALJA
211980	LUNG CANCER	
212050	CANDIDIASIS, FAMILIAL, 2; CANDF2	 CANDF2
212065	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	 CDG1A
212066	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	 CDG2A
212070	CARBOXYPEPTIDASE N DEFICIENCY	
212093	CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	 CVDD
212112	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	
212138	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD	 CACTD
212140	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP	 CDSP
212350	SENGERS SYNDROME	
212500	CATARACT 46, JUVENILE-ONSET; CTRCT46	 CTRCT46
212550	OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	 ODRMD
212720	MARTSOLF SYNDROME	
212780	CENANI-LENZ SYNDACTYLY SYNDROME; CLSS	 CLSS
212840	GORDON HOLMES SYNDROME; GDHS	 GDHS
213200	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	 SCAR2
213300	JOUBERT SYNDROME 1; JBTS1	 JBTS1
213600	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	 IBGC1
213700	CEREBROTENDINOUS XANTHOMATOSIS; CTX	 CTX
214100	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A	 PBD1A
214110	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	 PBD2A
214150	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1	 COFS1
214300	KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2	 KFS2
214400	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	 CMT4A
214450	GRISCELLI SYNDROME, TYPE 1; GS1	 GS1
214500	CHEDIAK-HIGASHI SYNDROME; CHS	 CHS
214700	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1	 DIAR1
214800	CHARGE SYNDROME	
214950	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4	 CBAS4
215045	CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	 BOCD
215100	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1	 RCDP1
215140	GREENBERG DYSPLASIA; GRBGD	 GRBGD
215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB	 OSMEDB
215300	CHONDROSARCOMA	
215400	CHORDOMA, SUSCEPTIBILITY TO; CHDM	 CHDM
215470	BOUCHER-NEUHAUSER SYNDROME; BNHS	 BNHS
215500	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1	 CACD1
215600	CIRRHOSIS, FAMILIAL	
215700	CITRULLINEMIA, CLASSIC	
216340	YUNIS-VARON SYNDROME; YVS	 YVS
216360	COACH SYNDROME	
216400	COCKAYNE SYNDROME A; CSA	 CSA
216550	COHEN SYNDROME; COH1	 COH1
216820	COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	
216900	ACHROMATOPSIA 2; ACHM2	 ACHM2
216950	COMPLEMENT COMPONENT C1r/C1s DEFICIENCY	
217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D	 C2D
217080	JALILI SYNDROME	
217085	CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY; CHDTHP	 CHDTHP
217090	PLASMINOGEN DEFICIENCY, TYPE I	
217095	CONOTRUNCAL HEART MALFORMATIONS; CTHM	 CTHM
217300	CORNEA PLANA 2, AUTOSOMAL RECESSIVE; CNA2	 CNA2
217400	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS; CDPD	 CDPD
217700	CORNEAL ENDOTHELIAL DYSTROPHY; CHED	 CHED
217800	MACULAR DYSTROPHY, CORNEAL; MCD	 MCD
218000	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN	 ACCPN
218030	APPARENT MINERALOCORTICOID EXCESS; AME	 AME
218040	COSTELLO SYNDROME; CSTLO	 CSTLO
218330	CRANIOECTODERMAL DYSPLASIA 1; CED1	 CED1
218340	TEMTAMY SYNDROME; TEMTYS	 TEMTYS
218400	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	 CMDR
218600	BALLER-GEROLD SYNDROME; BGS	 BGS
218700	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2	 CHNG2
218800	CRIGLER-NAJJAR SYNDROME, TYPE I	
219000	FRASER SYNDROME 1; FRASRS1	 FRASRS1
219050	CRYPTORCHIDISM, UNILATERAL OR BILATERAL	
219080	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	 AIMAH1
219090	PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	 PITA4
219100	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A	 ARCL1A
219150	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A	 ARCL3A
219200	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	 ARCL2A
219500	CYSTATHIONINURIA	
219700	CYSTIC FIBROSIS; CF	 CF
219730	VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	 VMCKD
219750	CYSTINOSIS, ADULT NONNEPHROPATHIC	
219800	CYSTINOSIS, NEPHROPATHIC; CTNS	 CTNS
219900	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE	
220100	CYSTINURIA	
220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY	
220111	LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	 LSFC
220120	D-GLYCERIC ACIDURIA	
220150	HYPOURICEMIA, RENAL, 1; RHUC1	 RHUC1
220210	RITSCHER-SCHINZEL SYNDROME 1; RTSC1	 RTSC1
220290	DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A	 DFNB1A
220400	JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1	 JLNS1
220500	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	 DOORS
220600	SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE; SHFM1D	 SHFM1D
221200	DEAFNESS AND MYOPIA; DFNMYP	 DFNMYP
221750	PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3	 CPHD3
221770	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1; PLOSL1	 PLOSL1
221820	LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS; HDLS	 HDLS
221900	PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR	 PHPVAR
222100	DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	 IDDM
222300	WOLFRAM SYNDROME 1; WFS1	 WFS1
222448	DONNAI-BARROW SYNDROME	
222470	TRICHOHEPATOENTERIC SYNDROME 1; THES1	 THES1
222600	DIASTROPHIC DYSPLASIA; DTD	 DTD
222700	LYSINURIC PROTEIN INTOLERANCE; LPI	 LPI
222730	DICARBOXYLIC AMINOACIDURIA; DCBXA	 DCBXA
222748	DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD	 DPYSD
222765	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2	 RCDP2
222800	ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	 ECYT8
222900	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID	 CSID
223000	LACTASE DEFICIENCY, CONGENITAL	
223360	ORTHOSTATIC HYPOTENSION 1; ORTHYP1	 ORTHYP1
223800	DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC	 DMC
223900	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3	 HSAN3
224050	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	 CAMRQ1
224100	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II; CDAN2	 CDAN2
224120	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A	 CDAN1A
224230	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	 DKCB1
224410	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	 DDSH
224500	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	 DYT2
224690	MEIER-GORLIN SYNDROME 1; MGORS1	 MGORS1
224750	SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	 SSPS
224900	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	 ECTD10B
225100	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2	 ECTOL2
225200	ECTOPIA LENTIS ET PUPILLAE	
225250	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	 CHNG5
225280	ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME; EEMS	 EEMS
225300	SPLIT-HAND/FOOT MALFORMATION 6; SHFM6	 SHFM6
225320	EHLERS-DANLOS SYNDROME, CARDIAC VALVULAR TYPE; EDSCV	 EDSCV
225400	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1; EDSKSCL1	 EDSKSCL1
225410	EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS	 EDSDERMS
225500	ELLIS-VAN CREVELD SYNDROME; EVC	 EVC
225750	AICARDI-GOUTIERES SYNDROME 1; AGS1	 AGS1
225753	PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	 PCH4
225790	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	 PVHH
226200	ENTEROKINASE DEFICIENCY	
226300	COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	 CHAPLE
226400	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	 EV1
226600	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB	 RDEB
226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	
226670	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY; EBSMD	 EBSMD
226700	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	
226730	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA	
226750	KOHLSCHUTTER-TONZ SYNDROME; KTZS	 KTZS
226900	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4	 EDM4
226980	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	
226990	IMMUNODEFICIENCY 32B; IMD32B	 IMD32B
227220	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1	 SHEP1
227240	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5	 SHEP5
227260	FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE; FFDD3	 FFDD3
227300	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1	 F5F8D1
227400	FACTOR V DEFICIENCY	
227500	FACTOR VII DEFICIENCY	
227600	FACTOR X DEFICIENCY	
227645	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC	 FANCC
227646	FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2	 FANCD2
227650	FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA	 FANCA
227810	FANCONI-BICKEL SYNDROME; FBS	 FBS
228000	FARBER LIPOGRANULOMATOSIS; FRBRL	 FRBRL
228300	HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	 HH23
228520	FIBROCHONDROGENESIS 1; FBCG1	 FBCG1
228550	MYOFIBROMATOSIS, INFANTILE, 1; IMF1	 IMF1
228600	HYALINE FIBROMATOSIS SYNDROME; HFS	 HFS
228900	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY	
228930	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	
228960	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY	
228980	FLECK RETINA, FAMILIAL BENIGN; FRFB	 FRFB
229050	FOLATE MALABSORPTION, HEREDITARY	
229070	HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	 HH24
229100	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	
229200	BRITTLE CORNEA SYNDROME 1; BCS1	 BCS1
229300	FRIEDREICH ATAXIA 1; FRDA	 FRDA
229600	FRUCTOSE INTOLERANCE, HEREDITARY	
229700	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D	 FBP1D
229800	FRUCTOSURIA, ESSENTIAL	
230000	FUCOSIDOSIS	
230200	GALACTOKINASE DEFICIENCY	
230350	GALACTOSE EPIMERASE DEFICIENCY	
230400	GALACTOSEMIA	
230450	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	
230500	GM1-GANGLIOSIDOSIS, TYPE I	
230600	GM1-GANGLIOSIDOSIS, TYPE II	
230650	GM1-GANGLIOSIDOSIS, TYPE III	
230740	GAPO SYNDROME; GAPOS	 GAPOS
230800	GAUCHER DISEASE, TYPE I	
230900	GAUCHER DISEASE, TYPE II	
231000	GAUCHER DISEASE, TYPE III	
231005	GAUCHER DISEASE, TYPE IIIC	
231050	GELEOPHYSIC DYSPLASIA 1; GPHYSD1	 GPHYSD1
231070	GERODERMA OSTEODYSPLASTICUM; GO	 GO
231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	 HYDM1
231095	GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD	 GHDD
231200	BERNARD-SOULIER SYNDROME; BSS	 BSS
231300	GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A	 GLC3A
231530	3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	
231550	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS	 AAAS
231670	GLUTARIC ACIDEMIA I; GA1	 GA1
231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	 MADD
231690	GLUTARIC ACIDURIA III; GA3	 GA3
231900	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO; GSSDE	 GSSDE
231950	GLUTATHIONURIA	
232200	GLYCOGEN STORAGE DISEASE Ia; GSD1A	 GSD1A
232220	GLYCOGEN STORAGE DISEASE Ib; GSD1B	 GSD1B
232240	GLYCOGEN STORAGE DISEASE Ic; GSD1C	 GSD1C
232300	GLYCOGEN STORAGE DISEASE II; GSD2	 GSD2
232400	GLYCOGEN STORAGE DISEASE III; GSD3	 GSD3
232500	GLYCOGEN STORAGE DISEASE IV; GSD4	 GSD4
232600	GLYCOGEN STORAGE DISEASE V; GSD5	 GSD5
232700	GLYCOGEN STORAGE DISEASE VI; GSD6	 GSD6
232800	GLYCOGEN STORAGE DISEASE VII; GSD7	 GSD7
233100	RENAL GLUCOSURIA; GLYS	 GLYS
233300	OVARIAN DYSGENESIS 1; ODG1	 ODG1
233400	PERRAULT SYNDROME 1; PRLTS1	 PRLTS1
233420	46,XY SEX REVERSAL 7; SRXY7	 SRXY7
233650	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG	 CCHIDG
233690	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	
233700	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	 CDG1
233710	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	 CDG2
233910	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	 HPABH4B
234000	FACTOR XII DEFICIENCY	
234050	TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	 TTD4
234100	HALLERMANN-STREIFF SYNDROME; HSS	 HSS
234200	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	 NBIA1
234500	HARTNUP DISORDER; HND	 HND
234580	HEIMLER SYNDROME 1; HMLR1	 HMLR1
234810	PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2	 PVOD2
235200	HEMOCHROMATOSIS, TYPE 1; HFE1	 HFE1
235400	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1	 AHUS1
235510	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1; HKLLS1	 HKLLS1
235550	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI	 VODI
235555	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2	 CBAS2
235700	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	
235730	MOWAT-WILSON SYNDROME; MOWS	 MOWS
235800	HISTIDINEMIA	
236200	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	
236250	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY	
236270	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE	 HMAE
236500	MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	 MARCH
236600	HYDROCEPHALUS, CONGENITAL, 1; HYC1	 HYC1
236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1	 MDDGA1
236680	HYDROLETHALUS SYNDROME 1; HLS1	 HLS1
236700	MCKUSICK-KAUFMAN SYNDROME; MKKS	 MKKS
236730	UROFACIAL SYNDROME 1; UFS1	 UFS1
236792	L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA	 L2HGA
236800	HYDROXYKYNURENINURIA	
237300	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO	
237310	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD	 NAGSD
237450	HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR	 HBLRR
237500	DUBIN-JOHNSON SYNDROME; DJS	 DJS
237900	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN	 HBLRTFN
238320	LEYDIG CELL HYPOPLASIA, TYPE I	
238600	HYPERLIPOPROTEINEMIA, TYPE I	
238970	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	
239000	PAGET DISEASE OF BONE 5, JUVENILE-ONSET; PDB5	 PDB5
239100	VAN BUCHEM DISEASE; VBCH	 VBCH
239200	HYPERPARATHYROIDISM, NEONATAL SEVERE; NSHPT	 NSHPT
239300	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1	 HPMRS1
239500	HYPERPROLINEMIA, TYPE I; HYRPRO1	 HYRPRO1
239510	HYPERPROLINEMIA, TYPE II; HYRPRO2	 HYRPRO2
239850	CANTU SYNDROME	
240300	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1	 APS1
240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	 CVID2
240600	GLYCOGEN STORAGE DISEASE 0, LIVER; GSD0A	 GSD0A
240800	HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	 LIH
240900	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	 HIHGHH
241080	WOODHOUSE-SAKATI SYNDROME	
241200	BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2	 BARTS2
241410	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRDS	 HRDS
241500	HYPOPHOSPHATASIA, INFANTILE	
241510	HYPOPHOSPHATASIA, CHILDHOOD	
241520	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1	 ARHR1
241530	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH	 HHRH
241550	HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1	 HLHS1
241600	IMMUNODEFICIENCY 43; IMD43	 IMD43
241850	HYPOTHYROIDISM, THYROIDAL OR ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	
242100	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2; ARCI2	 ARCI2
242300	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	 ARCI1
242500	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B	 ARCI4B
242600	IMINOGLYCINURIA	
242840	VICI SYNDROME; VICIS	 VICIS
242860	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1	 ICF1
242900	SCHIMKE IMMUNOOSSEOUS DYSPLASIA; SIOD	 SIOD
243000	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	 CIP
243150	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	 GIDID
243300	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1	 BRIC1
243310	BARAITSER-WINTER SYNDROME 1; BRWS1	 BRWS1
243500	ISOVALERIC ACIDEMIA; IVA	 IVA
243605	STROMME SYNDROME; STROMS	 STROMS
243700	HYPER-IgE RECURRENT INFECTION SYNDROME 2, AUTOSOMAL RECESSIVE; HIES2	 HIES2
243800	JOHANSON-BLIZZARD SYNDROME; JBS	 JBS
244200	HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	 HH3
244400	CILIARY DYSKINESIA, PRIMARY, 1; CILD1	 CILD1
244450	KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	 KOS
244460	KENNY-CAFFEY SYNDROME, TYPE 1; KCS1	 KCS1
245000	PAPILLON-LEFEVRE SYNDROME; PALS	 PALS
245010	HAIM-MUNK SYNDROME; HMS	 HMS
245050	SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY; SCOTD	 SCOTD
245150	KEUTEL SYNDROME; KTLS	 KTLS
245200	KRABBE DISEASE	
245300	KURU, SUSCEPTIBILITY TO	
245340	ERYTHROCYTE LACTATE TRANSPORTER DEFECT	
245348	PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	 PDHDD
245349	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD	 PDHXD
245400	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9	 MTDPS9
245570	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD	 FESD
245590	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY	
245600	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD	 JDSCD
245660	LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS	 LOCS
245800	LAURENCE-MOON SYNDROME; LNMS	 LNMS
245900	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	
246200	DONOHUE SYNDROME	
246450	3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	 HMGCLD
246650	LIPASE DEFICIENCY, COMBINED	
246700	CHYLOMICRON RETENTION DISEASE; CMRD	 CMRD
246900	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD	 DLDD
247100	LIPOID PROTEINOSIS OF URBACH AND WIETHE	
247200	MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	 MDLS
248000	MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE; MGCPH	 MGCPH
248190	HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	 HOMG5
248200	STARGARDT DISEASE 1; STGD1	 STGD1
248250	HYPOMAGNESEMIA 3, RENAL; HOMG3	 HOMG3
248300	MAL DE MELEDA; MDM	 MDM
248310	PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL	
248340	3MC SYNDROME 3; 3MC3	 3MC3
248370	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	 MADA
248390	TREACHER COLLINS SYNDROME 3; TCS3	 TCS3
248450	MANITOBA OCULOTRICHOANAL SYNDROME; MOTA	 MOTA
248500	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA	 MANSA
248510	MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB	 MANSB
248600	MAPLE SYRUP URINE DISEASE; MSUD	 MSUD
248700	MARDEN-WALKER SYNDROME; MWKS	 MWKS
248800	MARINESCO-SJOGREN SYNDROME; MSS	 MSS
249000	MECKEL SYNDROME, TYPE 1; MKS1	 MKS1
249100	FAMILIAL MEDITERRANEAN FEVER; FMF	 FMF
249270	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA	 TRMA
249400	MELANOSIS, NEUROCUTANEOUS; NCMS	 NCMS
249420	FRANK-TER HAAR SYNDROME; FTHS	 FTHS
249500	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1	 MRT1
249700	LANGER MESOMELIC DYSPLASIA; LMD	 LMD
249900	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	
250100	METACHROMATIC LEUKODYSTROPHY; MLD	 MLD
250220	SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	 SMDS
250400	METAPHYSEAL DYSPLASIA, SPAHR TYPE; MDST	 MDST
250410	RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES; RPSKA	 RPSKA
250620	3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD	 HIBCHD
250800	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	
250850	METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	
250940	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG	 HMAG
250950	3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	 MGCA1
251000	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY	
251100	METHYLMALONIC ACIDURIA, cblA TYPE	
251110	METHYLMALONIC ACIDURIA, cblB TYPE	
251120	METHYLMALONYL-CoA EPIMERASE DEFICIENCY	
251200	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1	 MCPH1
251230	MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	 MIMIS
251255	JAWAD SYNDROME; JWDS	 JWDS
251260	NIJMEGEN BREAKAGE SYNDROME; NBS	 NBS
251270	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	 MCCRP1
251280	MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	 MISSBC
251290	PSEUDO-TORCH SYNDROME 1; PTORCH1	 PTORCH1
251300	GALLOWAY-MOWAT SYNDROME 1; GAMOS1	 GAMOS1
251450	DESBUQUOIS DYSPLASIA 1; DBQD1	 DBQD1
251750	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	 MSPKA
251850	DIARRHEA 2, WITH MICROVILLUS ATROPHY; DIAR2	 DIAR2
251880	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3	 MTDPS3
252010	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	 MC1DN1
252011	MITOCHONDRIAL COMPLEX II DEFICIENCY	
252150	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	 MOCODA
252160	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	 MOCODB
252500	MUCOLIPIDOSIS II ALPHA/BETA	
252600	MUCOLIPIDOSIS III ALPHA/BETA	
252605	MUCOLIPIDOSIS III GAMMA	
252650	MUCOLIPIDOSIS IV; ML4	 ML4
252900	MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A	 MPS3A
252920	MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B	 MPS3B
252930	MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C	 MPS3C
253000	MUCOPOLYSACCHARIDOSIS, TYPE IVA; MPS4A	 MPS4A
253010	MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B	 MPS4B
253200	MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	 MPS6
253220	MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	 MPS7
253250	MULIBREY NANISM	
253260	BIOTINIDASE DEFICIENCY	
253270	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	
253280	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	 MDDGA3
253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS	 LMPS
253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1	 SMA1
253310	LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1	 LCCS1
253400	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	 SMA3
253550	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2	 SMA2
253600	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1	 LGMDR1
253601	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2; LGMDR2	 LGMDR2
253700	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5; LGMDR5	 LGMDR5
253800	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	 MDDGA4
254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1	 UCMD1
254110	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 8; LGMDR8	 LGMDR8
254130	MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	 MMD1
254200	MYASTHENIA GRAVIS; MG	 MG
254210	MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	 CMS6
254300	MYASTHENIC SYNDROME, CONGENITAL, 10; CMS10	 CMS10
254450	MYELOFIBROSIS	
254500	MYELOMA, MULTIPLE	
254600	MYELOPEROXIDASE DEFICIENCY; MPOD	 MPOD
254770	EPILEPSY, MYOCLONIC JUVENILE; EJM	 EJM
254780	MYOCLONIC EPILEPSY OF LAFORA	
254800	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	
254900	EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	 EPM4
254940	CAREY-FINEMAN-ZITER SYNDROME; CFZS	 CFZS
255100	LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD	 LSMFLAD
255110	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	
255120	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	
255125	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML	 HML
255160	MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB	 MSMB
255200	MYOPATHY, CENTRONUCLEAR, 2; CNM2	 CNM2
255310	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	 CFTD
255320	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	
255600	MYOSCLEROSIS, AUTOSOMAL RECESSIVE	
255700	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	
255800	SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	 SJS1
255960	MYXOMA, INTRACARDIAC	
255995	MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	 MYPBB
256000	LEIGH SYNDROME; LS	 LS
256030	NEMALINE MYOPATHY 2; NEM2	 NEM2
256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	 PRAAS1
256050	ATELOSTEOGENESIS, TYPE II; AO2	 AO2
256100	NEPHRONOPHTHISIS 1; NPHP1	 NPHP1
256300	NEPHROTIC SYNDROME, TYPE 1; NPHS1	 NPHS1
256370	NEPHROTIC SYNDROME, TYPE 4; NPHS4	 NPHS4
256450	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1	 HHF1
256500	NETHERTON SYNDROME; NETH	 NETH
256520	NEU-LAXOVA SYNDROME 1; NLS1	 NLS1
256540	GALACTOSIALIDOSIS; GSL	 GSL
256550	NEURAMINIDASE DEFICIENCY	
256600	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A	 NBIA2A
256700	NEUROBLASTOMA, SUSCEPTIBILITY TO	
256710	ELEJALDE DISEASE	
256730	CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1	 CLN1
256731	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5	 CLN5
256800	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	 CIPA
256810	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6	 MTDPS6
256840	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	
256850	GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1	 GAN1
257200	NIEMANN-PICK DISEASE, TYPE A	
257220	NIEMANN-PICK DISEASE, TYPE C1; NPC1	 NPC1
257270	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B	 CSNB1B
257300	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1	 MVA1
257320	LISSENCEPHALY 2; LIS2	 LIS2
257850	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	
257920	3MC SYNDROME 1; 3MC1	 3MC1
257980	ODONTOONYCHODERMAL DYSPLASIA; OODD	 OODD
258100	OGUCHI DISEASE 1	
258315	OMODYSPLASIA 1; OMOD1	 OMOD1
258450	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1; PEOB1	 PEOB1
258480	OPSISMODYSPLASIA; OPSMD	 OPSMD
258501	3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3	 MGCA3
258660	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO	
258860	OROFACIODIGITAL SYNDROME IV; OFD4	 OFD4
258870	GYRATE ATROPHY OF CHOROID AND RETINA; GACR	 GACR
258900	OROTIC ACIDURIA	
259050	PRIMROSE SYNDROME; PRIMS	 PRIMS
259100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	 PHOAR1
259420	OSTEOGENESIS IMPERFECTA, TYPE III; OI3	 OI3
259440	OSTEOGENESIS IMPERFECTA, TYPE IX; OI9	 OI9
259450	BRUCK SYNDROME 1; BRKS1	 BRKS1
259500	OSTEOGENIC SARCOMA	
259600	MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	 MONA
259700	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	 OPTB1
259710	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2	 OPTB2
259720	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	 OPTB5
259730	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	 OPTB3
259770	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG	 OPPG
259775	RAINE SYNDROME; RNS	 RNS
259900	HYPEROXALURIA, PRIMARY, TYPE I; HP1	 HP1
260000	HYPEROXALURIA, PRIMARY, TYPE II; HP2	 HP2
260005	5-OXOPROLINASE DEFICIENCY; OPLAHD	 OPLAHD
260300	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15	 PARK15
260350	PANCREATIC CANCER	
260370	PANCREATIC AGENESIS 1; PAGEN1	 PAGEN1
260400	SHWACHMAN-DIAMOND SYNDROME 1; SDS1	 SDS1
260500	PAPILLOMA OF CHOROID PLEXUS; CPP	 CPP
260540	PARKINSON-DEMENTIA SYNDROME	
260565	PEHO SYNDROME; PEHO	 PEHO
260600	LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	 HLD3
260660	COUSIN SYNDROME	
260920	HYPER-IgD SYNDROME; HIDS	 HIDS
261000	INTRINSIC FACTOR DEFICIENCY; IFD	 IFD
261100	MEGALOBLASTIC ANEMIA 1	
261500	EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD	 EPXD
261515	D-BIFUNCTIONAL PROTEIN DEFICIENCY	
261540	PETERS-PLUS SYNDROME; PTRPLS	 PTRPLS
261550	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS	 PMDS
261600	PHENYLKETONURIA; PKU	 PKU
261630	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	 HPABH4C
261640	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	 HPABH4A
261650	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL; PCKDM	 PCKDM
261670	GLYCOGEN STORAGE DISEASE X; GSD10	 GSD10
261680	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	 PCKDC
261740	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	
261750	GLYCOGEN STORAGE DISEASE IXb; GSD9B	 GSD9B
262000	BJORNSTAD SYNDROME; BJS	 BJS
262190	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	
262300	ACHROMATOPSIA 3; ACHM3	 ACHM3
262400	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A	 IGHD1A
262500	LARON SYNDROME	
262600	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2	 CPHD2
262650	KOWARSKI SYNDROME	
262700	PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4	 CPHD4
262850	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY	
262890	SCOTT SYNDROME; SCTS	 SCTS
263200	POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	 PKD4
263210	GILLESSEN-KAESBACH-NISHIMURA SYNDROME; GIKANIS	 GIKANIS
263300	POLYCYTHEMIA VERA; PV	 PV
263400	ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2	 ECYT2
263520	SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	 SRTD6
263570	POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN	 APBN
263650	BARTSOCAS-PAPAS SYNDROME; BPS	 BPS
263700	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	
263750	POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS	 POADS
263800	GITELMAN SYNDROME; GTLMNS	 GTLMNS
264070	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D	 HPABH4D
264300	17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	
264350	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B	 PHA1B
264470	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	
264600	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	 PPSH
264700	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A	 VDDR1A
264800	PSEUDOXANTHOMA ELASTICUM; PXE	 PXE
265000	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS	 EVMPS
265050	3MC SYNDROME 2; 3MC2	 3MC2
265100	PULMONARY ALVEOLAR MICROLITHIASIS	
265120	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	 SMDP1
265380	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	 ACDMPV
265450	PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1	 PVOD1
265800	PYCNODYSOSTOSIS	
265900	PYLE DISEASE; PYL	 PYL
266100	EPILEPSY, PYRIDOXINE-DEPENDENT; EPD	 EPD
266120	URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	
266130	GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD	 GSSD
266140	PYROPOIKILOCYTOSIS, HEREDITARY; HPP	 HPP
266150	PYRUVATE CARBOXYLASE DEFICIENCY	
266200	PYRUVATE KINASE DEFICIENCY OF RED CELLS	
266265	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	 CDG2C
266280	RAPADILINO SYNDROME	
266300	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2	 SHEP2
266500	REFSUM DISEASE, CLASSIC	
266510	PEROXISOME BIOGENESIS DISORDER 3B; PBD3B	 PBD3B
266600	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1; IBD1	 IBD1
266900	SENIOR-LOKEN SYNDROME 1; SLSN1	 SLSN1
266920	SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	 SRTD9
267000	PERLMAN SYNDROME; PRLMNS	 PRLMNS
267010	MECKEL SYNDROME, TYPE 7; MKS7	 MKS7
267300	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	
267430	RENAL TUBULAR DYSGENESIS; RTD	 RTD
267450	RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS	
267500	RETICULAR DYSGENESIS	
267750	KNOBLOCH SYNDROME 1; KNO1	 KNO1
268000	RETINITIS PIGMENTOSA; RP	 RP
268100	ENHANCED S-CONE SYNDROME; ESCS	 ESCS
268130	REVESZ SYNDROME	
268150	RH-NULL, REGULATOR TYPE; RHNR	 RHNR
268200	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE	
268210	RHABDOMYOSARCOMA, EMBRYONAL, 1; RMSE1	 RMSE1
268220	RHABDOMYOSARCOMA 2; RMS2	 RMS2
268300	ROBERTS SYNDROME; RBS	 RBS
268305	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	
268310	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS	 RRS
268400	ROTHMUND-THOMSON SYNDROME; RTS	 RTS
268800	SANDHOFF DISEASE	
268900	SARCOSINEMIA; SARCOS	 SARCOS
269000	SC PHOCOMELIA SYNDROME	
269150	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	
269160	SCHIZENCEPHALY	
269250	SCHNECKENBECKEN DYSPLASIA; SHNKND	 SHNKND
269400	ANTERIOR SEGMENT DYSGENESIS 7; ASGD7	 ASGD7
269500	SCLEROSTEOSIS 1; SOST1	 SOST1
269600	SEA-BLUE HISTIOCYTE DISEASE	
269700	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2	 CGL2
269840	IMMUNODEFICIENCY 48; IMD48	 IMD48
269880	SHORT SYNDROME	
269920	INFANTILE SIALIC ACID STORAGE DISEASE; ISSD	 ISSD
269921	SIALURIA	
270100	HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5	 HTX5
270200	SJOGREN-LARSSON SYNDROME; SLS	 SLS
270300	PEELING SKIN SYNDROME 1; PSS1	 PSS1
270400	SMITH-LEMLI-OPITZ SYNDROME; SLOS	 SLOS
270420	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES; DIAR3	 DIAR3
270450	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	 IGF1RES
270550	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS	 SACS
270685	SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17	 SPG17
270700	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15	 SPG15
270750	SPASTIC PARAPLEGIA 23; SPG23	 SPG23
270800	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	 SPG5A
270970	SPHEROCYTOSIS, TYPE 3; SPH3	 SPH3
271150	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4	 SMA4
271245	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7	 MTDPS7
271400	ASPLENIA, ISOLATED CONGENITAL; ICAS	 ICAS
271640	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	 SEMDJL1
271665	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	
271700	SPONDYLOPERIPHERAL DYSPLASIA	
271900	CANAVAN DISEASE	
271930	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI	 SNDI
271980	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD	 SSADHD
272120	SUDDEN INFANT DEATH SYNDROME	
272200	MULTIPLE SULFATASE DEFICIENCY; MSD	 MSD
272300	SULFITE OXIDASE DEFICIENCY, ISOLATED; ISOD	 ISOD
272430	CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	 CISS1
272440	FILIPPI SYNDROME; FLPIS	 FLPIS
272460	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	 SCT
272750	GM2-GANGLIOSIDOSIS, AB VARIANT	
272800	TAY-SACHS DISEASE; TSD	 TSD
273300	TESTICULAR GERM CELL TUMOR; TGCT	 TGCT
273750	THREE M SYNDROME 1; 3M1	 3M1
273800	GLANZMANN THROMBASTHENIA; GT	 GT
273900	THROMBOCYTOPENIA 3; THC3	 THC3
274150	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP	 TTP
274270	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	
274300	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTH	 GRTH
274400	THYROID DYSHORMONOGENESIS 1; TDH1	 TDH1
274500	THYROID DYSHORMONOGENESIS 2A; TDH2A	 TDH2A
274600	PENDRED SYNDROME; PDS	 PDS
274700	THYROID DYSHORMONOGENESIS 3; TDH3	 TDH3
274800	THYROID DYSHORMONOGENESIS 4; TDH4	 TDH4
274900	THYROID DYSHORMONOGENESIS 5; TDH5	 TDH5
275200	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1	 CHNG1
275210	RESTRICTIVE DERMOPATHY, LETHAL	
275350	TRANSCOBALAMIN II DEFICIENCY	
275355	SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC	 HNSCC
275400	OLIVER-MCFARLANE SYNDROME; OMCS	 OMCS
275630	CHANARIN-DORFMAN SYNDROME; CDS	 CDS
275900	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20	 SPG20
276300	MISMATCH REPAIR CANCER SYNDROME; MMRCS	 MMRCS
276600	TYROSINEMIA, TYPE II; TYRSN2	 TYRSN2
276700	TYROSINEMIA, TYPE I; TYRSN1	 TYRSN1
276710	TYROSINEMIA, TYPE III; TYRSN3	 TYRSN3
276820	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY	
276880	UROCANASE DEFICIENCY; UROCD	 UROCD
276900	USHER SYNDROME, TYPE I; USH1	 USH1
276901	USHER SYNDROME, TYPE IIA; USH2A	 USH2A
276902	USHER SYNDROME, TYPE IIIA; USH3A	 USH3A
276904	USHER SYNDROME, TYPE IC; USH1C	 USH1C
277170	OROFACIODIGITAL SYNDROME VI; OFD6	 OFD6
277180	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD	 CBAVD
277300	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1	 SCDO1
277380	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE; MAHCF	 MAHCF
277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	 MAHCC
277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD	 MAHCD
277440	VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A	 VDDR2A
277450	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	 VKCFD1
277460	VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED	 VED
277470	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	 PCH2A
277480	VON WILLEBRAND DISEASE, TYPE 3; VWD3	 VWD3
277580	WAARDENBURG SYNDROME, TYPE 4A; WS4A	 WS4A
277590	WEAVER SYNDROME; WVS	 WVS
277600	WEILL-MARCHESANI SYNDROME 1; WMS1	 WMS1
277700	WERNER SYNDROME; WRN	 WRN
277900	WILSON DISEASE	
277950	WINCHESTER SYNDROME; WNCHRS	 WNCHRS
278000	LYSOSOMAL ACID LIPASE DEFICIENCY	
278150	HYPOTRICHOSIS 8; HYPT8	 HYPT8
278250	WRINKLY SKIN SYNDROME; WSS	 WSS
278300	XANTHINURIA, TYPE I; XAN1	 XAN1
278700	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	 XPA
278720	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC	 XPC
278730	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	 XPD
278740	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	
278750	XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV	 XPV
278760	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	 XPF
278780	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	 XPG
278800	DE SANCTIS-CACCHIONE SYNDROME	
278850	46,XX SEX REVERSAL 2; SRXX2	 SRXX2
280000	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME	 CHIME
300000	OPITZ GBBB SYNDROME, TYPE I; GBBB1	 GBBB1
300004	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA	
300009	DENT DISEASE 1	
300018	46,XY SEX REVERSAL 2; SRXY2	 SRXY2
300029	RETINITIS PIGMENTOSA 3; RP3	 RP3
300048	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	
300049	PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1	 PVNH1
300055	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13	 MRXS13
300067	LISSENCEPHALY, X-LINKED, 1; LISX1	 LISX1
300068	ANDROGEN INSENSITIVITY SYNDROME; AIS	 AIS
300071	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A	 CSNB2A
300088	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	 EIEE9
300100	ADRENOLEUKODYSTROPHY; ALD	 ALD
300106	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED; SEMDX	 SEMDX
300114	RAYNAUD-CLAES SYNDROME; MRXSRC	 MRXSRC
300123	MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM	
300143	MENTAL RETARDATION, X-LINKED 21; MRX21	 MRX21
300148	MEHMO SYNDROME; MEHMO	 MEHMO
300166	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	 MCOPS2
300194	AMME COMPLEX	
300200	ADRENAL HYPOPLASIA, CONGENITAL; AHC	 AHC
300209	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	 SGBS2
300210	MENTAL RETARDATION, X-LINKED 58; MRX58	 MRX58
300215	LISSENCEPHALY, X-LINKED, 2; LISX2	 LISX2
300244	TERMINAL OSSEOUS DYSPLASIA; TOD	 TOD
300257	DANON DISEASE	
300260	LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	 MRXSL
300263	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	 MRXSSD
300271	MENTAL RETARDATION, X-LINKED 72; MRX72	 MRX72
300280	URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	 FCMSU
300291	ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1; EDAID1	 EDAID1
300299	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX	 SCNX
300301	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, AND LYMPHEDEMA; OLEDAID	 OLEDAID
300321	FG SYNDROME 2; FGS2	 FGS2
300322	LESCH-NYHAN SYNDROME; LNS	 LNS
300323	KELLEY-SEEGMILLER SYNDROME	
300352	CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1	 CCDS1
300354	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	 MRXSC
300367	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA	 XLTDA
300373	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS	 OSCS
300376	MUSCULAR DYSTROPHY, BECKER TYPE; BMD	 BMD
300387	MENTAL RETARDATION, X-LINKED 63; MRX63	 MRX63
300400	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1	 SCIDX1
300419	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED; MRXARX	 MRXARX
300422	FG SYNDROME 4; FGS4	 FGS4
300423	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	 MRXSH
300424	RETINITIS PIGMENTOSA 23; RP23	 RP23
300425	AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	 AUTSX1
300434	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	 SDSX
300438	HSD10 MITOCHONDRIAL DISEASE; HSD10MD	 HSD10MD
300448	ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS	 ATMDS
300455	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS	
300472	CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA	
300476	CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3	 CORDX3
300486	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	
300489	SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3; SMAX3	 SMAX3
300494	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	 ASPGX1
300495	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	 AUTSX2
300496	AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	 AUTSX3
300497	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	 ASPGX2
300500	ALBINISM, OCULAR, TYPE I; OA1	 OA1
300510	OVARIAN DYSGENESIS 2; ODG2	 ODG2
300511	PREMATURE OVARIAN FAILURE 2A; POF2A	 POF2A
300514	FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	 FANCB
300519	MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE; MRXSMP	 MRXSMP
300523	ALLAN-HERNDON-DUDLEY SYNDROME; AHDS	 AHDS
300534	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ	 MRXSCJ
300539	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	 NSIAD
300554	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	
300555	DENT DISEASE 2	
300558	MENTAL RETARDATION, X-LINKED 30; MRX30	 MRX30
300559	GLYCOGEN STORAGE DISEASE, TYPE IXd; GSD9D	 GSD9D
300582	SHORT STATURE, IDIOPATHIC, X-LINKED; ISS	 ISS
300584	IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA	
300590	CORNELIA DE LANGE SYNDROME 2; CDLS2	 CDLS2
300600	ALAND ISLAND EYE DISEASE; AIED	 AIED
300604	PREMATURE OVARIAN FAILURE 2B; POF2B	 POF2B
300607	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8	 EIEE8
300614	DEAFNESS, X-LINKED 5; DFNX5	 DFNX5
300615	BRUNNER SYNDROME; BRNRS	 BRNRS
300622	TN POLYAGGLUTINATION SYNDROME; TNPS	 TNPS
300623	FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	 FXTAS
300624	FRAGILE X SYNDROME; FXS	 FXS
300633	HYPOSPADIAS 1, X-LINKED; HYSP1	 HYSP1
300635	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	 XLP2
300636	IMMUNODEFICIENCY 33; IMD33	 IMD33
300640	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2	 IPD2
300643	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED; RESDX	 RESDX
300645	IMMUNODEFICIENCY 34; IMD34	 IMD34
300653	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	
300659	MENTAL RETARDATION, X-LINKED 93; MRX93	 MRX93
300661	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	
300672	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2	 EIEE2
300673	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	
300676	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	 MRXS14
300695	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM	 SPM
300696	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA	 XMPMA
300699	MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	 MRXSW
300705	CHROMOSOME Xp11.22 DUPLICATION SYNDROME	
300706	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	 MRXST
300707	TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	 STAR
300717	REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET; RBMX1A	 RBMX1A
300718	REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET; RBMX1B	 RBMX1B
300749	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	 MICPCH
300751	ANEMIA, SIDEROBLASTIC, 1; SIDBA1	 SIDBA1
300752	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP	 XLEPP
300755	AGAMMAGLOBULINEMIA, X-LINKED; XLA	 XLA
300758	HYPOSPADIAS 2, X-LINKED; HYSP2	 HYSP2
300770	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4	 SMDP4
300799	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	 MRXSR
300802	MENTAL RETARDATION, X-LINKED 96; MRX96	 MRX96
300803	MENTAL RETARDATION, X-LINKED 97; MRX97	 MRX97
300804	JOUBERT SYNDROME 10; JBTS10	 JBTS10
300807	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; THPH8	 THPH8
300814	NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6	 NYS6
300816	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	 COXPD6
300818	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1; PNH1	 PNH1
300830	AUTISM, SUSCEPTIBILITY TO, X-LINKED 4; AUTSX4	 AUTSX4
300831	CK SYNDROME	
300833	46,XX SEX REVERSAL 3; SRXX3	 SRXX3
300834	MACULAR DEGENERATION, X-LINKED ATROPHIC	
300835	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP	 XLANP
300842	MCLEOD SYNDROME; MCLDS	 MCLDS
300844	MENTAL RETARDATION, X-LINKED 19; MRX19	 MRX19
300847	AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5	 AUTSX5
300849	MENTAL RETARDATION, X-LINKED 41; MRX41	 MRX41
300850	MENTAL RETARDATION, X-LINKED 90; MRX90	 MRX90
300853	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN	 XMEN
300855	OGDEN SYNDROME; OGDNS	 OGDNS
300857	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	 ALS15
300860	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN	 MRXSN
300863	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	
300867	KABUKI SYNDROME 2; KABUK2	 KABUK2
300868	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	 MCAHS2
300872	AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6	 AUTSX6
300882	CORNELIA DE LANGE SYNDROME 5; CDLS5	 CDLS5
300884	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	 EIEE36
300886	MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	 MRXS32
300888	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT; CHTE	 CHTE
300895	OHDO SYNDROME, X-LINKED; OHDOX	 OHDOX
300896	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	 CDG2M
300905	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	 CMTX6
300908	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	
300909	ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO; AEACEI	 AEACEI
300911	PARKINSONISM WITH SPASTICITY, X-LINKED; XPDS	 XPDS
300912	MENTAL RETARDATION, X-LINKED 98; MRX98	 MRX98
300914	DEAFNESS, X-LINKED 6; DFNX6	 DFNX6
300915	MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	 MCOPS13
300918	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	
300919	MENTAL RETARDATION, X-LINKED 99; MRX99	 MRX99
300923	MENTAL RETARDATION, X-LINKED 100; MRX100	 MRX100
300928	MENTAL RETARDATION, X-LINKED 101; MRX101	 MRX101
300934	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	 CDG1Y
300943	PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	 PITA2
300946	DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	 DBA14
300952	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	 LSDMCA3
300957	MENTAL RETARDATION, X-LINKED 12; MRX12	 MRX12
300958	MENTAL RETARDATION, X-LINKED 102; MRX102	 MRX102
300960	MEND SYNDROME; MEND	 MEND
300963	RITSCHER-SCHINZEL SYNDROME 2; RTSC2	 RTSC2
300966	MENTAL RETARDATION, X-LINKED, SYNDROMIC 33; MRXS33	 MRXS33
300971	BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT; BARTS5	 BARTS5
300972	IMMUNODEFICIENCY 47; IMD47	 IMD47
300978	TONNE-KALSCHEUER SYNDROME; TOKAS	 TOKAS
300983	MENTAL RETARDATION, X-LINKED 104; MRX104	 MRX104
300984	MENTAL RETARDATION, X-LINKED 105; MRX105	 MRX105
300985	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED; CBAVDX	 CBAVDX
300986	MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	 MRXSB
300988	IMMUNODEFICIENCY 50; IMD50	 IMD50
300989	MEESTER-LOEYS SYNDROME; MRLS	 MRLS
300990	MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	 MFHIEN
300997	MENTAL RETARDATION, X-LINKED 106; MRX106	 MRX106
300998	MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	 MRXS35
301000	WISKOTT-ALDRICH SYNDROME; WAS	 WAS
301008	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	 MRXSHG
301010	MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26	 MYP26
301014	OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	 OI19
301015	HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	
301040	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	 ATRX
301050	ALPORT SYNDROME 1, X-LINKED; ATS1	 ATS1
301200	AMELOGENESIS IMPERFECTA, TYPE IE; AI1E	 AI1E
301220	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR	 PDR
301310	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT	 ASAT
301500	FABRY DISEASE	
301830	SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2	 SMAX2
301835	ARTS SYNDROME; ARTS	 ARTS
301900	BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	 BFLS
302045	CARDIOMYOPATHY, DILATED, 3B; CMD3B	 CMD3B
302060	BARTH SYNDROME; BTHS	 BTHS
302200	CATARACT 40; CTRCT40	 CTRCT40
302350	NANCE-HORAN SYNDROME; NHS	 NHS
302500	SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	 SCAX1
302800	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1	 CMTX1
302905	ABRUZZO-ERICKSON SYNDROME; ABERS	 ABERS
302950	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1	 CDPX1
302960	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	 CDPX2
303100	CHOROIDEREMIA; CHM	 CHM
303350	MASA SYNDROME	
303400	CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX	 CPX
303600	COFFIN-LOWRY SYNDROME; CLS	 CLS
303700	BLUE CONE MONOCHROMACY; BCM	 BCM
303800	COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD	 CBD
303900	COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP	 CBP
304020	CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	 CORDX1
304100	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	
304110	CRANIOFRONTONASAL SYNDROME; CFNS	 CFNS
304120	OTOPALATODIGITAL SYNDROME, TYPE II; OPD2	 OPD2
304150	OCCIPITAL HORN SYNDROME; OHS	 OHS
304400	DEAFNESS, X-LINKED 2; DFNX2	 DFNX2
304500	DEAFNESS, X-LINKED 1; DFNX1	 DFNX1
304700	MOHR-TRANEBJAERG SYNDROME; MTS	 MTS
304790	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	 IPEX
304800	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	
305000	DYSKERATOSIS CONGENITA, X-LINKED; DKCX	 DKCX
305100	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	 XHED
305390	EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2	 EVR2
305400	AARSKOG-SCOTT SYNDROME; AAS	 AAS
305450	OPITZ-KAVEGGIA SYNDROME; OKS	 OKS
305600	FOCAL DERMAL HYPOPLASIA; FDH	 FDH
305620	FRONTOMETAPHYSEAL DYSPLASIA 1; FMD1	 FMD1
306000	GLYCOGEN STORAGE DISEASE IXa1; GSD9A1	 GSD9A1
306400	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	 CDGX
306700	HEMOPHILIA A; HEMA	 HEMA
306900	HEMOPHILIA B; HEMB	 HEMB
306955	HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	 HTX1
307000	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS	 HSAS
307030	GLYCEROL KINASE DEFICIENCY; GKD	 GKD
307200	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III, WITH AGAMMAGLOBULINEMIA; IGHD3	 IGHD3
307800	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR	 XLHR
308050	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	
308100	ICHTHYOSIS, X-LINKED; XLI	 XLI
308205	IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	
308230	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1	 HIGM1
308240	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	 XLP1
308300	INCONTINENTIA PIGMENTI; IP	 IP
308350	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	 EIEE1
308700	HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	 HH1
308800	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	 KFSDX
308990	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	
309000	LOWE OCULOCEREBRORENAL SYNDROME; OCRL	 OCRL
309120	SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	 SPGFX2
309300	MEGALOCORNEA; MGC1	 MGC1
309350	MELNICK-NEEDLES SYNDROME; MNS	 MNS
309400	MENKES DISEASE	
309500	RENPENNING SYNDROME 1; RENS1	 RENS1
309510	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS	 PRTS
309520	LUJAN-FRYNS SYNDROME	
309530	MENTAL RETARDATION, X-LINKED 1; MRX1	 MRX1
309541	METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	
309548	MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE	
309580	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	 MRXHF1
309583	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR	 MRXSSR
309585	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	 WTS
309800	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1	 MCOPS1
309801	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1	 LSDMCA1
309900	MUCOPOLYSACCHARIDOSIS, TYPE II; MPS2	 MPS2
310200	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	 DMD
310300	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	 EDMD1
310400	MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	 CNMX
310468	NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN	 XRN
310490	COWCHOCK SYNDROME; COWCK	 COWCK
310500	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A	 CSNB1A
310600	NORRIE DISEASE; ND	 ND
310700	NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	 NYS1
311070	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5	 CMTX5
311200	OROFACIODIGITAL SYNDROME I; OFD1	 OFD1
311250	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO	
311300	OTOPALATODIGITAL SYNDROME, TYPE I; OPD1	 OPD1
311360	PREMATURE OVARIAN FAILURE 1; POF1	 POF1
311510	WAISMAN SYNDROME; WSMN	 WSMN
312000	PANHYPOPITUITARISM, X-LINKED; PHPX	 PHPX
312060	PROPERDIN DEFICIENCY, X-LINKED; CFPD	 CFPD
312080	PELIZAEUS-MERZBACHER DISEASE; PMD	 PMD
312170	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	 PDHAD
312300	ANDROGEN INSENSITIVITY, PARTIAL; PAIS	 PAIS
312600	RETINITIS PIGMENTOSA 2; RP2	 RP2
312700	RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	 RS1
312750	RETT SYNDROME; RTT	 RTT
312863	COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX	 CIDX
312870	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1	 SGBS1
312920	SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	 SPG2
313200	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1	 SMAX1
313400	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT	 SEDT
313500	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1	 STHAGX1
313900	THROMBOCYTOPENIA 1; THC1	 THC1
314050	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT	 XLTT
314250	DYSTONIA 3, TORSION, X-LINKED; DYT3	 DYT3
314390	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	 VACTERLX
314400	CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	 CVD1
314580	WIEACKER-WOLFF SYNDROME; WRWF	 WRWF
400044	46,XY SEX REVERSAL 1; SRXY1	 SRXY1
400045	46,XX SEX REVERSAL 1; SRXX1	 SRXX1
415000	SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2	 SPGFY2
500000	CARDIOMYOPATHY, INFANTILE HISTIOCYTOID	
500001	LEBER OPTIC ATROPHY AND DYSTONIA	
500003	STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	
500006	CARDIOMYOPATHY, INFANTILE HYPERTROPHIC	
500008	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL	
500010	ATAXIA AND POLYNEUROPATHY, ADULT-ONSET	
500011	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 3; MLASA3	 MLASA3
502500	ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL	
516060	ATP SYNTHASE 6; MTATP6	 MTATP6
516070	ATP SYNTHASE 8; MTATP8	 MTATP8
535000	LEBER OPTIC ATROPHY	
540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	 MELAS
550500	MYOGLOBINURIA, RECURRENT	
551500	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	
580000	DEAFNESS, AMINOGLYCOSIDE-INDUCED	
600001	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	 HDCA
600002	EIKEN SYNDROME	
600046	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1	 ABCA1
600059	RETINITIS PIGMENTOSA 13; RP13	 RP13
600060	DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2	 DFNB2
600072	FATAL FAMILIAL INSOMNIA; FFI	 FFI
600081	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B	 VDDR1B
600101	DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A	 DFNA2A
600105	RETINITIS PIGMENTOSA 12; RP12	 RP12
600110	STARGARDT DISEASE 3; STGD3	 STGD3
600116	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2	 PARK2
600118	WARBURG MICRO SYNDROME 1; WARBM1	 WARBM1
600121	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3	 RCDP3
600132	RETINITIS PIGMENTOSA 14; RP14	 RP14
600138	RETINITIS PIGMENTOSA 11; RP11	 RP11
600142	CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	 CARASIL
600143	CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8	 CLN8
600145	SACRAL DEFECT WITH ANTERIOR MENINGOCELE	
600151	BARDET-BIEDL SYNDROME 3; BBS3	 BBS3
600155	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2	 HSCR2
600175	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; HMN8	 HMN8
600195	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM	 VMCM
600202	DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2	 DYX2
600204	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	 EDM2
600224	SPINOCEREBELLAR ATAXIA 5; SCA5	 SCA5
600231	PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB	 PPKB
600251	FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	 OBLFC1
600263	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO	
600274	FRONTOTEMPORAL DEMENTIA; FTD	 FTD
600309	ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	 AVSD3
600316	DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3	 DFNB3
600320	DIABETES MELLITUS, INSULIN-DEPENDENT, 5; IDDM5	 IDDM5
600334	TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD	 TMD
600348	BAND HETEROTOPIA; BH	 BH
600363	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6	 SPG6
600373	CODAS SYNDROME	
600376	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	 HHT2
600430	CHROMOSOME 2q37 DELETION SYNDROME	
600462	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	 MLASA1
600496	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3	 MODY3
600501	ABCD SYNDROME; ABCDS	 ABCDS
600512	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1	 ETL1
600513	EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1	 ENFL1
600625	OROFACIAL CLEFT 11; OFC11	 OFC11
600628	LOOSE ANAGEN HAIR SYNDROME	
600630	UV-SENSITIVE SYNDROME 1; UVSS1	 UVSS1
600634	PITUITARY ADENOMA, PROLACTIN-SECRETING	
600638	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A	 CFEOM3A
600649	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	
600652	DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A	 DFNA4A
600666	POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD3	 PKD3
600721	D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1	 D2HGA1
600737	MOVED TO 605820	
600740	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3	 HHC3
600775	CRANIOSYNOSTOSIS 4; CRS4	 CRS4
600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4	 DFNB4
600794	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	 HMN5A
600795	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	 FTD3
600802	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	
600803	GALLBLADDER DISEASE 1; GBD1	 GBD1
600807	ASTHMA, SUSCEPTIBILITY TO	
600850	SCHIZOPHRENIA 4; SCZD4	 SCZD4
600852	RETINITIS PIGMENTOSA 17; RP17	 RP17
600858	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6	 CMH6
600880	BUDD-CHIARI SYNDROME; BDCHS	 BDCHS
600882	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	 CMT2B
600886	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT; HRFTC	 HRFTC
600901	FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	 FANCE
600919	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	
600920	VAN DEN ENDE-GUPTA SYNDROME; VDEGS	 VDEGS
600955	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	
600962	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK	 NEPPK
600965	DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6	 DFNA6
600969	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	 EDM3
600971	DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6	 DFNB6
600972	ACHONDROGENESIS, TYPE IB; ACG1B	 ACG1B
600974	DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7	 DFNB7
600977	CONE-ROD DYSTROPHY 5; CORD5	 CORD5
600994	DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5	 DFNA5
600995	NEPHROTIC SYNDROME, TYPE 2; NPHS2	 NPHS2
600996	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2	 ARVD2
601001	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1; EBSB1	 EBSB1
601003	BRODY MYOPATHY	
601005	TIMOTHY SYNDROME; TS	 TS
601042	DYSTONIA 9; DYT9	 DYT9
601067	USHER SYNDROME, TYPE ID; USH1D	 USH1D
601071	DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9	 DFNB9
601072	DEAFNESS, AUTOSOMAL RECESSIVE 8; DFNB8	 DFNB8
601088	AYME-GRIPP SYNDROME; AYGRP	 AYGRP
601098	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	 CMT1C
601104	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	 PSNP1
601110	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	 CDG1D
601144	BRUGADA SYNDROME 1; BRGDA1	 BRGDA1
601152	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA; HMSN6A	 HMSN6A
601154	CARDIOMYOPATHY, DILATED, 1E; CMD1E	 CMD1E
601162	SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	 SPG9A
601186	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	 MCOPS9
601198	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1; HYPOC1	 HYPOC1
601200	PLEUROPULMONARY BLASTOMA; PPB	 PPB
601214	NAXOS DISEASE; NXD	 NXD
601224	POTOCKI-SHAFFER SYNDROME	
601277	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A	 ARCI4A
601283	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1	 NIDDM1
601287	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6; LGMDR6	 LGMDR6
601313	POLYCYSTIN 1; PKD1	 PKD1
601316	DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10	 DFNA10
601317	DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11	 DFNA11
601321	NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	 NFNS
601331	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD	 CYSRD
601338	CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	 CAPOS
601358	NICOLAIDES-BARAITSER SYNDROME; NCBRS	 NCBRS
601367	STROKE, ISCHEMIC	
601369	DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9	 DFNA9
601382	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	 CMT4B1
601386	DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	 DFNB12
601388	DIABETES MELLITUS, INSULIN-DEPENDENT, 12; IDDM12	 IDDM12
601390	VAN MALDERGEM SYNDROME 1; VMLDS1	 VMLDS1
601399	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM	 FPDMM
601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	 TNDM1
601414	RETINITIS PIGMENTOSA 18; RP18	 RP18
601419	MYOPATHY, MYOFIBRILLAR, 1; MFM1	 MFM1
601455	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D	 CMT4D
601457	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	
601462	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A	 CMS1A
601472	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	 CMT2D
601492	MUCOPOLYSACCHARIDOSIS, TYPE IX; MPS9	 MPS9
601493	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C	 CMD1C
601494	CARDIOMYOPATHY, DILATED, 1D; CMD1D	 CMD1D
601495	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1	 AGM1
601518	PROSTATE CANCER, HEREDITARY, 1; HPC1	 HPC1
601536	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS	 ABDS
601539	PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	 PBD1B
601543	DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12	 DFNA12
601544	DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A	 DFNA3A
601547	CATARACT 3, MULTIPLE TYPES; CTRCT3	 CTRCT3
601550	BLOOD GROUP--SWANN SYSTEM; SW	 SW
601551	BLOOD GROUP--FROESE	
601552	FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	 FDLAB
601553	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD	 HJMD
601559	STUVE-WIEDEMANN SYNDROME; STWS	 STWS
601583	WILMS TUMOR 5; WT5	 WT5
601596	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	 CMT4C
601606	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	
601626	LEUKEMIA, ACUTE MYELOID; AML	 AML
601631	ANTERIOR SEGMENT DYSGENESIS 3; ASGD3	 ASGD3
601634	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS	 NTDFS
601650	PARAGANGLIOMAS 2; PGL2	 PGL2
601665	OBESITY	
601675	TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	 TTD1
601678	BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1	 BARTS1
601680	ARTHROGRYPOSIS, DISTAL, TYPE 2B; DA2B	 DA2B
601705	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY	
601707	CURRY-JONES SYNDROME; CRJS	 CRJS
601709	QUEBEC PLATELET DISORDER; QPD	 QPD
601718	RETINITIS PIGMENTOSA 19; RP19	 RP19
601744	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1	 SLEB1
601776	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	 EDSMC1
601777	CONE-ROD DYSTROPHY 6; CORD6	 CORD6
601780	CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6	 CLN6
601800	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3; SHEP3	 SHEP3
601812	PREMATURE AGING SYNDROME, PENTTINEN TYPE; PENTT	 PENTT
601813	EXUDATIVE VITREORETINOPATHY 4; EVR4	 EVR4
601815	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD	 PHGDHD
601816	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1	 BILIQTL1
601820	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	 HHF2
601847	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2	 PFIC2
601859	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS	 ALPS
601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13	 DFNA13
601869	DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15	 DFNB15
601877	LEFT-RIGHT DETERMINATION FACTOR 2; LEFTY2	 LEFTY2
601884	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1	 BMND1
601885	CATARACT 14, MULTIPLE TYPES; CTRCT14	 CTRCT14
601887	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	
601894	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2	 GFND2
601942	DIABETES MELLITUS, INSULIN-DEPENDENT, 10; IDDM10	 IDDM10
601954	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 7; LGMDR7	 LGMDR7
601977	THROMBOCYTHEMIA 2; THCYT2	 THCYT2
602014	HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	 HOMG1
602032	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4	 ECTD4
602066	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA	 ICCA
602078	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	 CFEOM2
602079	TRIMETHYLAMINURIA; TMAU	 TMAU
602080	PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	 PDB2
602081	SPEECH-LANGUAGE DISORDER 1; SPCH1	 SPCH1
602082	CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB	 CDTB
602083	USHER SYNDROME, TYPE IF; USH1F	 USH1F
602088	NEPHRONOPHTHISIS 2; NPHP2	 NPHP2
602089	HEMANGIOMA, CAPILLARY INFANTILE	
602092	DEAFNESS, AUTOSOMAL RECESSIVE 18A; DFNB18A	 DFNB18A
602093	CONE DYSTROPHY 3; COD3	 COD3
602099	AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5	 ALS5
602111	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	
602271	SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	 SMDAX
602342	PIERPONT SYNDROME; PRPTS	 PRPTS
602347	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	 PFIC3
602361	GRACILE BONE DYSPLASIA; GCLEB	 GCLEB
602390	HEMOCHROMATOSIS, TYPE 2A; HFE2A	 HFE2A
602398	DESMOSTEROLOSIS	
602400	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	 ARCI11
602433	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4	 ALS4
602450	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	
602459	DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	 DFNA15
602473	ENCEPHALOPATHY, ETHYLMALONIC; EE	 EE
602475	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	 OPLL
602481	MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	 FHM2
602482	AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3	 RIEG3
602483	AURICULOCONDYLAR SYNDROME 1; ARCND1	 ARCND1
602485	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	 HHF3
602501	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP	 MCAP
602522	BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4A	 BARTS4A
602531	GRANGE SYNDROME; GRNG	 GRNG
602535	MARSHALL-SMITH SYNDROME; MRSHSS	 MRSHSS
602540	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS	
602557	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	 SEMDSH
602579	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	 CDG1B
602588	BRANCHIOOTIC SYNDROME 1; BOS1	 BOS1
602601	LOW DENSITY LIPOPROTEIN, OXIDIZED, RECEPTOR 1; OLR1	 OLR1
602629	DYSTONIA 6, TORSION; DYT6	 DYT6
602722	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR	 RTADR
602723	PSORIASIS 2; PSORS2	 PSORS2
602771	RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1	 RSMD1
602772	RETINITIS PIGMENTOSA 25; RP25	 RP25
602782	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	
602849	MUENKE SYNDROME; MNKES	 MNKES
602875	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDM	 AMDM
602914	AQUAPORIN 9; AQP9	 AQP9
603034	MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	 CMS5
603041	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	 MTDPS1
603075	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	 ARMD1
603147	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	 CDG1C
603174	HOMOCYSTEINEMIA	
603194	MECKEL SYNDROME, TYPE 2; MKS2	 MKS2
603218	HUNTINGTON DISEASE-LIKE 1; HDL1	 HDL1
603233	PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B	 PHP1B
603278	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1	 FSGS1
603284	CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2	 CCM2
603285	CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	 CCM3
603324	GAP JUNCTION PROTEIN, BETA-3; GJB3	 GJB3
603358	GRACILE SYNDROME	
603372	THYROID-STIMULATING HORMONE RECEPTOR; TSHR	 TSHR
603373	HYPERTHYROIDISM, FAMILIAL GESTATIONAL	
603383	GLAUCOMA 1, OPEN ANGLE, F; GLC1F	 GLC1F
603387	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1	 MPPH1
603457	BOSMA ARHINIA MICROPHTHALMIA SYNDROME; BAMS	 BAMS
603467	FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF	 FANCF
603471	CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2	 CTLN2
603511	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1; LGMDD1	 LGMDD1
603513	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1	 CPSQ1
603543	LIMB-MAMMARY SYNDROME; LMS	 LMS
603546	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2; SEMDJL2	 SEMDJL2
603552	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4	 FHL4
603553	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2	 FHL2
603554	OMENN SYNDROME	
603563	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8	 SPG8
603592	XANTHINURIA, TYPE II; XAN2	 XAN2
603622	DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17	 DFNA17
603629	DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21	 DFNB21
603649	CONE-ROD DYSTROPHY 7; CORD7	 CORD7
603671	ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	 AFND
603688	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY	
603689	HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF	 HMERF
603720	DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	 DFNB16
603736	OHDO SYNDROME, SBBYS VARIANT; SBBYSS	 SBBYSS
603776	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3	 HCHOLA3
603786	STARGARDT DISEASE 4; STGD4	 STGD4
603813	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	 ARH
603829	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1	 VF1
603830	LONG QT SYNDROME 3; LQT3	 LQT3
603860	MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2	 MCKD2
603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	 VWM
603902	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE	
603903	SICKLE CELL ANEMIA	
603909	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A	 ALPS2A
603932	INTERVERTEBRAL DISC DISEASE; IDD	 IDD
603956	CERVICAL CANCER	
603965	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	 FSGS2
604004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1	 MLC1
604091	HYPOALPHALIPOPROTEINEMIA, PRIMARY	
604093	KERATOSIS PILARIS ATROPHICANS; KPA	 KPA
604116	CONE-ROD DYSTROPHY 3; CORD3	 CORD3
604117	VOHWINKEL SYNDROME, VARIANT FORM	
604121	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	 ADCADN
604129	EPIDERMOLYSIS BULLOSA PRURIGINOSA	
604131	ALPHA-THALASSEMIA	
604145	CARDIOMYOPATHY, DILATED, 1G; CMD1G	 CMD1G
604168	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	 CCFDN
604169	LEFT VENTRICULAR NONCOMPACTION 1; LVNC1	 LVNC1
604173	POIKILODERMA WITH NEUTROPENIA; PN	 PN
604187	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10	 SPG10
604218	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	 FENIB
604219	CATARACT 9, MULTIPLE TYPES; CTRCT9	 CTRCT9
604229	ANTERIOR SEGMENT DYSGENESIS 5; ASGD5	 ASGD5
604232	LEBER CONGENITAL AMAUROSIS 3; LCA3	 LCA3
604233	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1	 GEFSP1
604250	HEMOCHROMATOSIS, TYPE 3; HFE3	 HFE3
604271	GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	 GHIP
604273	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	 MC5DN1
604278	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION	
604286	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4; LGMDR4	 LGMDR4
604290	ACERULOPLASMINEMIA	
604292	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	 EEC3
604302	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE	
604307	CATARACT 2, MULTIPLE TYPES; CTRCT2	 CTRCT2
604308	MASS SYNDROME	
604317	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2	 MCPH2
604320	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	 DSMA1
604321	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	 MCPH4
604326	SPINOCEREBELLAR ATAXIA 12; SCA12	 SCA12
604348	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	 FASPS1
604352	FEBRILE SEIZURES, FAMILIAL, 4; FEB4	 FEB4
604356	DUANE RETRACTION SYNDROME 2; DURS2	 DURS2
604360	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11	 SPG11
604364	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1; FFEVF1	 FFEVF1
604367	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3	 FPLD3
604369	SALLA DISEASE; SD	 SD
604370	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1	 BROVCA1
604373	CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2	 CHEK2
604377	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	 CEMCOX1
604379	HYPOTRICHOSIS 7; HYPT7	 HYPT7
604387	NEPHRONOPHTHISIS 3; NPHP3	 NPHP3
604391	ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	 ATLD1
604393	LEBER CONGENITAL AMAUROSIS 4; LCA4	 LCA4
604400	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	 ARVD5
604403	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2	 GEFSP2
604416	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	
604432	SPINOCEREBELLAR ATAXIA 11; SCA11	 SCA11
604454	WELANDER DISTAL MYOPATHY; WDM	 WDM
604484	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	 HMSNO
604498	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT	 CAMT
604536	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME	
604537	LEBER CONGENITAL AMAUROSIS 5; LCA5	 LCA5
604559	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B	 PFHB1B
604563	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	 CMT4B2
604571	BARE LYMPHOCYTE SYNDROME, TYPE I	
604625	TOOTH AGENESIS, SELECTIVE, 3; STHAG3	 STHAG3
604715	ORTHOSTATIC INTOLERANCE	
604717	DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20	 DFNA20
604757	CRANIOSYNOSTOSIS 2; CRS2	 CRS2
604765	CARDIOMYOPATHY, DILATED, 1I; CMD1I	 CMD1I
604772	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	 CPVT1
604777	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5	 ARCI5
604804	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	 MCPH3
604805	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12	 SPG12
604841	STICKLER SYNDROME, TYPE II; STL2	 STL2
604864	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA; OSCDP	 OSCDP
604906	SCHIZOPHRENIA 9; SCZD9	 SCZD9
604931	CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	 CORTRD1
605019	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2	 FHBL2
605021	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME	 FIME
605027	LYMPHOMA, NON-HODGKIN, FAMILIAL	
605039	BOHRING-OPITZ SYNDROME; BOPS	 BOPS
605041	BROOKE-SPIEGLER SYNDROME; BRSS	 BRSS
605074	RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1	 RCCP1
605115	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY	
605130	WIEDEMANN-STEINER SYNDROME; WDSTS	 WDSTS
605192	DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	 DFNA23
605218	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2	 SLEB2
605231	BARDET-BIEDL SYNDROME 6; BBS6	 BBS6
605253	NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	 CHN1
605258	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2	 HIGM2
605259	SPINOCEREBELLAR ATAXIA 13; SCA13	 SCA13
605271	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 10; SERPINA10	 SERPINA10
605280	SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13	 SPG13
605282	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS	 TPBS
605285	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	 HMSNR
605289	SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	 SHFM4
605309	MACROCEPHALY/AUTISM SYNDROME	
605361	SPINOCEREBELLAR ATAXIA 14; SCA14	 SCA14
605362	CARDIOMYOPATHY, DILATED, 1J; CMD1J	 CMD1J
605375	EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	 ENFL3
605376	HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2	 HTX2
605387	CATARACT 31, MULTIPLE TYPES; CTRCT31	 CTRCT31
605389	HYPOTRICHOSIS 1; HYPT1	 HYPT1
605407	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	
605428	DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26	 DFNB26
605429	DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF; DFNB26M	 DFNB26M
605462	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1	 BCC1
605472	USHER SYNDROME, TYPE IIC; USH2C	 USH2C
605479	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	 BRIC2
605543	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4	 PARK4
605583	DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25	 DFNA25
605588	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	 CMT2B1
605589	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2	 CMT2B2
605594	DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	
605635	HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	 HALD2
605637	MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	
605670	LATE-ONSET RETINAL DEGENERATION; LORD	 LORD
605676	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	 DCWHK
605711	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	 MMDS1
605714	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED	
605724	FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1	 FANCD1
605726	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2	 DSMA2
605751	SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2	 BFIS2
605803	DERMATITIS, ATOPIC, 2; ATOD2	 ATOD2
605809	MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	 CMS4A
605814	CITRULLINEMIA, TYPE II, NEONATAL-ONSET	
605820	NONAKA MYOPATHY; NM	 NM
605822	SPONDYLOOCULAR SYNDROME; SOS	 SOS
605850	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD	 DMGDHD
605899	GLYCINE ENCEPHALOPATHY; GCE	 GCE
605906	LIM DOMAIN-BINDING 3; LDB3	 LDB3
605909	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6	 PARK6
605911	3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY; HMGCS2D	 HMGCS2D
605990	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO	
606002	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	 SCAR1
606054	PROPIONIC ACIDEMIA	
606056	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B	 CDG2B
606068	RETINITIS PIGMENTOSA 28; RP28	 RP28
606069	HEMOCHROMATOSIS, TYPE 4; HFE4	 HFE4
606070	AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21	 ALS21
606071	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	 HMSN2C
606072	RIPPLING MUSCLE DISEASE 2; RMD2	 RMD2
606159	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	 NBIA3
606170	GENITOPATELLAR SYNDROME; GTPTS	 GTPTS
606176	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	 PNDM
606217	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2	 AVSD2
606232	PHELAN-MCDERMID SYNDROME; PHMDS	 PHMDS
606255	STATURE AS A QUANTITATIVE TRAIT	
606324	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7	 PARK7
606346	DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	 DFNA22
606353	PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	 PLSJ
606367	IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41	 IMD41
606391	MATURITY-ONSET DIABETES OF THE YOUNG; MODY	 MODY
606392	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4; MODY4	 MODY4
606394	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6; MODY6	 MODY6
606407	HYPOTONIA-CYSTINURIA SYNDROME	
606408	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	 EDSCLL
606438	HUNTINGTON DISEASE-LIKE 2; HDL2	 HDL2
606482	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	 CMTDIB
606545	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3; ARCI3	 ARCI3
606574	ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4	 OCA4
606579	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1	 VAMAS1
606593	LIG4 SYNDROME	
606595	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	 CMT2F
606612	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT MENTAL RETARDATION), TYPE B, 5; MDDGB5	 MDDGB5
606641	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 1; BMIQ1	 BMIQ1
606657	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	
606658	SPINOCEREBELLAR ATAXIA 15; SCA15	 SCA15
606664	GLYCINE N-METHYLTRANSFERASE DEFICIENCY	
606685	CARDIOMYOPATHY, DILATED, 1L; CMD1L	 CMD1L
606688	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	
606690	LYMPHANGIOLEIOMYOMATOSIS; LAM	 LAM
606693	KUFOR-RAKEB SYNDROME; KRS	 KRS
606703	DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	 FDFM
606705	DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36	 DFNA36
606713	VAN DER WOUDE SYNDROME 2; VWS2	 VWS2
606719	MELANOMA-PANCREATIC CANCER SYNDROME	
606721	PARTIAL LIPODYSTROPHY, CONGENITAL CATARACTS, AND NEURODEGENERATION SYNDROME; LCCNS	 LCCNS
606744	SECKEL SYNDROME 2; SCKL2	 SCKL2
606762	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	 HHF6
606763	CILIARY DYSKINESIA, PRIMARY, 2; CILD2	 CILD2
606764	GASTROINTESTINAL STROMAL TUMOR; GIST	 GIST
606766	SPERMATOGENIC FAILURE 3; SPGF3	 SPGF3
606768	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	 DMAT
606777	GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1	 GLUT1DS1
606785	CRIGLER-NAJJAR SYNDROME, TYPE II	
606798	BLEPHAROSPASM, BENIGN ESSENTIAL, SUSCEPTIBILITY TO	
606812	FUMARASE DEFICIENCY; FMRD	 FMRD
606824	GLUCOSE/GALACTOSE MALABSORPTION; GGM	 GGM
606835	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB	 FDAB
606843	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3	 HIGM3
606854	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP	 BFPP
606856	PANCREATIC CANCER, SUSCEPTIBILITY TO, 1	
606857	GLUTAMATE-CYSTEINE LIGASE, CATALYTIC SUBUNIT; GCLC	 GCLC
606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	
606889	ALZHEIMER DISEASE 4	
606893	VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	
606943	USHER SYNDROME, TYPE IG; USH1G	 USH1G
606952	ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B	 OCA1B
606966	NEPHRONOPHTHISIS 4; NPHP4	 NPHP4
606996	SENIOR-LOKEN SYNDROME 4; SLSN4	 SLSN4
607014	HURLER SYNDROME	
607015	HURLER-SCHEIE SYNDROME	
607016	SCHEIE SYNDROME	
607060	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	 PARK8
607078	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	 EDM5
607080	46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY	
607084	DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31	 DFNB31
607091	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D	 CDG2D
607101	DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	 DFNB30
607115	CINCA SYNDROME; CINCA	 CINCA
607131	AL-GAZALI-BAKALINOVA SYNDROME; AGBK	 AGBK
607143	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	 CDG1G
607151	MOYAMOYA DISEASE 2; MYMY2	 MYMY2
607154	ALLERGIC RHINITIS	
607155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	 MDDGC5
607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	
607196	MICROCEPHALY, AMISH TYPE; MCPHA	 MCPHA
607200	THYROID DYSHORMONOGENESIS 6; TDH6	 TDH6
607208	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6	 EIEE6
607225	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	 IAHSP
607236	HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION	
607250	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY; SCAN1	 SCAN1
607259	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	 SPG7
607271	CASPASE 8 DEFICIENCY	
607277	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1	
607278	OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO; OSFD	 OSFD
607313	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	 HGPPS1
607323	DUANE-RADIAL RAY SYNDROME; DRRS	 DRRS
607326	SMITH-MCCORT DYSPLASIA 1; SMC1	 SMC1
607330	LATHOSTEROLOSIS	
607341	FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2	 FCORD2
607346	SPINOCEREBELLAR ATAXIA 19; SCA19	 SCA19
607361	MECKEL SYNDROME, TYPE 3; MKS3	 MKS3
607364	BARTTER SYNDROME, TYPE 3; BARTS3	 BARTS3
607371	DYSTONIA, JUVENILE-ONSET; DJO	 DJO
607417	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	 MRT2
607426	COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	 COQ10D1
607432	LISSENCEPHALY 1; LIS1	 LIS1
607447	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4	 BMIQ4
607450	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8	 ARVD8
607453	DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44	 DFNA44
607454	SPINOCEREBELLAR ATAXIA 21; SCA21	 SCA21
607459	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	 SANDO
607464	THYROID CARCINOMA, HURTHLE CELL	
607473	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2	 VKCFD2
607475	BOTHNIA RETINAL DYSTROPHY	
607476	NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD	 NFRCD
607482	CARDIOMYOPATHY, DILATED, 1M; CMD1M	 CMD1M
607483	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	 THMD2
607485	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	
607487	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25	 CMH25
607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO	
607514	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10; BMIQ10	 BMIQ10
607523	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8	 NDNC8
607539	CAMPTOSYNPOLYDACTYLY, COMPLEX; CCSPD	 CCSPD
607541	CORNEAL DYSTROPHY, AVELLINO TYPE; CDA	 CDA
607554	ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	 ATFB3
607595	BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES; BSVD	 BSVD
607598	LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2	 LCCS2
607602	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS	
607616	NIEMANN-PICK DISEASE, TYPE B	
607624	GRISCELLI SYNDROME, TYPE 2; GS2	 GS2
607625	NIEMANN-PICK DISEASE, TYPE C2; NPC2	 NPC2
607628	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11	 EIG11
607631	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1	 EJA1
607634	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	 OPTA1
607636	VAN BUCHEM DISEASE, TYPE 2	
607641	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B	 HMN7B
607654	KERATOSIS PALMOPLANTARIS STRIATA III; PPKS3	 PPKS3
607655	SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	 SFWHS
607676	IRAK4 DEFICIENCY	
607677	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I	 CMT2I
607678	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	 CMT1D
607681	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2; ECA2	 ECA2
607682	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9	 EIG9
607684	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	 CMT2E
607685	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES	 HES
607688	PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK11	 PARK11
607694	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7	 HLD7
607706	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE	
607721	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	 NSLH1
607734	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	 CMT1F
607736	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J	 CMT2J
607745	SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	 BFIS3
607748	HYPERCHOLANEMIA, FAMILIAL; FHCA	 FHCA
607765	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	 CBAS1
607778	ACROCAPITOFEMORAL DYSPLASIA; ACFD	 ACFD
607785	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML	 JMML
607791	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID	 CMTDID
607812	CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD	 CLSD
607821	DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	 DFNB37
607822	ALZHEIMER DISEASE 3; AD	 AD
607823	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	 HLTS
607829	MITRAL VALVE PROLAPSE 2; MVP2	 MVP2
607831	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	 CMT2K
607832	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3	 FSGS3
607842	AURAL ATRESIA, CONGENITAL; CAA	 CAA
607847	NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS	
607855	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	 MDC1A
607864	CAUDAL DUPLICATION ANOMALY	
607876	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2	 FAME2
607903	HYPOTRICHOSIS 6; HYPT6	 HYPT6
607906	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	 CDG1I
607907	DERMATOFIBROSARCOMA PROTUBERANS; DFSP	 DFSP
607932	MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	 MCOPS6
607936	PEELING SKIN SYNDROME 4; PSS4	 PSS4
607941	ATRIAL SEPTAL DEFECT 2; ASD2	 ASD2
607944	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	 SPENCDI
607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	
608013	GAUCHER DISEASE, PERINATAL LETHAL	
608022	DIAPHANOSPONDYLODYSOSTOSIS	
608027	PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3	 PCH3
608030	AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6	 ALS6
608033	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3	 IIAE3
608051	MACULAR DYSTROPHY, RETINAL, 2; MCDR2	 MCDR2
608089	ENDOMETRIAL CANCER	
608091	JOUBERT SYNDROME 2; JBTS2	 JBTS2
608093	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	 CDG1J
608097	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	 ARPHM
608099	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3; LGMDR3	 LGMDR3
608104	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	 CDG1H
608106	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5	 HIGM5
608115	OVARIAN HYPERSTIMULATION SYNDROME; OHSS	 OHSS
608118	ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	 TNZD
608133	RETINITIS PIGMENTOSA 7; RP7	 RP7
608161	MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	 VMD3
608175	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3	 AITD3
608180	SYNPOLYDACTYLY 2; SPD2	 SPD2
608189	TROPICAL CALCIFIC PANCREATITIS	
608194	CONE-ROD DYSTROPHY 13; CORD13	 CORD13
608203	NEUTROPHIL IMMUNODEFICIENCY SYNDROME	
608224	DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	 DFNA41
608232	LEUKEMIA, CHRONIC MYELOID; CML	 CML
608233	HERMANSKY-PUDLAK SYNDROME 2; HPS2	 HPS2
608236	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT; SNCV	 SNCV
608265	DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39	 DFNB39
608266	PARATHYROID CARCINOMA	
608320	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	 ADCAD1
608323	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	 CMTDIC
608328	WEILL-MARCHESANI SYNDROME 2; WMS2	 WMS2
608340	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA	 CMTRIA
608354	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1; CMAVM1	 CMAVM1
608355	MOVED TO 608354	
608358	MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA	 MSMA
608361	SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE; SEDK	 SEDK
608380	RETINITIS PIGMENTOSA 26; RP26	 RP26
608389	BRANCHIOOTIC SYNDROME 3; BOS3	 BOS3
608390	MYOTONIA, POTASSIUM-AGGRAVATED	
608393	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6	 MCPH6
608404	PLATELET GLYCOPROTEIN IV DEFICIENCY	
608415	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS	 PERRS
608423	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	 LGMDD2
608443	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	 MRT3
608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	
608456	FAMILIAL ADENOMATOUS POLYPOSIS 2; FAP2	 FAP2
608470	CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB	 CDRB
608471	CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A	 CDL3A
608516	MAJOR DEPRESSIVE DISORDER; MDD	 MDD
608540	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	 CDG1K
608553	LEBER CONGENITAL AMAUROSIS 9; LCA9	 LCA9
608556	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO	
608565	DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35	 DFNB35
608567	SICK SINUS SYNDROME 1; SSS1	 SSS1
608569	CARDIOMYOPATHY, DILATED, 1O; CMD1O	 CMD1O
608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO	
608584	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2	
608594	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1	 CGL1
608611	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY	
608612	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	 MADB
608615	OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS	 ODCRCS
608627	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	 ALS8
608629	JOUBERT SYNDROME 3; JBTS3	 JBTS3
608634	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	 HMN2B
608641	DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28	 DFNA28
608643	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	
608644	CILIARY DYSKINESIA, PRIMARY, 3; CILD3	 CILD3
608647	CILIARY DYSKINESIA, PRIMARY, 5; CILD5	 CILD5
608649	ICHTHYOSIS PREMATURITY SYNDROME; IPS	 IPS
608653	DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	 DFNB32
608654	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5	 HSAN5
608673	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	 CMT2L
608681	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	 SCDO2
608687	SPINOCEREBELLAR ATAXIA 20; SCA20	 SCA20
608688	AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	
608709	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD	 APLD
608716	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5	 MCPH5
608728	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED	
608747	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY	
608751	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8	 CMH8
608758	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	 CMH10
608765	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3; IS3	 IS3
608776	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	 CDG1L
608779	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	 CDG2E
608799	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E	 CDG1E
608800	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT	 SIDDT
608804	LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2	 HLD2
608805	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1; ANFH1	 ANFH1
608807	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	 LGMDR10
608808	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1; DTGA1	 DTGA1
608810	MYOPATHY, MYOFIBRILLAR, 2; MFM2	 MFM2
608812	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1	 CRCS1
608836	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	
608837	CARNEY COMPLEX VARIANT	
608840	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6; MDDGB6	 MDDGB6
608864	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	 OFC6
608874	OROFACIAL CLEFT 5; OFC5	 OFC5
608885	STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	 SDCHCN
608890	WAARDENBURG SYNDROME, TYPE 2D; WS2D	 WS2D
608895	NEUROPATHY, HEREDITARY, WITH OR WITHOUT AGE-RELATED MACULAR DEGENERATION; HNARMD	 HNARMD
608898	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3	 FHL3
608901	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5	
608907	ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	 AD9
608908	MYOPIA 6; MYP6	 MYP6
608930	MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	 CMS1B
608931	MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C	 CMS4C
608940	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	 SMDCRD
608957	CD8 DEFICIENCY, FAMILIAL	
608970	MACULAR DYSTROPHY, PATTERNED, 2; MDPT2	 MDPT2
608971	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	
608978	MEACHAM SYNDROME	
608980	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	 BNAR
608984	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1	 SNAX1
608996	PREMATURE OVARIAN FAILURE 3; POF3	 POF3
609006	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT; DFNB36	 DFNB36
609015	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	 MTPD
609016	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	
609033	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	 AXPC1
609040	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9	 ARVD9
609048	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3	 CMM3
609049	PIERSON SYNDROME	
609053	FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	 FANCI
609054	FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	 FANCJ
609056	SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	 SPDRS
609057	NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	
609060	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1	 COXPD1
609069	PANCREATIC AND CEREBELLAR AGENESIS; PACA	 PACA
609115	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 3; LGMDD3	 LGMDD3
609129	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1; AUNA1	 AUNA1
609135	APLASTIC ANEMIA	
609136	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	 PCWH
609140	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2	 PPCD2
609141	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3	 PPCD3
609152	HYPERTHYROIDISM, NONAUTOIMMUNE	
609153	PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK; PSHK2	 PSHK2
609161	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1; ADSD1	 ADSD1
609162	CZECH DYSPLASIA	
609165	ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE	 CRIE
609180	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F	 CDG1F
609192	LOEYS-DIETZ SYNDROME 1; LDS1	 LDS1
609195	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	 SPG26
609200	MYOPATHY, MYOFIBRILLAR, 3; MFM3	 MFM3
609218	FOVEAL HYPOPLASIA 2; FVH2	 FVH2
609220	BRUCK SYNDROME 2; BRKS2	 BRKS2
609227	GRISCELLI SYNDROME, TYPE 3; GS3	 GS3
609241	SCHINDLER DISEASE, TYPE I	
609242	KANZAKI DISEASE	
609254	SENIOR-LOKEN SYNDROME 5; SLSN5	 SLSN5
609260	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A	 CMT2A2A
609265	LI-FRAUMENI SYNDROME 2; LFS2	 LFS2
609270	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	 SCAR7
609273	NEMALINE MYOPATHY 6; NEM6	 NEM6
609283	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	 PEOA2
609284	NEMALINE MYOPATHY 1; NEM1	 NEM1
609285	NEMALINE MYOPATHY 4; NEM4	 NEM4
609286	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	 PEOA3
609304	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	 EIEE3
609306	SPINOCEREBELLAR ATAXIA 26; SCA26	 SCA26
609307	SPINOCEREBELLAR ATAXIA 27; SCA27	 SCA27
609308	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1	 MDDGC1
609310	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2	 HNPCC2
609311	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	 CMT4H
609322	RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1	 RTPS1
609338	CAROTID INTIMAL MEDIAL THICKNESS 1	
609352	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA	
609404	PREECLAMPSIA/ECLAMPSIA 4; PEE4	 PEE4
609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO	
609432	SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD	 MSSD
609439	DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48	 DFNB48
609441	ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	 AMDD
609446	PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	 PNKD3
609452	MYOPATHY, MYOFIBRILLAR, 4; MFM4	 MFM4
609460	GOLDBERG-SHPRINTZEN SYNDROME; GOSHS	 GOSHS
609508	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	
609524	MYOPATHY, MYOFIBRILLAR, 5; MFM5	 MFM5
609529	IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2	 IGAD2
609533	DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23	 DFNB23
609536	COMPLEMENT COMPONENT 5 DEFICIENCY; C5D	 C5D
609541	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	 SPOAN
609549	NANOPHTHALMOS 2; NNO2	 NNO2
609560	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2	 MTDPS2
609579	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION	
609583	JOUBERT SYNDROME 4; JBTS4	 JBTS4
609597	PARIETAL FORAMINA 2; PFM2	 PFM2
609620	SHORT QT SYNDROME 1; SQT1	 SQT1
609621	SHORT QT SYNDROME 2; SQT2	 SQT2
609622	SHORT QT SYNDROME 3; SQT3	 SQT3
609628	MAJEED SYNDROME; MJDS	 MJDS
609634	MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3	 FHM3
609637	HOLOPROSENCEPHALY 5; HPE5	 HPE5
609638	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	 EBLA
609646	DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42	 DFNB42
609698	THYROID HORMONE METABOLISM, ABNORMAL	
609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53	 DFNB53
609734	OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	 OBAIRH
609741	CATARACT 22, MULTIPLE TYPES; CTRCT22	 CTRCT22
609755	CELIAC DISEASE, SUSCEPTIBILITY TO, 3; CELIAC3	 CELIAC3
609796	PEELING SKIN SYNDROME 2; PSS2	 PSS2
609813	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	 SCDO3
609814	COMPLEMENT FACTOR H DEFICIENCY; CFHD	 CFHD
609820	ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3	 ECYT3
609821	BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	 BDPLT8
609823	DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28	 DFNB28
609886	GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA	
609887	GLAUCOMA 1, OPEN ANGLE, G; GLC1G	 GLC1G
609889	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY	
609909	CARDIOMYOPATHY, DILATED, 1P; CMD1P	 CMD1P
609923	RETINITIS PIGMENTOSA 31; RP31	 RP31
609924	AMINOACYLASE 1 DEFICIENCY; ACY1D	 ACY1D
609939	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	 SLEB6
609942	NOONAN SYNDROME 3; NS3	 NS3
609968	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	 HHF5
609975	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	 HHF4
609981	IMMUNODEFICIENCY 54; IMD54	 IMD54
610003	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	
610006	2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	
610015	GLUTAMINE DEFICIENCY, CONGENITAL	
610017	MULTIPLE SYNOSTOSES SYNDROME 2; SYNS2	 SYNS2
610019	CATARACT 18; CTRCT18	 CTRCT18
610021	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	 HHF7
610031	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7	 CDCBM7
610042	PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	 PTHSL1
610048	CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD	 CSCD
610069	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2	 HMPS2
610090	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD	 PNPOD
610092	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3	 MCOPCB3
610093	MICROPHTHALMIA, ISOLATED 2; MCOP2	 MCOP2
610100	GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT; GAN2	 GAN2
610102	COMPLEMENT COMPONENT 7 DEFICIENCY; C7D	 C7D
610125	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	 MCOPS5
610127	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10	 CLN10
610131	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	 PEOA4
610140	HEART-HAND SYNDROME, SLOVENIAN TYPE	
610149	MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7	 ARMD7
610153	DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49	 DFNB49
610154	DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44	 DFNB44
610155	DIABETES MELLITUS, INSULIN-DEPENDENT, 19; IDDM19	 IDDM19
610156	MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	 MORMS
610168	LOEYS-DIETZ SYNDROME 2; LDS2	 LDS2
610181	AICARDI-GOUTIERES SYNDROME 2; AGS2	 AGS2
610185	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2	 CAMRQ2
610187	DIAPHRAGMATIC HERNIA 3; DIH3	 DIH3
610188	JOUBERT SYNDROME 5; JBTS5	 JBTS5
610189	SENIOR-LOKEN SYNDROME 6; SLSN6	 SLSN6
610193	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10	 ARVD10
610199	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	 NDH
610202	CATARACT 21, MULTIPLE TYPES; CTRCT21	 CTRCT21
610204	PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	 PCH5
610205	ALAGILLE SYNDROME 2; ALGS2	 ALGS2
610212	DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	 DFNB66
610217	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	 NBIA2B
610220	DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59	 DFNB59
610227	SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS	
610244	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33	 SPG33
610245	SPINOCEREBELLAR ATAXIA 23; SCA23	 SCA23
610246	SPINOCEREBELLAR ATAXIA 28; SCA28	 SCA28
610250	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31	 SPG31
610253	KLEEFSTRA SYNDROME 1; KLEFS1	 KLEFS1
610256	ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	 ASGD2
610265	DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67	 DFNB67
610282	RETINITIS PIGMENTOSA 35; RP35	 RP35
610283	CONE-ROD DYSTROPHY 10; CORD10	 CORD10
610293	GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY; GPID	 GPID
610297	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13	 PARK13
610313	CRISPONI/COLD-INDUCED SWEATING SYNDROME 2; CISS2	 CISS2
610329	AICARDI-GOUTIERES SYNDROME 3; AGS3	 AGS3
610333	AICARDI-GOUTIERES SYNDROME 4; AGS4	 AGS4
610353	EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	 ENFL4
610356	RETINAL CONE DYSTROPHY 3B; RCD3B	 RCD3B
610357	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30	 SPG30
610359	RETINITIS PIGMENTOSA 33; RP33	 RP33
610370	DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4	 DIAR4
610374	DIABETES MELLITUS, TRANSIENT NEONATAL, 2	
610377	MEVALONIC ACIDURIA; MEVA	 MEVA
610379	WEST NILE VIRUS, SUSCEPTIBILITY TO	
610381	CONE-ROD DYSTROPHY 11; CORD11	 CORD11
610419	DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68	 DFNB68
610424	HEPATITIS B VIRUS, SUSCEPTIBILITY TO	
610425	CATARACT 23, MULTIPLE TYPES; CTRCT23	 CTRCT23
610427	CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD	 CRSD
610442	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	 SEMDG
610444	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	 CSNBAD3
610445	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1	 CSNBAD1
610448	CHILBLAIN LUPUS 1; CHBL1	 CHBL1
610455	TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC	 NFTC
610460	THIOPURINES, POOR METABOLISM OF, 1; THPM1	 THPM1
610474	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS	 CATSHLS
610475	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2	 PPNAD2
610476	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11	 ARVD11
610478	RETINAL CONE DYSTROPHY 4; RCD4	 RCD4
610489	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1	 PPNAD1
610498	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	 COXPD2
610504	PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM	 PPROM
610505	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3	 COXPD3
610508	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7	 MODY7
610532	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	 HLD5
610536	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	 MFDGA
610539	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	
610542	MYASTHENIC SYNDROME, CONGENITAL, 12; CMS12	 CMS12
610549	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	
610551	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 1; IIAE1	 IIAE1
610582	DIABETES MELLITUS, TRANSIENT NEONATAL, 3	
610599	RETINITIS PIGMENTOSA 36; RP36	 RP36
610600	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	
610612	LEBER CONGENITAL AMAUROSIS 12; LCA12	 LCA12
610618	ANGIOEDEMA, HEREDITARY, TYPE III; HAE3	 HAE3
610623	CATARACT 11, MULTIPLE TYPES; CTRCT11	 CTRCT11
610628	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	 HH4
610651	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB	 XPB
610682	OSTEOGENESIS IMPERFECTA, TYPE VII; OI7	 OI7
610687	NEMALINE MYOPATHY 7; NEM7	 NEM7
610688	JOUBERT SYNDROME 6; JBTS6	 JBTS6
610698	MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4	 ARMD4
610706	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	
610708	OPTIC ATROPHY 5; OPA5	 OPA5
610713	BRACHYDACTYLY-SYNDACTYLY SYNDROME; BDSD	 BDSD
610717	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	 NLSDM
610725	NEPHROTIC SYNDROME, TYPE 3; NPHS3	 NPHS3
610733	NOONAN SYNDROME 4; NS4	 NS4
610738	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	 SCN3
610743	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	 SCAR8
610755	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	 MEN4
610756	CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	 COFS2
610758	CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	 COFS4
610768	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M	 CDG1M
610773	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY	
610799	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1	 IPD1
610805	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1; CAKUT1	 CAKUT1
610828	HOLOPROSENCEPHALY 7; HPE7	 HPE7
610829	HOLOPROSENCEPHALY 9; HPE9	 HPE9
610832	FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	 FANCN
610842	PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	
610852	CILIARY DYSKINESIA, PRIMARY, 6; CILD6	 CILD6
610878	VESICOURETERAL REFLUX 2; VUR2	 VUR2
610896	BRANCHIOOTORENAL SYNDROME 2; BOR2	 BOR2
610913	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2	 SMDP2
610915	OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8	 OI8
610921	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3	 SMDP3
610927	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9; SLEB9	 SLEB9
610938	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7	 CHDS7
610947	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	 ADCAD2
610951	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	 CLN7
610954	PITT-HOPKINS SYNDROME; PTHS	 PTHS
610965	XFE PROGEROID SYNDROME; XFEPS	 XFEPS
610967	OSTEOGENESIS IMPERFECTA, TYPE V; OI5	 OI5
610968	OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	 OI11
610978	CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP	 CAHTP
610984	COMPLEMENT FACTOR I DEFICIENCY; CFID	 CFID
610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4	 LPRS4
610992	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	 PSATD
611022	DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24	 DFNB24
611038	MICROPHTHALMIA, ISOLATED 3; MCOP3	 MCOP3
611040	MICROPHTHALMIA, ISOLATED 5; MCOP5	 MCOP5
611064	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5	
611067	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4	 DSMA4
611081	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 10; IBD10	 IBD10
611087	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	 PMSE
611090	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12	 MRT12
611091	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5	 MRT5
611092	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	 MRT6
611093	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7	 MRT7
611102	DEAFNESS-INFERTILITY SYNDROME; DIS	 DIS
611105	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	 LBSL
611126	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20	 MC1DN20
611131	RETINITIS PIGMENTOSA 37; RP37	 RP37
611134	MECKEL SYNDROME, TYPE 4; MKS4	 MKS4
611136	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EIG13	 EIG13
611162	MALARIA, SUSCEPTIBILITY TO	
611174	HAMAMY SYNDROME; HMMS	 HMMS
611182	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H	 CDG2H
611209	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	 CDG2G
611225	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	 SPG18
611228	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J	 CMT4J
611263	SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY; SRTD2	 SRTD2
611277	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3; GEFSP3	 GEFSP3
611283	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	
611291	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	
611302	SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	 SPAX2
611307	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12	 LGMDR12
611363	ATRIAL SEPTAL DEFECT 4; ASD4	 ASD4
611369	LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3	 LCCS3
611376	MUNGAN SYNDROME; MGS	 MGS
611377	BRACHYDACTYLY, TYPE B2; BDB2	 BDB2
611378	MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9	 ARMD9
611383	USHER SYNDROME, TYPE IID; USH2D	 USH2D
611390	SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3	 SPAX3
611391	CATARACT 33, MULTIPLE TYPES; CTRCT33	 CTRCT33
611407	CARDIOMYOPATHY, DILATED, 1W; CMD1W	 CMD1W
611431	LEGIUS SYNDROME; LGSS	 LGSS
611451	DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63	 DFNB63
611465	GALLBLADDER DISEASE 4; GBD4	 GBD4
611489	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	
611490	OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	 OPTB4
611493	ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4	 ATFB4
611497	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6	 OPTB6
611498	NEPHRONOPHTHISIS 7; NPHP7	 NPHP7
611521	IMMUNODEFICIENCY 35; IMD35	 IMD35
611523	PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6	 PCH6
611528	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12	 ARVD12
611543	CAVITARY OPTIC DISC ANOMALIES; CODA	 CODA
611544	CATARACT 17, MULTIPLE TYPES; CTRCT17	 CTRCT17
611548	PREMATURE OVARIAN FAILURE 5; POF5	 POF5
611553	NOONAN SYNDROME 5; NS5	 NS5
611554	LEOPARD SYNDROME 2; LPRD2	 LPRD2
611556	GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	 GSD0B
611560	JOUBERT SYNDROME 7; JBTS7	 JBTS7
611561	MECKEL SYNDROME, TYPE 5; MKS5	 MKS5
611584	WAARDENBURG SYNDROME, TYPE 2E; WS2E	 WS2E
611588	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	 MDDGC4
611590	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	
611597	CATARACT 12, MULTIPLE TYPES; CTRCT12	 CTRCT12
611603	LISSENCEPHALY 3; LIS3	 LIS3
611615	CARDIOMYOPATHY, DILATED, 1X; CMD1X	 CMD1X
611638	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5	 MCOPCB5
611664	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7; SHEP7	 SHEP7
611705	SALIH MYOPATHY; SALMY	 SALMY
611718	HYPOMAGNESEMIA 4, RENAL; HOMG4	 HOMG4
611719	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	 COXPD5
611721	COMBINED SAPOSIN DEFICIENCY	
611722	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY	
611726	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3	 EPM3
611755	LEBER CONGENITAL AMAUROSIS 10; LCA10	 LCA10
611762	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	 FCAS2
611771	LIPOPROTEIN GLOMERULOPATHY; LPG	 LPG
611773	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC	 HANAC
611777	BRUGADA SYNDROME 2; BRGDA2	 BRGDA2
611783	ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4	 ECYT4
611788	AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6	 AAT6
611804	ELLIPTOCYTOSIS 1; EL1	 EL1
611809	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB	 ARB
611812	46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	 SERKAL
611816	TEMPLE-BARAITSER SYNDROME; TMBTS	 TMBTS
611818	LONG QT SYNDROME 9; LQT9	 LQT9
611819	LONG QT SYNDROME 10; LQT10	 LQT10
611820	LONG QT SYNDROME 11; LQT11	 LQT11
611868	PROSTATE CANCER, HEREDITARY, 12; HPC12	 HPC12
611875	BRUGADA SYNDROME 3; BRGDA3	 BRGDA3
611876	BRUGADA SYNDROME 4; BRGDA4	 BRGDA4
611878	CARDIOMYOPATHY, DILATED, 1Y; CMD1Y	 CMD1Y
611879	CARDIOMYOPATHY, DILATED, 1Z; CMD1Z	 CMD1Z
611880	CARDIOMYOPATHY, DILATED, 2A; CMD2A	 CMD2A
611881	GLYCOGEN STORAGE DISEASE XII; GSD12	 GSD12
611884	CILIARY DYSKINESIA, PRIMARY, 7; CILD7	 CILD7
611890	CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	 CAAHD
611895	AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9	 ALS9
611928	PROSTATE CANCER, HEREDITARY, 13; HPC13	 HPC13
611938	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	 CPVT2
611942	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6	 ECA6
611943	RIDDLE SYNDROME	
611953	MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11	 ARMD11
611955	PROSTATE CANCER, HEREDITARY, 11; HPC11	 HPC11
611960	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7	 ASRT7
612004	THROMBOCYTOPENIA 4; THC4	 THC4
612011	CELIAC DISEASE, SUSCEPTIBILITY TO, 13; CELIAC13	 CELIAC13
612015	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N	 CDG1N
612016	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4	 COQ10D4
612018	CATARACT 47; CTRCT47	 CTRCT47
612020	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39	 SPG39
612067	DYSTONIA 16; DYT16	 DYT16
612069	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	 ALS10
612073	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	 MTDPS5
612075	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A	 MTDPS8A
612076	HYPOURICEMIA, RENAL, 2; RHUC2	 RHUC2
612079	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	 ANES
612095	RETINITIS PIGMENTOSA 41; RP41	 RP41
612098	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11	 CMH11
612100	AUTISM, SUSCEPTIBILITY TO, 15; AUTS15	 AUTS15
612119	TREHALASE DEFICIENCY	
612124	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12	 CMH12
612126	GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	 GLUT1DS2
612132	ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2; EDAID2	 EDAID2
612138	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA; EBSPA	 EBSPA
612158	CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1AA	 CMD1AA
612160	HISTIOCYTOMA, ANGIOMATOID FIBROUS	
612164	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4	 EIEE4
612199	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1; CRMCC1	 CRMCC1
612201	ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6	 ATFB6
612219	EWING SARCOMA; ES	 ES
612221	STATURE QUANTITATIVE TRAIT LOCUS 10; STQTL10	 STQTL10
612223	STATURE QUANTITATIVE TRAIT LOCUS 11; STQTL11	 STQTL11
612225	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9	 MODY9
612227	DIABETES MELLITUS, KETOSIS-PRONE; KPD	 KPD
612233	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4	 HLD4
612240	ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7	 ATFB7
612242	CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	
612244	INFLAMMATORY BOWEL DISEASE 13; IBD13	 IBD13
612247	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN	 CAN
612253	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11	 SLEB11
612260	MYD88 DEFICIENCY; MYD88D	 MYD88D
612261	INFLAMMATORY BOWEL DISEASE 17; IBD17	 IBD17
612269	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	 ECA5
612271	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11	 SHEP11
612278	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 19; IBD19	 IBD19
612281	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6; ARCI6	 ARCI6
612284	MECKEL SYNDROME, TYPE 6; MKS6	 MKS6
612285	JOUBERT SYNDROME 9; JBTS9	 JBTS9
612286	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1	 NPHLOP1
612287	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2	 NPHLOP2
612290	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE	
612291	JOUBERT SYNDROME 8; JBTS8	 JBTS8
612292	BIRK-BAREL SYNDROME	
612300	HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	 HACD59
612301	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	 OPTB7
612304	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	 THPH4
612310	PREMATURE OVARIAN FAILURE 6; POF6	 POF6
612318	PSEUDOFOLLICULITIS BARBAE	
612319	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35	 SPG35
612336	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5	 THPH5
612337	MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	 MRD22
612347	JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2	 JLNS2
612350	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 3; EDSSPD3	 EDSSPD3
612356	HEPARIN COFACTOR II DEFICIENCY	
612362	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12	 BMIQ12
612370	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5	 HH5
612371	MAJOR AFFECTIVE DISORDER 7; MAFD7	 MAFD7
612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	 SS2
612389	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	 PCH2B
612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	 PCH2C
612394	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	
612400	OSTEOARTHRITIS SUSCEPTIBILITY 5; OS5	 OS5
612416	FACTOR XI DEFICIENCY	
612422	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3	 RCM3
612423	PREKALLIKREIN DEFICIENCY	
612437	EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B	 EPM1B
612438	LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6	 HLD6
612444	CILIARY DYSKINESIA, PRIMARY, 9; CILD9	 CILD9
612446	COMPLEMENT COMPONENT 6 DEFICIENCY; C6D	 C6D
612447	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	
612460	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14; BMIQ14	 BMIQ14
612462	PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C	 PHP1C
612518	CILIARY DYSKINESIA, PRIMARY, 10; CILD10	 CILD10
612520	DIABETES MELLITUS, INSULIN-DEPENDENT, 20; IDDM20	 IDDM20
612522	DIABETES MELLITUS, INSULIN-DEPENDENT, 22; IDDM22	 IDDM22
612526	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	 CGL3
612527	DIAMOND-BLACKFAN ANEMIA 4; DBA4	 DBA4
612528	DIAMOND-BLACKFAN ANEMIA 5; DBA5	 DBA5
612529	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2	 AI2A2
612539	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	 SPG42
612540	MYOPATHY, CONGENITAL, COMPTON-NORTH; MYPCN	 MYPCN
612541	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	 SCN4
612542	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1	 B12QTL1
612551	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4	 FSGS4
612555	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2	 BROVCA2
612556	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; ADIPQTL1	 ADIPQTL1
612561	DIAMOND-BLACKFAN ANEMIA 6; DBA6	 DBA6
612567	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25	 IBD25
612572	RETINITIS PIGMENTOSA 46; RP46	 RP46
612576	CHROMOSOME 17p13.3, TELOMERIC, DUPLICATION SYNDROME	
612577	AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11	 ALS11
612580	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	 MRD3
612591	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10	 CRCS10
612595	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3	 MS3
612599	PSORIASIS 11, SUSCEPTIBILITY TO; PSORS11	 PSORS11
612621	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5	 MRD5
612623	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2	 MVCD2
612624	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3	 MVCD3
612628	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4; MVCD4	 MVCD4
612630	HAIR MORPHOLOGY 1; HRM1	 HRM1
612631	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	
612633	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5; MVCD5	 MVCD5
612634	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6	 MVCD6
612635	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7; MVCD7	 MVCD7
612643	DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B	 DFNA3B
612644	DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B	 DFNA2B
612645	DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	 DFNB1B
612649	CILIARY DYSKINESIA, PRIMARY, 11; CILD11	 CILD11
612650	CILIARY DYSKINESIA, PRIMARY, 12; CILD12	 CILD12
612651	ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	 ECO
612653	SPHEROCYTOSIS, TYPE 4; SPH4	 SPH4
612656	EPISODIC ATAXIA, TYPE 6; EA6	 EA6
612657	CONE-ROD DYSTROPHY 12; CORD12	 CORD12
612674	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC	 PHARC
612690	SPHEROCYTOSIS, TYPE 5; SPH5	 SPH5
612691	POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	 BTOP
612692	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6	 AGM6
612702	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	 HH6
612703	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7	 MCPH7
612712	LEBER CONGENITAL AMAUROSIS 13; LCA13	 LCA13
612714	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS	
612716	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	
612718	CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3	 CCDS3
612736	CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2	 CCDS2
612740	PORPHYRIA, ACUTE HEPATIC	
612780	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES	 SESAMES
612781	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B	 IGHD1B
612782	IMMUNODEFICIENCY 9; IMD9	 IMD9
612783	IMMUNODEFICIENCY 10; IMD10	 IMD10
612794	ATRIAL SEPTAL DEFECT 5; ASD5	 ASD5
612797	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12	 HDLCQ12
612798	QUESTION MARK EARS, ISOLATED; QME	 QME
612813	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	 SEMDAG
612838	BRUGADA SYNDROME 5; BRGDA5	 BRGDA5
612847	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	 BCYM4
612852	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	 OMPP
612853	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7; RLS7	 RLS7
612874	ERYTHROCYTE AMP DEAMINASE DEFICIENCY	
612877	CARDIOMYOPATHY, DILATED, 1BB; CMD1BB	 CMD1BB
612885	PREMATURE OVARIAN FAILURE 10; POF10	 POF10
612899	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8; EIG8	 EIG8
612900	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2	 CPSQ2
612908	KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2	 PPKS2
612918	CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	
612922	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2	 AHUS2
612923	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3	 AHUS3
612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4	 AHUS4
612925	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5	 AHUS5
612926	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6	 AHUS6
612932	GLYCOGEN STORAGE DISEASE XIII; GSD13	 GSD13
612933	GLYCOGEN STORAGE DISEASE XI; GSD11	 GSD11
612937	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	 MDDGC15
612938	GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM; GDFD	 GDFD
612940	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	 ARCL2B
612943	RETINITIS PIGMENTOSA 42; RP42	 RP42
612949	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39; EIEE39	 EIEE39
612951	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	
612952	AICARDI-GOUTIERES SYNDROME 5; AGS5	 AGS5
612953	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	 PARK14
612954	MYOPATHY, MYOFIBRILLAR, 6; MFM6	 MFM6
612955	LONG QT SYNDROME 12; LQT12	 LQT12
612956	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2	 VF2
612961	MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	 SYNS3
612964	PREMATURE OVARIAN FAILURE 7; POF7	 POF7
612965	46,XY SEX REVERSAL 3; SRXY3	 SRXY3
612968	CATARACT 34, MULTIPLE TYPES; CTRCT34	 CTRCT34
612975	SHORT SLEEPER	
612989	OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	 OPA7
612997	SPERMATOGENIC FAILURE 7; SPGF7	 SPGF7
612998	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4	 EDMD4
612999	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5	 EDMD5
613000	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1; FNEPPK1	 FNEPPK1
613001	ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	 ECCL
613002	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	 IIAE2
613003	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7	
613011	LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	 LPFS1
613013	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2	 NBLST2
613014	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3	 NBLST3
613021	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2	 BESC2
613027	GLYCOGEN STORAGE DISEASE IXc; GSD9C	 GSD9C
613028	GLIOMA SUSCEPTIBILITY 2; GLM2	 GLM2
613029	GLIOMA SUSCEPTIBILITY 3; GLM3	 GLM3
613038	PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1	 CPHD1
613060	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10	 EIG10
613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL	 ALL
613068	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	
613070	LIVER FAILURE, INFANTILE, TRANSIENT; LFIT	 LFIT
613071	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3	 BESC3
613073	METAPHYSEAL ANADYSPLASIA 2; MANDP2	 MANDP2
613075	MACS SYNDROME	
613076	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING LOSS, AND DEVELOPMENTAL DELAY	
613077	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	 PEOA5
613078	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD	 NBSLD
613079	DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	 DFNB77
613080	46,XY SEX REVERSAL 5; SRXY5	 SRXY5
613086	GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D	 GLC3D
613087	ATRIAL SEPTAL DEFECT 6; ASD6	 ASD6
613090	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B	 BARTS4B
613091	SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3	 SRTD3
613092	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2	 HNFJ2
613093	CONE DYSTROPHY 4; COD4	 COD4
613094	MICROPHTHALMIA, ISOLATED 4; MCOP4	 MCOP4
613095	POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD2	 PKD2
613098	INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC	
613099	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5; CMM5	 CMM5
613100	GLAUCOMA 1, OPEN ANGLE, O; GLC1O	 GLC1O
613101	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	 FHL5
613102	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES	
613105	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	 CACD2
613107	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2	 SCN2
613108	CANDIDIASIS, FAMILIAL, 4; CANDF4	 CANDF4
613112	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	
613115	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	 HSAN2B
613116	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11	 THPH11
613118	ANTITHROMBIN III DEFICIENCY; AT3D	 AT3D
613120	BRUGADA SYNDROME 7; BRGDA7	 BRGDA7
613122	CARDIOMYOPATHY, DILATED, 1CC; CMD1CC	 CMD1CC
613123	BRUGADA SYNDROME 8; BRGDA8	 BRGDA8
613135	PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	 PKDYS1
613148	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28	 IBD28
613150	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2	 MDDGA2
613151	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3; MDDGB3	 MDDGB3
613152	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4; MDDGB4	 MDDGB4
613153	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	 MDDGA5
613154	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6	 MDDGA6
613155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	 MDDGB1
613156	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2; MDDGB2	 MDDGB2
613157	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3	 MDDGC3
613158	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2	 MDDGC2
613159	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1	 NPHPL1
613161	BETA-UREIDOPROPIONASE DEFICIENCY; UPB1D	 UPB1D
613162	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	 SPG45
613163	GABA-TRANSAMINASE DEFICIENCY	
613172	CARDIOMYOPATHY, DILATED, 1DD; CMD1DD	 CMD1DD
613177	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	 ARCL1C
613179	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	
613180	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 8; CDCBM8	 CDCBM8
613193	CILIARY DYSKINESIA, PRIMARY, 13; CILD13	 CILD13
613194	RETINITIS PIGMENTOSA 50; RP50	 RP50
613195	WEILL-MARCHESANI SYNDROME 4; WMS4	 WMS4
613204	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	
613205	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	
613206	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	 SPG44
613211	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3	 AI2A3
613216	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C	 CSNB1C
613217	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5	 DIAR5
613224	NOONAN SYNDROME 6; NS6	 NS6
613225	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	
613227	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3	 CAMRQ3
613229	TRICHOTILLOMANIA; TTM	 TTM
613235	FACTOR XIII, B SUBUNIT, DEFICIENCY OF	
613237	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5	 FSGS5
613239	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	 TTPP2
613243	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	 CMH13
613244	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8; HNPCC8	 HNPCC8
613251	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14	 CMH14
613252	CARDIOMYOPATHY, DILATED, 1EE; CMD1EE	 CMD1EE
613254	TUBEROUS SCLEROSIS 2; TSC2	 TSC2
613255	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15	 CMH15
613265	WAARDENBURG SYNDROME, TYPE 4B; WS4B	 WS4B
613266	WAARDENBURG SYNDROME, TYPE 4C; WS4C	 WS4C
613267	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	 FECD3
613268	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4	 FECD4
613270	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6	 FECD6
613280	HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	 HMNDYT1
613282	FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1	 NAFLD1
613285	DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25	 DFNB25
613286	CARDIOMYOPATHY, DILATED, 1FF; CMD1FF	 CMD1FF
613287	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N	 CMT2N
613291	BILE ACID MALABSORPTION, PRIMARY; PBAM	 PBAM
613309	DIAMOND-BLACKFAN ANEMIA 10; DBA10	 DBA10
613310	EXUDATIVE VITREORETINOPATHY 5; EVR5	 EVR5
613312	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	 ARHR2
613313	HEMOCHROMATOSIS, TYPE 2B; HFE2B	 HFE2B
613319	MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	 MMD3
613320	SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	 SMDMDM
613325	RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	 RTPS2
613327	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	 CGL4
613329	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY	
613341	LEBER CONGENITAL AMAUROSIS 14; LCA14	 LCA14
613345	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	 HOKPP2
613347	PANCREATIC CANCER, SUSCEPTIBILITY TO, 2	
613348	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3	
613353	MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN	 MNMN
613370	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	 MODY10
613375	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11	 MODY11
613376	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C	 HMN2C
613382	BRACHYDACTYLY, TYPE E2; BDE2	 BDE2
613388	FANCONI RENOTUBULAR SYNDROME 2; FRTS2	 FRTS2
613390	FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO	 FANCO
613391	DEAFNESS, AUTOSOMAL RECESSIVE 84A; DFNB84A	 DFNB84A
613393	BIRBECK GRANULE DEFICIENCY	
613398	WARSAW BREAKAGE SYNDROME; WABS	 WABS
613399	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3	 BROVCA3
613402	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ	 MCSZ
613410	AUTISM, SUSCEPTIBILITY TO, 16; AUTS16	 AUTS16
613411	OGUCHI DISEASE 2	
613424	CARDIOMYOPATHY, DILATED, 1R; CMD1R	 CMD1R
613426	CARDIOMYOPATHY, DILATED, 1S; CMD1S	 CMD1S
613428	RETINITIS PIGMENTOSA 54; RP54	 RP54
613435	AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12	 ALS12
613443	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20; MRD20	 MRD20
613451	FRONTONASAL DYSPLASIA 2; FND2	 FND2
613453	DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91	 DFNB91
613454	RETT SYNDROME, CONGENITAL VARIANT	
613463	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5; FGQTL5	 FGQTL5
613470	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	
613471	REYNOLDS SYNDROME	
613477	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5; EIEE5	 EIEE5
613480	LYMPHATIC MALFORMATION 3; LMPHM3	 LMPHM3
613485	LONG QT SYNDROME 13; LQT13	 LQT13
613489	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	 CDG2J
613490	ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	 A1ATD
613493	IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3	 CVID3
613494	IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4	 CVID4
613500	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2	 AGM2
613507	GLYCOGEN STORAGE DISEASE XV; GSD15	 GSD15
613508	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1	 SSQTL1
613517	MICROPHTHALMIA, ISOLATED 6; MCOP6	 MCOP6
613546	AROMATASE DEFICIENCY	
613550	NEPHRONOPHTHISIS 11; NPHP11	 NPHP11
613551	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6; AIS6	 AIS6
613554	VON WILLEBRAND DISEASE, TYPE 2; VWD2	 VWD2
613559	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	 COXPD7
613561	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	 MLASA2
613563	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL	 NSLL
613566	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6	 HBFQTL6
613571	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	
613573	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1; EDSS1	 EDSS1
613575	RETINITIS PIGMENTOSA 55; RP55	 RP55
613581	RETINITIS PIGMENTOSA 56; RP56	 RP56
613587	OCCULT MACULAR DYSTROPHY; OCMD	 OCMD
613589	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; LDLCQ6	 LDLCQ6
613610	CRANIOECTODERMAL DYSPLASIA 2; CED2	 CED2
613611	CHOANAL ATRESIA AND LYMPHEDEMA; CATLPH	 CATLPH
613612	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I	 CDG2I
613615	SENIOR-LOKEN SYNDROME 7; SLSN7	 SLSN7
613616	HYPEROXALURIA, PRIMARY, TYPE III; HP3	 HP3
613617	RETINITIS PIGMENTOSA 58; RP58	 RP58
613625	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2	 F5F8D2
613630	COCOON SYNDROME	
613640	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	 HSAN1C
613641	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB	 CMTRIB
613642	CARDIOMYOPATHY, DILATED, 1GG; CMD1GG	 CMD1GG
613643	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK5	 PARK5
613646	METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT	
613647	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	 SPG48
613652	C1q DEFICIENCY; C1QD	 C1QD
613656	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13	 MGR13
613657	D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2	 D2HGA2
613659	GASTRIC CANCER	
613660	CONE-ROD DYSTROPHY 15; CORD15	 CORD15
613661	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	 CDG1P
613662	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	 MTDPS4B
613668	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	
613670	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	
613671	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	 MRAMS
613672	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	 SPAX4
613673	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV; CDAN4	 CDAN4
613674	VESICOURETERAL REFLUX 3; VUR3	 VUR3
613676	SECKEL SYNDROME 4; SCKL4	 SCKL4
613677	HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3	 HALD3
613679	PROTHROMBIN DEFICIENCY, CONGENITAL	
613680	BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	 BBIS
613684	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	 RSTS2
613686	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	 SCDO4
613688	LONG QT SYNDROME 2; LQT2	 LQT2
613690	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7	 CMH7
613693	LONG QT SYNDROME 6; LQT6	 LQT6
613694	CARDIOMYOPATHY, DILATED, 1U; CMD1U	 CMD1U
613695	LONG QT SYNDROME 5; LQT5	 LQT5
613697	CARDIOMYOPATHY, DILATED, 1V; CMD1V	 CMD1V
613702	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3	 KFS3
613703	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6	 MCOPCB6
613704	MICROPHTHALMIA, ISOLATED 7; MCOP7	 MCOP7
613706	NOONAN SYNDROME 7; NS7	 NS7
613707	LEOPARD SYNDROME 3; LPRD3	 LPRD3
613708	NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D	 HSN1D
613710	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4	 THMD4
613711	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3; HSCR3	 HSCR3
613712	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4; HSCR4	 HSCR4
613717	TREACHER COLLINS SYNDROME 2; TCS2	 TCS2
613718	DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	 DFNB74
613720	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7	 EIEE7
613721	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	 EIEE11
613722	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	 EIEE12
613723	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17; LGMDR17	 LGMDR17
613728	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	 SCAR10
613730	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS; HDBSCC	 HDBSCC
613731	RETINITIS PIGMENTOSA 4; RP4	 RP4
613737	ACNE INVERSA, FAMILIAL, 3; ACNINV3	 ACNINV3
613743	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	
613744	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51	 SPG51
613750	RETINITIS PIGMENTOSA 27; RP27	 RP27
613751	HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4	 HTX4
613752	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	
613756	RETINITIS PIGMENTOSA 49; RP49	 RP49
613757	MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6	 ARMD6
613758	RETINITIS PIGMENTOSA 47; RP47	 RP47
613759	INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	
613761	MACULAR DEGENERATION, AGE-RELATED, 5; ARMD5	 ARMD5
613762	46,XY SEX REVERSAL 6; SRXY6	 SRXY6
613763	CATARACT 16, MULTIPLE TYPES; CTRCT16	 CTRCT16
613765	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9	 CMH9
613767	RETINITIS PIGMENTOSA 45; RP45	 RP45
613769	RETINITIS PIGMENTOSA 44; RP44	 RP44
613778	MACULAR DEGENERATION, AGE-RELATED, 8; ARMD8	 ARMD8
613779	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	 C3D
613780	AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7	 AAT7
613783	COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD	 C1SD
613784	MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12	 ARMD12
613789	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2	 C8D2
613790	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1	 C8D1
613791	MASP2 DEFICIENCY	
613793	BLOOD GROUP, CROMER SYSTEM; CROM	 CROM
613794	RETINITIS PIGMENTOSA 20; RP20	 RP20
613795	LOEYS-DIETZ SYNDROME 3; LDS3	 LDS3
613796	IMMUNODEFICIENCY 31B; IMD31B	 IMD31B
613800	MEIER-GORLIN SYNDROME 2; MGORS2	 MGORS2
613801	RETINITIS PIGMENTOSA 40; RP40	 RP40
613803	MEIER-GORLIN SYNDROME 3; MGORS3	 MGORS3
613804	MEIER-GORLIN SYNDROME 4; MGORS4	 MGORS4
613805	MEIER-GORLIN SYNDROME 5; MGORS5	 MGORS5
613807	CILIARY DYSKINESIA, PRIMARY, 14; CILD14	 CILD14
613808	CILIARY DYSKINESIA, PRIMARY, 15; CILD15	 CILD15
613809	RETINITIS PIGMENTOSA 39; RP39	 RP39
613810	RETINITIS PIGMENTOSA 43; RP43	 RP43
613811	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D	 PCH2D
613812	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	 CBAS3
613818	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	 MDDGC9
613819	SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	 SRTD4
613820	NEPHRONOPHTHISIS 12; NPHP12	 NPHP12
613823	SECKEL SYNDROME 5; SCKL5	 SCKL5
613824	NEPHRONOPHTHISIS 9; NPHP9	 NPHP9
613825	COMPLEMENT COMPONENT 9 DEFICIENCY; C9D	 C9D
613826	LEBER CONGENITAL AMAUROSIS 6; LCA6	 LCA6
613827	RETINITIS PIGMENTOSA 48; RP48	 RP48
613829	LEBER CONGENITAL AMAUROSIS 7; LCA7	 LCA7
613830	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	 CSNB1D
613834	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	
613835	LEBER CONGENITAL AMAUROSIS 8; LCA8	 LCA8
613838	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16; CMH16	 CMH16
613839	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	
613843	LEBER CONGENITAL AMAUROSIS 15; LCA15	 LCA15
613845	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS	 HUPRAS
613848	OSTEOGENESIS IMPERFECTA, TYPE X; OI10	 OI10
613850	INOSINE TRIPHOSPHATASE DEFICIENCY	
613854	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6	 CHTD6
613855	EPISODIC ATAXIA, TYPE 5; EA5	 EA5
613856	ACHROMATOPSIA 4; ACHM4	 ACHM4
613861	RETINITIS PIGMENTOSA 59; RP59	 RP59
613862	RETINITIS PIGMENTOSA 38; RP38	 RP38
613863	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7	 GEFSP7
613869	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	
613870	HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD	 HCAD
613873	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17	 CMH17
613874	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18	 CMH18
613875	MOVED TO 192600	
613876	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20	 CMH20
613877	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4	 FPLD4
613881	CARDIOMYOPATHY, DILATED, 1HH; CMD1HH	 CMD1HH
613882	HYPOMAGNESEMIA 6, RENAL; HOMG6	 HOMG6
613886	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	 OBHD
613887	CATARACT 36; CTRCT36	 CTRCT36
613908	SPINOCEREBELLAR ATAXIA 35; SCA35	 SCA35
613912	COMPLEMENT FACTOR D DEFICIENCY; CFDD	 CFDD
613916	DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	 DFNB89
613925	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	 MLC2A
613926	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	 MLC2B
613933	ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD	 ACACAD
613943	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8	 ARCI8
613950	SCHIZOPHRENIA 15; SCZD15	 SCZD15
613951	FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	 FANCP
613953	IMMUNODEFICIENCY 51; IMD51	 IMD51
613954	AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS14	 ALS14
613955	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2; PLCA2	 PLCA2
613956	CANDIDIASIS, FAMILIAL, 6; CANDF6	 CANDF6
613957	SPERMATOGENIC FAILURE 8; SPGF8	 SPGF8
613958	SPERMATOGENIC FAILURE 9; SPGF9	 SPGF9
613960	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III; CDG3	 CDG3
613970	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	 MRD6
613972	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6	 CMM6
613977	CYANOSIS, TRANSIENT NEONATAL; TNCY	 TNCY
613978	HEMOGLOBIN H DISEASE; HBH	 HBH
613980	ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9	 ATFB9
613981	HYPOTRICHOSIS 3; HYPT3	 HYPT3
613982	OSTEOGENESIS IMPERFECTA, TYPE VI; OI6	 OI6
613983	RETINITIS PIGMENTOSA 60; RP60	 RP60
613985	BETA-THALASSEMIA	
613986	PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6	 CPHD6
613987	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2	 DKCB2
613988	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3; DKCB3	 DKCB3
613989	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	 DKCA2
613990	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	 DKCA3
614008	NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	 NGPS
614009	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13	 BDPLT13
614017	CILIARY DYSKINESIA, PRIMARY, 16; CILD16	 CILD16
614018	EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	 EPM6
614020	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14	 MRT14
614021	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3	 CPVT3
614022	ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10	 ATFB10
614023	PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	 PSPHD
614025	HEPATIC LIPASE DEFICIENCY	
614028	APOLIPOPROTEIN C-III DEFICIENCY	
614034	HEME OXYGENASE 1 DEFICIENCY; HMOX1D	 HMOX1D
614035	DEAFNESS, AUTOSOMAL RECESSIVE 29; DFNB29	 DFNB29
614038	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	
614039	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1	 CDCBM1
614042	MOYAMOYA DISEASE 5; MYMY5	 MYMY5
614049	ATRIAL FIBRILLATION, FAMILIAL, 11; ATFB11	 ATFB11
614050	ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12	 ATFB12
614052	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	 MC5DN2
614053	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3	 MC5DN3
614065	MYOPATHY, DISTAL, 4; MPD4	 MPD4
614066	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	 SPG47
614069	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2	 ICF2
614070	PSORIASIS 13, SUSCEPTIBILITY TO; PSORS13	 PSORS13
614072	HERMANSKY-PUDLAK SYNDROME 3; HPS3	 HPS3
614073	HERMANSKY-PUDLAK SYNDROME 4; HPS4	 HPS4
614074	HERMANSKY-PUDLAK SYNDROME 5; HPS5	 HPS5
614076	HERMANSKY-PUDLAK SYNDROME 7; HPS7	 HPS7
614078	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	
614079	ASPERGILLOSIS, SUSCEPTIBILITY TO	
614080	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	 MCAHS1
614081	ANHAPTOGLOBINEMIA; AHP	 AHP
614082	FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	 FANCG
614083	FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL	 FANCL
614089	ATRIAL SEPTAL DEFECT 3; ASD3	 ASD3
614090	SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3	 SSS3
614091	SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	 SRTD7
614096	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8	 COXPD8
614098	KEPPEN-LUBINSKY SYNDROME; KPLBS	 KPLBS
614099	CRANIOECTODERMAL DYSPLASIA 3; CED3	 CED3
614104	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7	 MRD7
614105	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD	 MMSDHD
614111	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	 PDHBD
614113	MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2	 MRD2
614114	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	 MVA2
614115	CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	 OCCM
614116	NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	 HSN1E
614120	HYDROLETHALUS SYNDROME 2; HLS2	 HLS2
614128	LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD	 LDHBD
614129	PERRAULT SYNDROME 3; PRLTS3	 PRLTS3
614131	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6	 FSGS6
614134	STICKLER SYNDROME, TYPE IV; STL4	 STL4
614135	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6	 EDM6
614152	DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	 DFNA64
614153	SPINOCEREBELLAR ATAXIA 36; SCA36	 SCA36
614156	HYPERBILIVERDINEMIA; HBLVD	 HBLVD
614157	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10; NDNC10	 NDNC10
614160	MUSCLE HYPERTROPHY; MSLHP	 MSLHP
614162	IMMUNODEFICIENCY 31C; IMD31C	 IMD31C
614165	PARAGANGLIOMAS 5; PGL5	 PGL5
614167	MYOPIA 21, AUTOSOMAL DOMINANT; MYP21	 MYP21
614170	BRITTLE CORNEA SYNDROME 2; BCS2	 BCS2
614172	IMMUNODEFICIENCY 21; IMD21	 IMD21
614175	MECKEL SYNDROME, TYPE 10; MKS10	 MKS10
614180	RETINITIS PIGMENTOSA 61; RP61	 RP61
614181	RETINITIS PIGMENTOSA 62; RP62	 RP62
614185	GELEOPHYSIC DYSPLASIA 2; GPHYSD2	 GPHYSD2
614186	LEBER CONGENITAL AMAUROSIS 16; LCA16	 LCA16
614188	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	 CRSDA
614190	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3	 PPNAD3
614192	MOVED TO 613675	
614193	TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2	 TFQTL2
614195	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	 CAASDS
614198	MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	 CMS16
614199	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5	 NPHS5
614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	 BDPLT11
614202	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	 MRT15
614203	PARKINSON DISEASE 17; PARK17	 PARK17
614204	PSORIASIS 14, PUSTULAR; PSORS14	 PSORS14
614205	THREE M SYNDROME 3; 3M3	 3M3
614207	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	 HPMRS3
614209	MECKEL SYNDROME, TYPE 9; MKS9	 MKS9
614212	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	 IIAE4
614213	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	 HSN2C
614219	ADAMS-OLIVER SYNDROME 2; AOS2	 AOS2
614222	WARBURG MICRO SYNDROME 3; WARBM3	 WARBM3
614224	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS; RAMSVPS	 RAMSVPS
614225	WARBURG MICRO SYNDROME 2; WARBM2	 WARBM2
614226	HOLOPROSENCEPHALY 11; HPE11	 HPE11
614228	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	 CMT2O
614229	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	 SCAR11
614231	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS	 MEDS
614250	NARCOLEPSY 7; NRCLP7	 NRCLP7
614251	PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK18	 PARK18
614254	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	 NDHMSD
614255	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	 MRD9
614261	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP	 MICCAP
614262	ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	 APUG
614265	COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	 CMAMMA
614266	BARRETT ESOPHAGUS	
614278	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY; PAFAD	 PAFAD
614279	46,XY SEX REVERSAL 8; SRXY8	 SRXY8
614284	STICKLER SYNDROME, TYPE V; STL5	 STL5
614286	MYELODYSPLASTIC SYNDROME; MDS	 MDS
614291	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4	 BROVCA4
614292	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD	 MCVD
614293	HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2	 HYDM2
614296	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	 WFSL
614298	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	 NBIA4
614299	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	 MMDS2
614300	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	
614302	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7	 EDMD7
614305	SCLEROSTEOSIS 2; SOST2	 SOST2
614306	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	 CIAT
614307	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	 AMACRD
614320	PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4	 PNCA4
614321	MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT	 MPDT
614322	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12	 SCAR12
614324	OVARIAN DYSGENESIS 3; ODG3	 ODG3
614325	PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	 PTHSL2
614327	TUMOR PREDISPOSITION SYNDROME; TPDS	 TPDS
614328	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1	 NISBD1
614331	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6	 HNPCC6
614332	CHROMOSOME 2p16.3 DELETION SYNDROME	
614335	ARTHROGRYPOSIS, DISTAL, TYPE 1B; DA1B	 DA1B
614337	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4	 HNPCC4
614338	PANCREATIC LIPASE DEFICIENCY; PNLIPD	 PNLIPD
614340	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27; MRT27	 MRT27
614350	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5	 HNPCC5
614369	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	 PNMHH
614370	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5	 SMDP5
614373	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	 ALS16
614374	BLOOD GROUP, CHIDO/RODGERS SYSTEM	
614376	SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	 SRTD5
614377	NEPHRONOPHTHISIS 13; NPHP13	 NPHP13
614378	CRANIOECTODERMAL DYSPLASIA 4; CED4	 CED4
614379	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD	 C4BD
614380	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD	 C4AD
614381	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8	 HLD8
614385	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7	 HNPCC7
614388	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1; EMPF1	 EMPF1
614389	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1; RPRGL1	 RPRGL1
614390	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2	 RPRGL2
614399	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD	 EMARDD
614402	MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	 MCOPS11
614408	MOVED TO 160150	
614409	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	 SPG46
614415	CHILBLAIN LUPUS 2; CHBL2	 CHBL2
614416	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA	 RHFCA
614417	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5	 ETL5
614418	FEBRILE SEIZURES, FAMILIAL, 11; FEB11	 FEB11
614420	SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16	 SLEB16
614429	VENTRICULAR SEPTAL DEFECT 1; VSD1	 VSD1
614430	ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4	 AVSD4
614432	VENTRICULAR SEPTAL DEFECT 3; VSD3	 VSD3
614434	CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2	 ADCL2
614435	HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2	 HLHS2
614436	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	 CMT2P
614437	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B	 ARCL1B
614438	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B	 ARCL3B
614441	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2	 PHOAR2
614455	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE	 CMTDIE
614456	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8	 CMM8
614457	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	 ISQMR
614458	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5	 THMD5
614462	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS	 HGCLAS
614464	JOUBERT SYNDROME 15; JBTS15	 JBTS15
614465	JOUBERT SYNDROME 16; JBTS16	 JBTS16
614466	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6	 CHDS6
614468	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	 FCAS3
614470	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	 RALD
614473	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	 GACI2
614474	ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5	 AVSD5
614475	ATRIAL SEPTAL DEFECT 9; ASD9	 ASD9
614480	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	 HTGTI
614482	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	 CCHLND
614483	PORENCEPHALY 2; POREN2	 POREN2
614485	TRIGONOCEPHALY 2; TRIGNO2	 TRIGNO2
614486	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12	 THPH12
614487	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5	 SPAX5
614491	PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	 PHA2B
614492	PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C	 PHA2C
614493	WISKOTT-ALDRICH SYNDROME 2; WAS2	 WAS2
614495	PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D	 PHA2D
614496	PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	 PHA2E
614497	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7	 MCOPCB7
614498	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	 RMFSL
614499	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	 MRT34
614500	CONE-ROD DYSTROPHY 16; CORD16	 CORD16
614501	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM; PMRED	 PMRED
614504	USHER SYNDROME, TYPE IIIB; USH3B	 USH3B
614507	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R	 CDG1R
614508	MIRROR MOVEMENTS 2; MRMV2	 MRMV2
614514	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	 THPH6
614519	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH	 ICH
614521	THROMBOCYTHEMIA 3; THCYT3	 THCYT3
614524	FIBROCHONDROGENESIS 2; FBCG2	 FBCG2
614558	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13	 EIEE13
614559	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD	 ICRD
614563	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13; MRD13	 MRD13
614564	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS	 FCTCS
614565	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E	 CSNB1E
614576	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	 CDG2L
614582	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	 COXPD9
614583	BARAITSER-WINTER SYNDROME 2; BRWS2	 BRWS2
614592	BENT BONE DYSPLASIA SYNDROME; BBDS	 BBDS
614594	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES	
614595	PREECLAMPSIA/ECLAMPSIA 5; PEE5	 PEE5
614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2	 THES2
614607	COFFIN-SIRIS SYNDROME 2; CSS2	 CSS2
614608	COFFIN-SIRIS SYNDROME 3; CSS3	 CSS3
614609	COFFIN-SIRIS SYNDROME 4; CSS4	 CSS4
614613	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2	 ACRDYS2
614614	DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	 DFNA4B
614615	JOUBERT SYNDROME 17; JBTS17	 JBTS17
614616	DIARRHEA 6; DIAR6	 DIAR6
614617	DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	 DFNB86
614618	HYPEREKPLEXIA 3; HKPX3	 HKPX3
614619	HYPEREKPLEXIA 2; HKPX2	 HKPX2
614621	UV-SENSITIVE SYNDROME 2; UVSS2	 UVSS2
614640	UV-SENSITIVE SYNDROME 3; UVSS3	 UVSS3
614643	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	 MDDGA7
614650	COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	 COQ10D6
614651	COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	 COQ10D2
614652	COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	 COQ10D3
614653	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6	 HSAN6
614665	MECONIUM ILEUS	
614669	AURICULOCONDYLAR SYNDROME 2; ARCND2	 ARCND2
614672	CARDIOMYOPATHY, DILATED, 2B; CMD2B	 CMD2B
614673	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	 MCPH8
614674	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	
614675	BONE MARROW FAILURE SYNDROME 1; BMFS1	 BMFS1
614678	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B	 PCH1B
614679	CILIARY DYSKINESIA, PRIMARY, 17; CILD17	 CILD17
614691	CATARACT 38; CTRCT38	 CTRCT38
614696	AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17	 ALS17
614699	IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7	 CVID7
614700	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	 CVID8
614701	CORNELIA DE LANGE SYNDROME 4; CDLS4	 CDLS4
614702	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10	 COXPD10
614706	CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	 CLN11
614707	BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	 BVVLS2
614714	POROKERATOSIS 7, MULTIPLE TYPES; POROK7	 POROK7
614723	ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD	 APRTD
614727	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K	 CDG2K
614728	SECKEL SYNDROME 6; SCKL6	 SCKL6
614731	PROSTATE CANCER, HEREDITARY, 2; HPC2	 HPC2
614732	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE	 IMAGE
614736	GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	 GCCD4
614739	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	 MEGDEL
614740	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7	 BCC7
614741	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD	 MPYCD
614742	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	 PFBMFT1
614744	FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	 HCFP3
614748	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	 ILNEB
614749	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	 HPMRS2
614750	MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13	 CMS13
614751	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B	 HMN5B
614753	SOTOS SYNDROME 2; SOTOS2	 SOTOS2
614756	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	 CANPMR
614779	HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6	 HTX6
614782	TREMOR, HEREDITARY ESSENTIAL, 4; ETM4	 ETM4
614800	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	 SOPH
614807	MYOPATHY, CENTRONUCLEAR, 4; CNM4	 CNM4
614808	AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18	 ALS18
614809	CFHR5 DEFICIENCY	
614810	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5; MS5	 MS5
614813	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT	 SOFT
614814	ADAMS-OLIVER SYNDROME 3; AOS3	 AOS3
614815	JOUBERT SYNDROME 18; JBTS18	 JBTS18
614816	LOEYS-DIETZ SYNDROME 4; LDS4	 LDS4
614817	INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN	 KMIN
614819	WEILL-MARCHESANI SYNDROME 3; WMS3	 WMS3
614820	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2	 AHC2
614822	SPERMATOGENIC FAILURE 10; SPGF10	 SPGF10
614823	AORTIC VALVE DISEASE 2; AOVD2	 AOVD2
614830	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8	 MDDGA8
614831	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13	 SCAR13
614832	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4	 AI2A4
614833	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	 MSSP
614837	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	 HH8
614838	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	 HH9
614839	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10	 HH10
614840	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11	 HH11
614841	HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12	 HH12
614842	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13	 HH13
614844	NEPHRONOPHTHISIS 14; NPHP14	 NPHP14
614845	NEPHRONOPHTHISIS 15; NPHP15	 NPHP15
614847	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12	 EIG12
614849	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 5; IIAE5	 IIAE5
614850	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 6; IIAE6	 IIAE6
614851	SECKEL SYNDROME 7; SCKL7	 SCKL7
614852	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	 MCPH9
614856	OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13	 OI13
614857	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ	 MAHCJ
614858	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14	 HH14
614859	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	 PBD3A
614860	DYSTONIA 23; DYT23	 DYT23
614861	DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98	 DFNB98
614862	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A	 PBD4A
614863	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	 PBD4B
614866	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A	 PBD5A
614867	PEROXISOME BIOGENESIS DISORDER 5B; PBD5B	 PBD5B
614868	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS; TIIAC	 TIIAC
614869	USHER SYNDROME, TYPE IJ; USH1J	 USH1J
614870	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	 PBD6A
614871	PEROXISOME BIOGENESIS DISORDER 6B; PBD6B	 PBD6B
614872	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	 PBD7A
614873	PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	 PBD7B
614874	CILIARY DYSKINESIA, PRIMARY, 18; CILD18	 CILD18
614876	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	 PBD8A
614877	PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	 PBD8B
614878	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED; APLAID	 APLAID
614879	PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	 PBD9B
614880	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15	 HH15
614881	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5; DSMA5	 DSMA5
614882	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	 PBD10A
614883	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A	 PBD11A
614885	PEROXISOME BIOGENESIS DISORDER 11B; PBD11B	 PBD11B
614887	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A	 PBD13A
614889	IMMUNODEFICIENCY 28; IMD28	 IMD28
614890	IMMUNODEFICIENCY 29; IMD29	 IMD29
614891	IMMUNODEFICIENCY 30; IMD30	 IMD30
614892	IMMUNODEFICIENCY 31A; IMD31A	 IMD31A
614893	IMMUNODEFICIENCY 32A; IMD32A	 IMD32A
614895	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	 CMT4F
614896	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	 SANDD
614897	HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16	 HH16
614898	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53	 SPG53
614899	DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93	 DFNB93
614915	LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4	 LCCS4
614916	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4	 CPVT4
614921	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T	 CDG1T
614922	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	 COXPD11
614923	BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD	 BCKDKD
614924	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	 COXPD12
614926	PERRAULT SYNDROME 2; PRLTS2	 PRLTS2
614929	ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	 ECTD7
614931	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE; ECTD9	 ECTD9
614932	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	 COXPD13
614934	DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70	 DFNB70
614935	CILIARY DYSKINESIA, PRIMARY, 19; CILD19	 CILD19
614937	MYOCLONUS, FAMILIAL CORTICAL; FCM	 FCM
614940	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	 ECTD11A
614941	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	 ECTD11B
614944	DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B	 DFNB84B
614945	DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	 DFNB18B
614946	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	 COXPD14
614947	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	 COXPD15
614959	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	 EIEE14
614962	LEPTIN DEFICIENCY OR DYSFUNCTION; LEPD	 LEPD
614963	LEPTIN RECEPTOR DEFICIENCY	
614969	PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	 PCH7
614970	JOUBERT SYNDROME 20; JBTS20	 JBTS20
614972	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3	 ICP3
614974	FOCAL FACIAL DERMAL DYSPLASIA 4; FFDD4	 FFDD4
614976	CARPENTER SYNDROME 2; CRPT2	 CRPT2
614980	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	 CHTD2
615005	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	 ENFL5
615006	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	 EIEE15
615007	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	 IBGC4
615008	NEPHROTIC SYNDROME, TYPE 7; NPHS7	 NPHS7
615009	SCHUURS-HOEIJMAKERS SYNDROME; SHMS	 SHMS
615010	AICARDI-GOUTIERES SYNDROME 6; AGS6	 AGS6
615011	PHOSPHOHYDROXYLYSINURIA; PHLU	 PHLU
615023	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9; ARCI9	 ARCI9
615024	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10	 ARCI10
615025	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	 CMT2Q
615026	RIBOFLAVIN DEFICIENCY; RBFVD	 RBFVD
615028	EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE; EBNS	 EBNS
615030	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	 SPG56
615031	SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE; SPG49	 SPG49
615032	AUTISM, SUSCEPTIBILITY TO, 18; AUTS18	 AUTS18
615033	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	 SPG54
615034	DYSTONIA 24; DYT24	 DYT24
615035	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	 SPG55
615040	EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1	 FEPS1
615041	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10; MDDGA10	 MDDGA10
615042	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	 CDG1U
615043	SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	 SPG43
615048	SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	 SMAJ
615058	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F	 CSNB1F
615059	HYPOTRICHOSIS 11; HYPT11	 HYPT11
615065	ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	 DA5D
615066	OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14	 OI14
615067	CILIARY DYSKINESIA, PRIMARY, 20; CILD20	 CILD20
615072	BRACHYDACTYLY, TYPE A1, C; BDA1C	 BDA1C
615073	DYSTONIA 25; DYT25	 DYT25
615075	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19; MRD19	 MRD19
615081	SPERMATOGENIC FAILURE 11; SPGF11	 SPGF11
615083	COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12	 CRCS12
615084	MITOCHONDRIAL DNA DEPLETION SYNDROME 11; MTDPS11	 MTDPS11
615085	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	 OPTB8
615092	LEFT VENTRICULAR NONCOMPACTION 7; LVNC7	 LVNC7
615095	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	 MCPH10
615108	COWDEN SYNDROME 5; CWS5	 CWS5
615109	COWDEN SYNDROME 6; CWS6	 CWS6
615113	MICROPHTHALMIA, ISOLATED 8; MCOP8	 MCOP8
615119	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	 CEMCOX2
615120	MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	 CMS8
615122	LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	 LPFS2
615134	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9	 CMM9
615135	MAPLE SYRUP URINE DISEASE, MILD VARIANT; MSUDMV	 MSUDMV
615139	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	 FILS
615145	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	 MCOPCB9
615147	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME; RDCCAS	 RDCCAS
615155	STEEL SYNDROME; STLS	 STLS
615156	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6; PEOA6	 PEOA6
615158	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	 MC3DN3
615159	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	 MC3DN4
615160	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	 MC3DN5
615179	ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7	 OCA7
615181	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	 MDDGA11
615182	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	 D2L2AD
615184	CARDIOMYOPATHY, DILATED, 1II; CMD1II	 CMD1II
615185	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF	 CMTDIF
615188	CATARACT 39, MULTIPLE TYPES; CTRCT39	 CTRCT39
615190	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	 DKCB5
615191	LISSENCEPHALY 5; LIS5	 LIS5
615193	BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	 BDPLT15
615206	IMMUNODEFICIENCY 11; IMD11A	 IMD11A
615207	IMMUNODEFICIENCY 56; IMD56	 IMD56
615214	AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7	 AGM7
615217	ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	 AOA3
615219	HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	 HYC2
615220	OSTEOGENESIS IMPERFECTA, TYPE XV; OI15	 OI15
615221	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16; BMND16	 BMND16
615222	SMITH-MCCORT DYSPLASIA 2; SMC2	 SMC2
615224	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	 FASPS2
615225	PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	 MSPC
615226	POLYDACTYLY, POSTAXIAL, TYPE A6; PAPA6	 PAPA6
615228	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	 MC5DN4
615232	SCHIZOPHRENIA 18; SCZD18	 SCZD18
615233	RETINITIS PIGMENTOSA 66; RP66	 RP66
615234	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	 AHMIO2
615235	CARDIOMYOPATHY, DILATED, 1JJ; CMD1JJ	 CMD1JJ
615237	CONGENITAL SHORT BOWEL SYNDROME; CSBS	 CSBS
615248	CARDIOMYOPATHY, DILATED, 1KK; CMD1KK	 CMD1KK
615249	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	 MDDGA12
615266	HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	 HH17
615267	HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	 HH18
615268	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4	 CAMRQ4
615269	HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	 HH19
615270	HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	 HH20
615271	HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	 HH21
615272	FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	 FANCQ
615273	CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	 CDDG
615274	CATARACT 15, MULTIPLE TYPES; CTRCT15	 CTRCT15
615277	CATARACT 19, MULTIPLE TYPES; CTRCT19	 CTRCT19
615278	CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	 CFC2
615279	CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	 CFC3
615280	CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	 CFC4
615281	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL	 HBSL
615282	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	 CDCBM2
615284	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	 CMT4B3
615285	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	 SCN5
615287	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	 MDDGA13
615290	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT; SMALED2A	 SMALED2A
615293	MYOFIBROMATOSIS, INFANTILE, 2; IMF2	 IMF2
615294	CILIARY DYSKINESIA, PRIMARY, 21; CILD21	 CILD21
615297	ADAMS-OLIVER SYNDROME 4; AOS4	 AOS4
615298	SYMPHALANGISM, PROXIMAL, 1B; SYM1B	 SYM1B
615300	PERRAULT SYNDROME 4; PRLTS4	 PRLTS4
615311	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17; BMND17	 BMND17
615314	CRANIOSYNOSTOSIS 3; CRS3	 CRS3
615327	DOWLING-DEGOS DISEASE 2; DDD2	 DDD2
615328	SHAHEEN SYNDROME; SHNS	 SHNS
615330	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	 MMDS3
615338	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	 EIEE16
615342	PULMONARY HYPERTENSION, PRIMARY, 2; PPH2	 PPH2
615343	PULMONARY HYPERTENSION, PRIMARY, 3; PPH3	 PPH3
615344	PULMONARY HYPERTENSION, PRIMARY, 4; PPH4	 PPH4
615346	PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2	 CPPB2
615348	NEMALINE MYOPATHY 8; NEM8	 NEM8
615349	EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	 EDSSPD2
615350	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	 MDDGA14
615351	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	 MDDGB14
615352	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	 MDDGC14
615355	NOONAN SYNDROME 8; NS8	 NS8
615356	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	 LGMDR18
615360	LEBER CONGENITAL AMAUROSIS 17; LCA17	 LCA17
615361	HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2	 HYPOC2
615362	CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	 CLN13
615363	ESTROGEN RESISTANCE; ESTRR	 ESTRR
615368	LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5	 LCCS5
615369	EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	 EEOC
615371	PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO; PHN	 PHN
615373	LEFT VENTRICULAR NONCOMPACTION 8; LVNC8	 LVNC8
615376	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C; CMTRIC	 CMTRIC
615377	ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13	 ATFB13
615378	ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14	 ATFB14
615381	MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	 MDPL
615382	NEPHRONOPHTHISIS 16; NPHP16	 NPHP16
615386	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14	 SCAR14
615395	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16	 COXPD16
615396	LEFT VENTRICULAR NONCOMPACTION 10; LVNC10	 LVNC10
615397	MECKEL SYNDROME, TYPE 11; MKS11	 MKS11
615398	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	 MCAHS3
615399	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	 PNH2
615400	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	 FAME5
615401	IMMUNODEFICIENCY 8; IMD8	 IMD8
615402	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3; DUH3	 DUH3
615411	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	 CDCBM3
615412	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	 CDCBM4
615413	SPERMATOGENIC FAILURE 12; SPGF12	 SPGF12
615414	MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	 MCPH11
615415	RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	 RHPD2
615418	MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE; MTDPS12B	 MTDPS12B
615419	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	 IHPRF1
615420	MYOPIA 22, AUTOSOMAL DOMINANT; MYP22	 MYP22
615422	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2	 IBMPFD2
615424	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	 IBMPFD3
615425	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2; EBSB2	 EBSB2
615426	AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20	 ALS20
615429	DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88	 DFNB88
615431	MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23	 MYP23
615432	SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	 SLI5
615434	RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS; RP82	 RP82
615436	AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8	 AAT8
615438	INFANTILE LIVER FAILURE SYNDROME 1; ILFS1	 ILFS1
615439	MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	 ARMD13
615440	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17	 COXPD17
615441	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5	 CPVT5
615444	CILIARY DYSKINESIA, PRIMARY, 22; CILD22	 CILD22
615451	CILIARY DYSKINESIA, PRIMARY, 23; CILD23	 CILD23
615453	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	 MC3DN6
615457	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18; BMIQ18	 BMIQ18
615458	MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	 MMCAT
615465	HARTSFIELD SYNDROME; HRTFDS	 HRTFDS
615468	IMMUNODEFICIENCY 12; IMD12	 IMD12
615471	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	 MTDPS13
615473	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	 EIEE17
615474	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA	 PASNA
615476	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18; EIEE18	 EIEE18
615481	CILIARY DYSKINESIA, PRIMARY, 24; CILD24	 CILD24
615482	CILIARY DYSKINESIA, PRIMARY, 25; CILD25	 CILD25
615483	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	 IBGC5
615485	BAINBRIDGE-ROPERS SYNDROME; BRPS	 BRPS
615486	INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	 ILLD
615490	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	 CMT2R
615491	SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	 SPG79
615493	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37; MRT37	 MRT37
615500	CILIARY DYSKINESIA, PRIMARY, 26; CILD26	 CILD26
615501	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	 MOCODC
615502	MENTAL RETARDATION, AUTOSOMAL DOMINANT 21; MRD21	 MRD21
615503	SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY; SRTD8	 SRTD8
615504	CILIARY DYSKINESIA, PRIMARY, 27; CILD27	 CILD27
615505	CILIARY DYSKINESIA, PRIMARY, 28; CILD28	 CILD28
615506	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	 HHT5
615508	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE	 EPKHE
615510	ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME; AAMR	 AAMR
615511	MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD	 MMDD
615512	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID	 TPID
615513	IMMUNODEFICIENCY 14; IMD14	 IMD14
615515	AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	 ALS19
615516	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	 MRT38
615518	IMMUNODEFICIENCY 13; IMD13	 IMD13
615522	COLE DISEASE; COLED	 COLED
615523	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8; FECD8	 FECD8
615527	CANDIDIASIS, FAMILIAL, 8; CANDF8	 CANDF8
615528	PARKINSON DISEASE 19A, JUVENILE-ONSET; PARK19A	 PARK19A
615529	CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5	 CRS5
615530	PARKINSON DISEASE 20, EARLY-ONSET; PARK20	 PARK20
615537	RETICULATE ACROPIGMENTATION OF KITAMURA; RAK	 RAK
615539	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	 EDSMC2
615540	DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76	 DFNB76
615541	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	 MRT39
615542	TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD	 TACHD
615544	PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	 PVNH6
615546	VAN MALDERGEM SYNDROME 2; VMLDS2	 VMLDS2
615548	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	 HSAN7
615551	EPISODIC PAIN SYNDROME, FAMILIAL, 2; FEPS2	 FEPS2
615552	EPISODIC PAIN SYNDROME, FAMILIAL, 3; FEPS3	 FEPS3
615554	MULTIPLE FIBROADENOMAS OF THE BREAST; MFAB	 MFAB
615555	HYPERPROLACTINEMIA; HPRL	 HPRL
615557	MELIOIDOSIS, SUSCEPTIBILITY TO	
615558	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1	 FHBL1
615559	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	 ALPS3
615560	OTOFACIOCERVICAL SYNDROME 2; OTFCS2	 OTFCS2
615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD	 CFBD
615565	RETINITIS PIGMENTOSA 67; RP67	 RP67
615573	NEPHROTIC SYNDROME, TYPE 9; NPHS9	 NPHS9
615574	ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	 ASNSD
615575	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D	 HMN2D
615577	IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	 CVID10
615582	LOEYS-DIETZ SYNDROME 5; LDS5	 LDS5
615583	VERHEIJ SYNDROME; VRJS	 VRJS
615590	ALZHEIMER DISEASE 18; AD18	 AD18
615591	MACULAR DEGENERATION, AGE-RELATED, 15; ARMD15	 ARMD15
615592	IMMUNODEFICIENCY 15B; IMD15B	 IMD15B
615593	IMMUNODEFICIENCY 16; IMD16	 IMD16
615595	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	 COXPD19
615596	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	 CDG1W
615598	PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN	 PPKN
615599	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	 MRT40
615604	L-FERRITIN DEFICIENCY; LFTD	 LFTD
615605	FANCONI RENOTUBULAR SYNDROME 3; FRTS3	 FRTS3
615607	IMMUNODEFICIENCY 17; IMD17	 IMD17
615616	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13; ARVD13	 ARVD13
615617	IMMUNODEFICIENCY 19; IMD19	 IMD19
615625	SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72	 SPG72
615629	DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56	 DFNA56
615630	SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	 SRTD10
615631	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B	 CDAN1B
615632	NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	 HSN1F
615633	SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	 SRTD11
615636	JOUBERT SYNDROME 21; JBTS21	 JBTS21
615643	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	 NBIA6
615651	LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	 LKPAT
615658	SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	 SPG57
615663	WARBURG MICRO SYNDROME 4; WARBM4	 WARBM4
615670	SCHWANNOMATOSIS 2; SWNTS2	 SWNTS2
615683	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	 SPG64
615686	SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	 SPG63
615688	POLYARTERITIS NODOSA, CHILDHOOD-ONSET; PAN	 PAN
615696	DOWLING-DEGOS DISEASE 4; DDD4	 DDD4
615704	POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	 POIKTMP
615706	AURICULOCONDYLAR SYNDROME 3; ARCND3	 ARCND3
615707	IMMUNODEFICIENCY 20; IMD20	 IMD20
615709	SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA	 SAVA
615710	MITCHELL-RILEY SYNDROME; MTCHRS	 MTCHRS
615715	BONE MARROW FAILURE SYNDROME 2; BMFS2	 BMFS2
615716	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4; HPMRS4	 HPMRS4
615721	RENAL HYPODYSPLASIA/APLASIA 2; RHDA2	 RHDA2
615722	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	 BBSOAS
615724	PREMATURE OVARIAN FAILURE 9; POF9	 POF9
615725	RETINITIS PIGMENTOSA 68; RP68	 RP68
615726	PACHYONYCHIA CONGENITA 3; PC3	 PC3
615728	PACHYONYCHIA CONGENITA 4; PC4	 PC4
615731	NEMALINE MYOPATHY 9; NEM9	 NEM9
615735	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE; PPKNEFD	 PPKNEFD
615744	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	 EIEE19
615745	ATRIAL STANDSTILL 2; ATRST2	 ATRST2
615749	ECULIZUMAB, POOR RESPONSE TO	
615750	MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA; MYMY6	 MYMY6
615751	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD	 CA5AD
615752	POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR	 BPPR
615758	IMMUNODEFICIENCY 22; IMD22	 IMD22
615760	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA	 MSCCA
615761	MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	 MRD23
615763	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	 CDCBM5
615768	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	 SCAR16
615770	ATRIAL FIBRILLATION, FAMILIAL, 15; ATFB15	 ATFB15
615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	 CDCBM6
615774	OOCYTE MATURATION DEFECT 1; OOMD1	 OOMD1
615777	DESBUQUOIS DYSPLASIA 2; DBQD2	 DBQD2
615779	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4	 CHTD4
615780	RETINITIS PIGMENTOSA 69; RP69	 RP69
615785	WHITE SPONGE NEVUS 2; WSN2	 WSN2
615789	SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	 SSMCF
615803	PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	 PCH10
615807	SECKEL SYNDROME 8; SCKL8	 SCKL8
615809	PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9	 PCH9
615812	ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	 AOMS3
615816	IMMUNODEFICIENCY 23; IMD23	 IMD23
615817	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	 MRT43
615821	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA	 DCWHKTA
615828	MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	 MRD24
615829	XIA-GIBBS SYNDROME	
615830	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4	 PPNAD4
615833	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	 EIEE21
615834	MENTAL RETARDATION, AUTOSOMAL DOMINANT 26; MRD26	 MRD26
615837	DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	 DFNB101
615838	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	 MC3DN8
615841	SPERMATOGENIC FAILURE 13; SPGF13	 SPGF13
615842	SPERMATOGENIC FAILURE 14; SPGF14	 SPGF14
615846	AICARDI-GOUTIERES SYNDROME 7; AGS7	 AGS7
615848	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10	 CMM10
615849	CULLER-JONES SYNDROME; CJS	 CJS
615851	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	 PCH2E
615859	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	 EIEE23
615860	CONE-ROD DYSTROPHY 19; CORD19	 CORD19
615861	NEPHROTIC SYNDROME, TYPE 10; NPHS10	 NPHS10
615862	NEPHRONOPHTHISIS 18; NPHP18	 NPHP18
615866	MENTAL RETARDATION, AUTOSOMAL DOMINANT 27; MRD27	 MRD27
615871	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	 EIEE24
615872	CILIARY DYSKINESIA, PRIMARY, 29; CILD29	 CILD29
615873	HELSMOORTEL-VAN DER AA SYNDROME; HVDAS	 HVDAS
615877	MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	 MCSKS
615878	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4; PFIC4	 PFIC4
615879	TATTON-BROWN-RAHMAN SYNDROME; TBRS	 TBRS
615883	MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	 TAM2
615885	HYPOTRICHOSIS 12; HYPT12	 HYPT12
615887	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5	 AI2A5
615888	BLEEDING DISORDER, PLATELET-TYPE, 18; BDPLT18	 BDPLT18
615889	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	 LKENP
615895	POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	 PGBM1
615896	HYPOTRICHOSIS 13; HYPT13	 HYPT13
615897	IMMUNODEFICIENCY 24; IMD24	 IMD24
615905	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	 EIEE25
615909	DIAMOND-BLACKFAN ANEMIA 13; DBA13	 DBA13
615911	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	 FTDALS2
615916	CARDIOMYOPATHY, DILATED, 1NN; CMD1NN	 CMD1NN
615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20	 COXPD20
615918	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21	 COXPD21
615919	ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	 ATLD2
615922	RETINITIS PIGMENTOSA 70; RP70	 RP70
615923	EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	 ECDM
615924	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	 PELD
615925	GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	 GHDP
615926	WEBB-DATTANI SYNDROME; WEDAS	 WEDAS
615934	STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	 SAVI
615935	PANCREATIC AGENESIS 2; PAGEN2	 PAGEN2
615937	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2	 MPPH2
615938	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	 MPPH3
615942	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44; MRT44	 MRT44
615945	SPINOCEREBELLAR ATAXIA 37; SCA37	 SCA37
615946	MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	 MYP24
615947	HYPERLIPOPROTEINEMIA, TYPE ID	
615948	OROFACIODIGITAL SYNDROME XIV; OFD14	 OFD14
615952	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	 ADMIO1
615954	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	 AIMAH2
615957	SPINOCEREBELLAR ATAXIA 38; SCA38	 SCA38
615959	MYOPATHY, CENTRONUCLEAR, 5; CNM5	 CNM5
615960	PORETTI-BOLTSHAUSER SYNDROME; PTBHS	 PTBHS
615961	ACID-LABILE SUBUNIT DEFICIENCY; ACLSD	 ACLSD
615962	GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	 GCCR
615963	VESICOURETERAL REFLUX 8; VUR8	 VUR8
615966	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	 IMD26
615969	ALPHA-FETOPROTEIN DEFICIENCY; AFPD	 AFPD
615970	ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF; HPAFP	 HPAFP
615972	NANOPHTHALMOS 4; NNO4	 NNO4
615973	CONE-ROD DYSTROPHY 20; CORD20	 CORD20
615974	DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	 DFNB102
615978	IMMUNODEFICIENCY 27B; IMD27B	 IMD27B
615980	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	 FPLD6
615981	BARDET-BIEDL SYNDROME 2; BBS2	 BBS2
615982	BARDET-BIEDL SYNDROME 4; BBS4	 BBS4
615983	BARDET-BIEDL SYNDROME 5; BBS5	 BBS5
615984	BARDET-BIEDL SYNDROME 7; BBS7	 BBS7
615986	BARDET-BIEDL SYNDROME 9; BBS9	 BBS9
615987	BARDET-BIEDL SYNDROME 10; BBS10	 BBS10
615988	BARDET-BIEDL SYNDROME 11; BBS11	 BBS11
615989	BARDET-BIEDL SYNDROME 12; BBS12	 BBS12
615990	BARDET-BIEDL SYNDROME 13; BBS13	 BBS13
615991	BARDET-BIEDL SYNDROME 14; BBS14	 BBS14
615992	BARDET-BIEDL SYNDROME 15; BBS15	 BBS15
615993	BARDET-BIEDL SYNDROME 16; BBS16	 BBS16
615994	BARDET-BIEDL SYNDROME 17; BBS17	 BBS17
615996	BARDET-BIEDL SYNDROME 19; BBS19	 BBS19
615999	HYPERTHYROXINEMIA, FAMILIAL DYSALBUMINEMIC; FDAH	 FDAH
616000	ANALBUMINEMIA; ANALBA	 ANALBA
616001	BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	 BNAH2
616002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7	 FSGS7
616004	DYSFIBRINOGENEMIA, CONGENITAL	
616005	IMMUNODEFICIENCY 36; IMD36	 IMD36
616006	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	 HKLLS2
616007	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	 CAGSSS
616022	NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	 SCN6
616025	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	 GPIBD11
616026	FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	 FRTS4
616028	ADAMS-OLIVER SYNDROME 5; AOS5	 AOS5
616029	ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME; ECTDS	 ECTDS
616030	HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22	 HH22
616032	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8	 FSGS8
616033	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	 MSSGM1
616034	2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	 DECRD
616037	CILIARY DYSKINESIA, PRIMARY, 30; CILD30	 CILD30
616038	NEU-LAXOVA SYNDROME 2; NLS2	 NLS2
616040	MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	 CMS7
616042	DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	 DFNB103
616044	DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	 DFNA65
616045	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22; COXPD22	 COXPD22
616050	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	 AIFEC
616051	MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	 MCPH13
616052	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	 MDDGC7
616053	SPINOCEREBELLAR ATAXIA 40; SCA40	 SCA40
616056	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	 EIEE26
616063	POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8	 POROK8
616067	46,XY SEX REVERSAL 9; SRXY9	 SRXY9
616069	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	 NISBD2
616078	MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	 MRD29
616079	RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	 RDGCA
616080	MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	 MCPH12
616081	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	 PCH1C
616084	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	 SIFD
616087	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 5; NIDDM5	 NIDDM5
616094	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	 MDDGC12
616095	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	 MCT1D
616098	IMMUNODEFICIENCY 37; IMD37	 IMD37
616099	PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH	 PPKWH
616100	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	 ALPS5
616106	PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15	 PSORS15
616111	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9; MC3DN9	 MC3DN9
616113	POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	 PEPNS
616115	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	 FCAS4
616116	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46; MRT46	 MRT46
616117	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY; CCDD	 CCDD
616118	MACULAR DEGENERATION, EARLY-ONSET; EOMD	 EOMD
616126	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	 IMD38
616127	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	 SCAR17
616138	PERRAULT SYNDROME 5; PRLTS5	 PRLTS5
616139	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	 EIEE27
616140	LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	 HLD9
616145	CATEL-MANZKE SYNDROME; CATMANS	 CATMANS
616151	MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	 VMD4
616152	MACULAR DYSTROPHY, VITELLIFORM, 5; VMD5	 VMD5
616154	PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD	 PFCRD
616155	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	 CMT2S
616158	MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	 MRD31
616165	NEMALINE MYOPATHY 10; NEM10	 NEM10
616166	AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	 AAT9
616170	MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	 CCMD
616171	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	 MCCRP2
616172	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	 GEFSP9
616176	BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	 BDPLT19
616187	EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	 EPM7
616193	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47; MRT47	 MRT47
616198	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23; COXPD23	 COXPD23
616199	POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	 PGBM2
616200	RUIJS-AALFS SYNDROME; RJALS	 RJALS
616201	CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	 CAID
616202	CEREBELLOFACIODENTAL SYNDROME; CFDS	 CFDS
616204	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18	 SCAR18
616208	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22	 ALS22
616209	MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	 IMMD
616211	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	 EIEE28
616212	LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	 LIS6
616214	HYPERPROINSULINEMIA	
616216	THROMBOCYTOPENIA 5; THC5	 THC5
616217	NEPHRONOPHTHISIS 19; NPHP19	 NPHP19
616219	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5	 CFEOM5
616220	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9	 FSGS9
616221	AMELOGENESIS IMPERFECTA, TYPE IH; AI1H	 AI1H
616227	MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	 CMS15
616228	MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	 CMS14
616229	OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	 OI16
616230	EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	 EPM8
616231	MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA	 VMCQA
616239	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	 COXPD24
616247	LONG QT SYNDROME 14; LQT14	 LQT14
616248	LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6	 LCCS6
616249	LONG QT SYNDROME 15; LQT15	 LQT15
616255	SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK	 SNSK
616258	MECKEL SYNDROME 12; MKS12	 MKS12
616260	TENORIO SYNDROME; TNORS	 TNORS
616263	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	 IMNEPD
616265	PEELING SKIN SYNDROME 3; PSS3	 PSS3
616266	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD	 CLIFAHDD
616267	ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	 AOA4
616268	MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	 MRD32
616269	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	 MRT48
616270	AMELOGENESIS IMPERFECTA, TYPE IF; AI1F	 AI1F
616271	3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	 MEGCANN
616276	COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	 COQ10D7
616277	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	 ECHS1D
616278	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	 CBAS5
616279	CATARACT 43; CTRCT43	 CTRCT43
616280	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	 CMT2U
616281	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	 MRT49
616282	SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	 SPG73
616286	LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	 LCCS7
616287	LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8	 LCCS8
616289	OPTIC ATROPHY 9; OPA9	 OPA9
616291	LICHTENSTEIN-KNORR SYNDROME; LIKNS	 LIKNS
616294	COLE-CARPENTER SYNDROME 2; CLCRP2	 CLCRP2
616295	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS; PLACK	 PLACK
616298	SINGLETON-MERTEN SYNDROME 2; SGMRT2	 SGMRT2
616299	LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	 LIPT1D
616300	SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	 SRTD13
616304	MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	 CMS17
616307	SENIOR-LOKEN SYNDROME 8; SLSN8	 SLSN8
616311	MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	 MRD33
616313	MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	 CMS2A
616314	MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	 CMS2C
616321	MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	 CMS3A
616322	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	 CMS3B
616323	MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	 CMS3C
616324	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	 CMS4B
616325	MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	 CMS9
616326	MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	 CMS11
616329	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13	 MODY13
616339	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	 EIEE29
616341	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	 EIEE30
616342	LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	 LIS7
616345	IMMUNODEFICIENCY 39; IMD39	 IMD39
616346	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	 EIEE31
616351	MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	 MRD34
616353	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6; DKCB6	 DKCB6
616355	MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	 MRD35
616357	DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40	 DFNA40
616362	MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	 MRD36
616364	WHITE-SUTTON SYNDROME; WHSUS	 WHSUS
616366	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	 EIEE32
616367	MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	 MFDA
616368	CHOPS SYNDROME; CHOPS	 CHOPS
616370	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	 MMDS4
616371	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4	 PFBMFT4
616373	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3	 PFBMFT3
616389	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	 CSNB1G
616390	TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE; TTD2	 TTD2
616393	MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	 MRD38
616394	RETINITIS PIGMENTOSA 71; RP71	 RP71
616395	TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3	 TTD3
616398	DYSTONIA 26, MYOCLONIC; DYT26	 DYT26
616399	BRUGADA SYNDROME 9; BRGDA9	 BRGDA9
616400	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2; FNEPPK2	 FNEPPK2
616402	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	 MCPH14
616409	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	 EIEE33
616411	DYSTONIA 27; DYT27	 DYT27
616413	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	 IBGC6
616414	AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	 AILJK
616415	FAMILIAL ADENOMATOUS POLYPOSIS 3; FAP3	 FAP3
616418	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 1; HOMGSMR1	 HOMGSMR1
616420	LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	 HLD10
616421	MYOCLONIC-ATONIC EPILEPSY; MAE	 MAE
616425	46,XY SEX REVERSAL 10; SRXY10	 SRXY10
616428	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10; MCOPCB10	 MCOPCB10
616430	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	 COXPD25
616433	IMMUNODEFICIENCY 40; IMD40	 IMD40
616435	FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	 FANCT
616436	EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	 ETL7
616437	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	 FTDALS3
616439	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	 FTDALS4
616445	CANDIDIASIS, FAMILIAL, 9; CANDF9	 CANDF9
616449	BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	 BVSYS
616451	SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	 SPG74
616452	B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	 BENTA
616455	ZIMMERMANN-LABAND SYNDROME 2; ZLS2	 ZLS2
616457	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	 EIEE50
616459	AL-RAQAD SYNDROME; ARS	 ARS
616460	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	 MRT50
616461	EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	 ETL8
616462	ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	 AFDCIN
616468	EXUDATIVE VITREORETINOPATHY 6; EVR6	 EVR6
616469	RETINITIS PIGMENTOSA 72; RP72	 RP72
616470	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	 UCMD2
616471	BETHLEM MYOPATHY 2; BTHLM2	 BTHLM2
616479	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	 PEOB2
616481	CILIARY DYSKINESIA, PRIMARY, 32; CILD32	 CILD32
616482	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	 SADDAN
616483	INFANTILE LIVER FAILURE SYNDROME 2; ILFS2	 ILFS2
616486	MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE; MCPH15	 MCPH15
616487	EPIDERMOLYSIS BULLOSA SIMPLEX WITH NAIL DYSTROPHY; EBSND	 EBSND
616488	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	 HSAN8
616489	GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	 GRDF
616490	JOUBERT SYNDROME 23; JBTS23	 JBTS23
616491	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V	 CMT2V
616494	LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	 HLD11
616500	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 3; CEMCOX3	 CEMCOX3
616501	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4	 CEMCOX4
616502	CONE-ROD DYSTROPHY 21; CORD21	 CORD21
616503	LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	 LCCS9
616505	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	 HMSN6B
616507	OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	 OI17
616509	CATARACT 44; CTRCT44	 CTRCT44
616511	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14	 MODY14
616515	DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	 DFNB104
616516	EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	 EDMD3
616517	ACHROMATOPSIA 7; ACHM7	 ACHM7
616531	POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	 PMGYCHA
616532	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	 IIAE7
616534	THYROID CANCER, NONMEDULLARY, 4; NMTC4	 NMTC4
616535	THYROID CANCER, NONMEDULLARY, 5; NMTC5	 NMTC5
616538	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	 MDDGA9
616539	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	 COXPD26
616540	EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	 EPM9
616541	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	 SSMED
616544	RETINITIS PIGMENTOSA 73; RP73	 RP73
616546	SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY; SRTD14	 SRTD14
616549	KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	 KFS4
616553	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	 DKCA6
616559	NOONAN SYNDROME 9; NS9	 NS9
616562	RETINITIS PIGMENTOSA 74; RP74	 RP74
616564	NOONAN SYNDROME 10; NS10	 NS10
616568	GLIOMA SUSCEPTIBILITY 9; GLM9	 GLM9
616570	CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	 COFS3
616576	IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	 CVID12
616577	EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	 EHLMRS
616579	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	 MRD40
616583	SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE; SEDSTN	 SEDSTN
616586	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	 SPG9B
616589	ADAMS-OLIVER SYNDROME 6; AOS6	 AOS6
616592	KOSAKI OVERGROWTH SYNDROME; KOGS	 KOGS
616602	CRANIOSYNOSTOSIS 6; CRS6	 CRS6
616603	CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	 ADCL3
616617	HEIMLER SYNDROME 2; HMLR2	 HMLR2
616622	IMMUNODEFICIENCY 42; IMD42	 IMD42
616625	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W; CMT2W	 CMT2W
616629	SENIOR-LOKEN SYNDROME 9; SLSN9	 SLSN9
616631	POROKERATOSIS 9, MULTIPLE TYPES; POROK9	 POROK9
616632	SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS	 SCBMS
616636	IMMUNODEFICIENCY 44; IMD44	 IMD44
616638	SMITH-KINGSMORE SYNDROME; SKS	 SKS
616640	EPILEPSY, PROGRESSIVE MYOCLONIC, 10; EPM10	 EPM10
616645	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	 EIEE34
616647	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35; EIEE35	 EIEE35
616649	SPHEROCYTOSIS, TYPE 2; SPH2	 SPH2
616657	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	 SPATCCM
616668	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	 CMT2X
616669	IMMUNODEFICIENCY 45; IMD45	 IMD45
616672	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	 COXPD27
616680	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE; SPG75	 SPG75
616681	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16	 MCPH16
616682	SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME; SSMS	 SSMS
616683	LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12	 HLD12
616684	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	 CMT4K
616685	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14	 EIG14
616687	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	 CMT2Y
616688	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	 CMT2Z
616689	DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	 DHS2
616697	DEAFNESS, AUTOSOMAL DOMINANT 69; DFNA69	 DFNA69
616705	DEAFNESS, AUTOSOMAL RECESSIVE 97; DFNB97	 DFNB97
616707	DEAFNESS, AUTOSOMAL DOMINANT 68; DFNA68	 DFNA68
616708	DESANTO-SHINAWI SYNDROME; DESSH	 DESSH
616710	PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	 PARK22
616716	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	 RCDP5
616719	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21	 SCAR21
616720	MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	 CMS19
616721	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N	 CDG2N
616723	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	 SEMDFA
616724	TOOTH AGENESIS, SELECTIVE, 7; STHAG7	 STHAG7
616726	CILIARY DYSKINESIA, PRIMARY, 33; CILD33	 CILD33
616728	CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES; CPRF	 CPRF
616730	NEPHROTIC SYNDROME, TYPE 11; NPHS11	 NPHS11
616732	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA10	 OPA10
616733	COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	 COQ10D8
616734	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	 CSCSC2
616736	TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	 ETM5
616737	TAKENOUCHI-KOSAKI SYNDROME; TKS	 TKS
616738	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2	 RUSAT2
616739	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51; MRT51	 MRT51
616740	IMMUNODEFICIENCY 46; IMD46	 IMD46
616744	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE; AISBL	 AISBL
616749	HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	 HTX7
616756	SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES; SPPRS	 SPPRS
616760	WOOLLY HAIR, AUTOSOMAL RECESSIVE 3; ARWH3	 ARWH3
616763	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	 LDAMD
616777	SECKEL SYNDROME 9; SCKL9	 SCKL9
616779	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	 CADASIL2
616780	OOCYTE MATURATION DEFECT 2; OOMD2	 OOMD2
616781	JOUBERT SYNDROME 25; JBTS25	 JBTS25
616784	JOUBERT SYNDROME 26; JBTS26	 JBTS26
616789	MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD	 MRFACD
616794	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28; COXPD28	 COXPD28
616795	SPINOCEREBELLAR ATAXIA 42; SCA42	 SCA42
616801	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	 IHPRF2
616803	LAMB-SHAFFER SYNDROME; LAMSHF	 LAMSHF
616806	WILMS TUMOR 6; WT6	 WT6
616809	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6; HPMRS6	 HPMRS6
616812	CARDIAC ARRHYTHMIA WITH INCREASED SERUM CREATINE KINASE; CARICK	 CARICK
616814	PREIMPLANTATION EMBRYONIC LETHALITY 1; PREMBL1	 PREMBL1
616816	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	 IHPMR
616817	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2; MSSGM2	 MSSGM2
616818	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3; IGAN3	 IGAN3
616819	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	 CCAFCA
616827	MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE; MDRCMTT	 MDRCMTT
616828	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O	 CDG2O
616829	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp; CDG2P	 CDG2P
616831	LUSCAN-LUMISH SYNDROME; LLS	 LLS
616833	PAGET DISEASE OF BONE 6; PDB6	 PDB6
616834	MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS; MCCPD	 MCCPD
616835	MEIER-GORLIN SYNDROME 6; MGORS6	 MGORS6
616839	EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE; RREI	 RREI
616840	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23	 PARK23
616843	LYMPHATIC MALFORMATION 6; LMPHM6	 LMPHM6
616849	BRACHYDACTYLY, TYPE A1, D; BDA1D	 BDA1D
616851	CATARACT 45; CTRCT45	 CTRCT45
616852	MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM	 SHPM
616854	EVEN-PLUS SYNDROME; EVPLS	 EVPLS
616858	COWDEN SYNDROME 7; CWS7	 CWS7
616859	SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA; SPAHGC	 SPAHGC
616860	ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	 SIDBA3
616867	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2; SMABF2	 SMABF2
616868	DIARRHEA 8, SECRETORY SODIUM, CONGENITAL; DIAR8	 DIAR8
616871	MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	 MPLPF
616873	IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13	 CVID13
616875	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	 CAVIPMR
616878	METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	 MECRCN
616881	LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	 HLD13
616882	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	 FASPS3
616887	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52; MRT52	 MRT52
616890	SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	 SFMMP
616892	NEPHROTIC SYNDROME, TYPE 12; NPHS12	 NPHS12
616893	NEPHROTIC SYNDROME, TYPE 13; NPHS13	 NPHS13
616894	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	 DRS3
616896	MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE); MTDPS14	 MTDPS14
616897	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE; OCLSBG	 OCLSBG
616900	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	 IHPRF3
616901	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR; DEDSSH	 DEDSSH
616907	SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE; SPG76	 SPG76
616910	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	 ICF3
616911	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	 ICF4
616913	BLEEDING DISORDER, PLATELET-TYPE, 20; BDPLT20	 BDPLT20
616914	MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME; MFLS	 MFLS
616917	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	 MRT53
616921	DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	 IOLOD
616922	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2; ADSD2	 ADSD2
616924	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	 CMT2CC
616937	THROMBOCYTOPENIA 6; THC6	 THC6
616938	COFFIN-SIRIS SYNDROME 5; CSS5	 CSS5
616939	CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION; COCPMR	 COCPMR
616941	AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT; AGM8	 AGM8
616943	TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	 TTD6
616944	MENTAL RETARDATION, AUTOSOMAL DOMINANT 41; MRD41	 MRD41
616946	PREMATURE OVARIAN FAILURE 11; POF11	 POF11
616947	PREMATURE OVARIAN FAILURE 12; POF12	 POF12
616948	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22; SCAR22	 SCAR22
616949	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	 SCAR23
616950	SPERMATOGENIC FAILURE 15; SPGF15	 SPGF15
616954	YOU-HOOVER-FONG SYNDROME; YHFS	 YHFS
616959	RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	 RPEM
616963	HYPERCALCEMIA, INFANTILE, 2; HCINF2	 HCINF2
616968	DEAFNESS, AUTOSOMAL DOMINANT 70; DFNA70	 DFNA70
616973	MENTAL RETARDATION, AUTOSOMAL DOMINANT 42; MRD42	 MRD42
616974	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30; COXPD30	 COXPD30
616975	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	 NEDBEH
616977	MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	 MRD43
617004	POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS; PCLD2	 PCLD2
617006	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2	 ADMIO2
617008	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	 CPSQ3
617011	MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	 MDFPMR
617013	HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2	 HMNDYT2
617014	NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE; SCN7	 SCN7
617017	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	 CMT2T
617018	SPINOCEREBELLAR ATAXIA 43; SCA43	 SCA43
617020	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	 EIEE38
617021	HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	 HLASA
617022	LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	 LCCS10
617023	RETINITIS PIGMENTOSA 75; RP75	 RP75
617024	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	 CSNB1H
617025	NEVUS COMEDONICUS; NC	 NC
617026	PONTOCEREBELLAR HYPOPLASIA, TYPE 2F; PCH2F	 PCH2F
617027	HYPERALDOSTERONISM, FAMILIAL, TYPE IV; HALD4	 HALD4
617028	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54; MRT54	 MRT54
617030	MYOPATHY, DISTAL, 5; MPD5	 MPD5
617035	PATENT DUCTUS ARTERIOSUS 2; PDA2	 PDA2
617039	PATENT DUCTUS ARTERIOSUS 3; PDA3	 PDA3
617041	DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3	 DURS3
617044	SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS; SDDHD	 SDDHD
617046	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE; SPG77	 SPG77
617047	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26	 CMH26
617050	HERMANSKY-PUDLAK SYNDROME 10; HPS10	 HPS10
617051	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55; MRT55	 MRT55
617052	BONE MARROW FAILURE SYNDROME 3; BMFS3	 BMFS3
617053	MIRAGE SYNDROME; MIRAGE	 MIRAGE
617054	STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET; SNDC	 SNDC
617055	CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	 CISS3
617056	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	 HNFJ4
617061	MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	 MRD44
617062	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	 OCNDS
617063	MEIER-GORLIN SYNDROME 7; MGORS7	 MGORS7
617065	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40; EIEE40	 EIEE40
617068	PORTAL HYPERTENSION, NONCIRRHOTIC; NCPH	 NCPH
617069	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3; PEOB3	 PEOB3
617070	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4; PEOB4	 PEOB4
617072	MYOPATHY, AUTOSOMAL RECESSIVE, WITH RIGID SPINE AND DISTAL JOINT CONTRACTURES; MRRSDC	 MRRSDC
617073	TOOTH AGENESIS, SELECTIVE, 8; STHAG8	 STHAG8
617075	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3; NPCA3	 NPCA3
617080	SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5	 BFIS5
617082	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa; CDG1AA	 CDG1AA
617086	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2; EMPF2	 EMPF2
617087	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	 CMT2A2B
617088	SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	 SRTD15
617090	MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	 MCPH17
617091	CILIARY DYSKINESIA, PRIMARY, 34; CILD34	 CILD34
617092	CILIARY DYSKINESIA, PRIMARY, 35; CILD35	 CILD35
617093	GROWTH RETARDATION, INTELLECTUAL DEVELOPMENTAL DISORDER, HYPOTONIA, AND HEPATOPATHY; GRIDHH	 GRIDHH
617099	AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	 AIPDS
617100	FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4	 FAP4
617101	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	
617102	SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	 SRTD16
617105	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	 EIEE41
617106	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	 EIEE42
617107	THAUVIN-ROBINET-FAIVRE SYNDROME; TROFAS	 TROFAS
617108	SESSILE SERRATED POLYPOSIS CANCER SYNDROME; SSPCS	 SSPCS
617111	MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	 MDPT3
617113	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43; EIEE43	 EIEE43
617115	PEELING SKIN SYNDROME 5; PSS5	 PSS5
617116	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	 FFEVF2
617118	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	 FFEVF3
617119	BARDET-BIEDL SYNDROME 20; BBS20	 BBS20
617120	JOUBERT SYNDROME 27; JBTS27	 JBTS27
617121	JOUBERT SYNDROME 28; JBTS28	 JBTS28
617123	RETINITIS PIGMENTOSA 76; RP76	 RP76
617126	ALAZAMI-YUAN SYNDROME; ALYUS	 ALYUS
617127	OROFACIODIGITAL SYNDROME XV; OFD15	 OFD15
617132	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44; EIEE44	 EIEE44
617133	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	 SCAR24
617137	FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	 FMD2
617140	ZTTK SYNDROME; ZTTKS	 ZTTKS
617141	ANIRIDIA 2; AN2	 AN2
617142	ANIRIDIA 3; AN3	 AN3
617143	MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	 CMS20
617145	NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET; NADGP	 NADGP
617146	ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	 DAIPT
617153	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45; EIEE45	 EIEE45
617156	MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	 MTDPS15
617157	SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	 SBIDDS
617158	MYOPATHY, DISTAL, WITH RIMMED VACUOLES; DMRV	 DMRV
617159	SIFRIM-HITZ-WEISS SYNDROME; SIHIWES	 SIHIWES
617162	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	 EIEE46
617164	SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	 SRMMD
617166	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47; EIEE47	 EIEE47
617168	AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	 AAT10
617169	SOTOS SYNDROME 3; SOTOS3	 SOTOS3
617171	DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; DYSEIDD	 DYSEIDD
617173	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA; IDDCA	 IDDCA
617174	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	 EDSPD2
617175	RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA	 RDEOA
617180	CHITAYAT SYNDROME; CHYTS	 CHYTS
617182	LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	 LADCI
617183	HAREL-YOON SYNDROME; HAYOS	 HAYOS
617184	MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	 MTDPS12A
617186	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY; PEBEL	 PEBEL
617187	SPERMATOGENIC FAILURE 16; SPGF16	 SPGF16
617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	 MRT57
617190	SHASHI-PENA SYNDROME; SHAPNS	 SHAPNS
617193	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	 PEBAT
617194	LETHAL CONGENITAL CONTRACTURE SYNDROME 11; LCCS11	 LCCS11
617201	PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	 PVNH7
617205	HETEROTAXY, VISCERAL, 8, AUTOSOMAL; HTX8	 HTX8
617207	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	 PEAMO
617213	SEDOHEPTULOKINASE DEFICIENCY; SHPKD	 SHPKD
617214	SPERMATOGENIC FAILURE 17; SPGF17	 SPGF17
617217	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6; AI2A6	 AI2A6
617222	SUDDEN CARDIAC FAILURE, INFANTILE; SCFI	 SCFI
617223	SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED; SCFAI	 SCFAI
617225	SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78	 SPG78
617228	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31; COXPD31	 COXPD31
617232	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21; LGMDR21	 LGMDR21
617234	PREIMPLANTATION EMBRYONIC LETHALITY 2; PREMBL2	 PREMBL2
617235	MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	 NEIMY
617237	IMMUNODEFICIENCY 49; IMD49	 IMD49
617238	MYOPIA 25, AUTOSOMAL DOMINANT; MYP25	 MYP25
617239	MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC; CMS21	 CMS21
617241	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	 LICS
617243	FANCONI ANEMIA, COMPLEMENTATION GROUP V; FANCV	 FANCV
617244	FANCONI ANEMIA, COMPLEMENTATION GROUP R; FANCR	 FANCR
617247	FANCONI ANEMIA, COMPLEMENTATION GROUP U; FANCU	 FANCU
617248	3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	 MGCA8
617251	UNCOMBABLE HAIR SYNDROME 2; UHS2	 UHS2
617252	UNCOMBABLE HAIR SYNDROME 3; UHS3	 UHS3
617253	SECKEL SYNDROME 10; SCKL10	 SCKL10
617258	MYOPATHY, MYOFIBRILLAR, 8; MFM8	 MFM8
617268	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	 NDHSAL
617270	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	 MRT58
617271	NEPHRONOPHTHISIS 20; NPHP20	 NPHP20
617272	GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	 GLC3E
617275	TOOTH AGENESIS, SELECTIVE, 9; STHAG9	 STHAG9
617280	ATRIAL FIBRILLATION, FAMILIAL, 18; ATFB18	 ATFB18
617281	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	 EIEE49
617282	DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	 DYTOABG
617284	DYSTONIA 28, CHILDHOOD-ONSET; DYT28	 DYT28
617290	EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	 EPVB6D
617296	SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	 SINO
617297	AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J	 AI1J
617300	LYMPHATIC MALFORMATION 7; LMPHM7	 LMPHM7
617301	GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	
617302	OPTIC ATROPHY 11; OPA11	 OPA11
617303	MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	 MPSPS
617304	RETINITIS PIGMENTOSA 77; RP77	 RP77
617306	COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	 COMMAD
617308	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6	 CBAS6
617315	ANTERIOR SEGMENT DYSGENESIS 6; ASGD6	 ASGD6
617319	ANTERIOR SEGMENT DYSGENESIS 8; ASGD8	 ASGD8
617321	YAO SYNDROME; YAOS	 YAOS
617323	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59; MRT59	 MRT59
617330	HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	 HADDS
617333	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	 IDDDFP
617336	NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	 NEM11
617337	ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE; ECTD12	 ECTD12
617339	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	 EIEE51
617341	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2; CRMCC2	 CRMCC2
617343	HYPERPARATHYROIDISM 4; HRPT4	 HRPT4
617347	HYPERLIPOPROTEINEMIA, TYPE III	
617349	AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO; AAT11	 AAT11
617350	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	 EIEE52
617360	CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	 CHDFIDD
617364	CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA; CHDED	 CHDED
617370	PEROXISOME BIOGENESIS DISORDER 10B; PBD10B	 PBD10B
617383	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2; ANFH2	 ANFH2
617384	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	 HPANBH4
617388	AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	 AIADK
617389	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	 EIEE53
617391	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	 EIEE54
617392	ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	 ECTD13
617393	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM	 NECFM
617394	SCLEROSING CHOLANGITIS, NEONATAL; NSC	 NSC
617395	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	 CDG2Q
617396	ANAUXETIC DYSPLASIA 2; ANXD2	 ANXD2
617397	PSEUDO-TORCH SYNDROME 2; PTORCH2	 PTORCH2
617402	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	 ARCL2C
617403	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	 ARCL2D
617404	MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY; MDCCAID	 MDCCAID
617406	BARDET-BIEDL SYNDROME 21; BBS21	 BBS21
617412	BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	 BTDD
617425	IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	 ISDNA
617432	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60; MRT60	 MRT60
617433	RETINITIS PIGMENTOSA 78; RP78	 RP78
617435	LOPES-MACIEL-RODAN SYNDROME; LOMARS	 LOMARS
617439	CRANIOSYNOSTOSIS 7; CRS7	 CRS7
617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	 THAMY
617442	PREMATURE OVARIAN FAILURE 13; POF13	 POF13
617443	BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	 BDPLT21
617450	INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD; IDDGIP	 IDDGIP
617452	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA	 IDDFSDA
617460	RETINITIS PIGMENTOSA 79; RP79	 RP79
617466	TOWNES-BROCKS SYNDROME 2; TBS2	 TBS2
617468	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT; AMCNMY	 AMCNMY
617478	STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME; SHDRA	 SHDRA
617480	46,XX SEX REVERSAL 4; SRXX4	 SRXX4
617481	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	 NMIHBA
617493	NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	 NEDIM
617506	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	 NSLH2
617516	STANKIEWICZ-ISIDOR SYNDROME; STISS	 STISS
617519	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	 NEDHND
617520	MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	 MCPH18
617524	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2	 EKVP2
617525	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3; EKVP3	 EKVP3
617526	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4	 EKVP4
617527	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	 NDMSBA
617532	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	 IDDNPF
617537	RAHMAN SYNDROME; RMNS	 RMNS
617540	PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5	 PITA5
617542	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 2; HGPPS2	 HGPPS2
617547	RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	 RDMS
617557	GABRIELE-DE VRIES SYNDROME; GADEVS	 GADEVS
617560	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	 SPAX8
617561	COHEN-GIBSON SYNDROME; COGIS	 COGIS
617564	MEIER-GORLIN SYNDROME 8; MGORS8	 MGORS8
617565	PERRAULT SYNDROME 6; PRLTS6	 PRLTS6
617571	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14; ARCI14	 ARCI14
617572	EXUDATIVE VITREORETINOPATHY 7; EVR7	 EVR7
617574	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13	 ARCI13
617575	NEPHROTIC SYNDROME, TYPE 14; NPHS14	 NPHS14
617576	SPERMATOGENIC FAILURE 18; SPGF18	 SPGF18
617577	CILIARY DYSKINESIA, PRIMARY, 37; CILD37	 CILD37
617584	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	 SCAR25
617585	IMMUNODEFICIENCY 53; IMD53	 IMD53
617591	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	 PRAAS3
617592	SPERMATOGENIC FAILURE 19; SPGF19	 SPGF19
617593	SPERMATOGENIC FAILURE 20; SPGF20	 SPGF20
617595	BIRK-LANDAU-PEREZ SYNDROME; BILAPES	 BILAPES
617596	MALEYLACETOACETATE ISOMERASE DEFICIENCY; MAAID	 MAAID
617599	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	 EIEE55
617600	MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	 MRD45
617601	MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	 MRD46
617602	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	 CHDSKM
617604	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	 MISSLA
617605	DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	 DFNA71
617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	 DFNA72
617607	AMELOGENESIS IMPERFECTA, TYPE IIIB; AI3B	 AI3B
617610	POLYCYSTIC KIDNEY DISEASE 5; PKD5	 PKD5
617613	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	 MMDS5
617622	JOUBERT SYNDROME 30; JBTS30	 JBTS30
617626	FIBROMATOSIS, GINGIVAL, 5; GINGF5	 GINGF5
617629	SCHIZOPHRENIA 19; SCZD19	 SCZD19
617633	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	 SCAR26
617635	MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	 MRD47
617638	IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	 IMD11B
617639	DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	 DFNB107
617641	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	 CAKUTHED
617642	POLYDACTYLY, POSTAXIAL, TYPE A7; PAPA7	 PAPA7
617644	SPERMATOGENIC FAILURE 21; SPGF21	 SPGF21
617654	DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	 DFNB108
617660	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	 VCRL1
617661	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	 VCRL2
617662	JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	 JLSM
617663	DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	 DFNA73
617664	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	 COXPD32
617666	FRASER SYNDROME 2; FRASRS2	 FRASRS2
617667	FRASER SYNDROME 3; FRASRS3	 FRASRS3
617668	ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	 NELABA
617669	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	 PEBAS
617671	HELIX SYNDROME; HELIX	 HELIX
617675	MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	 MMYAT
617681	BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	 BCDS2
617682	PILAROWSKI-BJORNSSON SYNDROME; PILBOS	 PILBOS
617690	OVARIAN DYSGENESIS 5; ODG5	 ODG5
617691	SPINOCEREBELLAR ATAXIA 44; SCA44	 SCA44
617694	AL KAISSI SYNDROME; ALKAS	 ALKAS
617698	3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	 MGCA9
617706	SPERMATOGENIC FAILURE 22; SPGF22	 SPGF22
617707	SPERMATOGENIC FAILURE 23; SPGF23	 SPGF23
617710	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	 NEMMLAS
617712	OOCYTE MATURATION DEFECT 3; OOMD3	 OOMD3
617713	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	 COXPD33
617717	AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	 ANOA
617718	PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	 PLTEID
617719	EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	 EDM7
617721	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	 HMN9
617729	GALLOWAY-MOWAT SYNDROME 3; GAMOS3	 GAMOS3
617730	GALLOWAY-MOWAT SYNDROME 4; GAMOS4	 GAMOS4
617731	GALLOWAY-MOWAT SYNDROME 5; GAMOS5	 GAMOS5
617743	OOCYTE MATURATION DEFECT 4; OOMD4	 OOMD4
617744	IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	 IMDDHH
617746	SWEENEY-COX SYNDROME; SWCOS	 SWCOS
617751	MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	 MRD48
617752	MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	 MRD49
617756	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5; EKVP5	 EKVP5
617757	JOUBERT SYNDROME 32; JBTS32	 JBTS32
617760	MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	 CNM6
617761	JOUBERT SYNDROME 31; JBTS31	 JBTS31
617763	SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	 SHRF
617765	IMMUNODEFICIENCY, COMMON VARIABLE, 14; CVID14	 CVID14
617767	JOUBERT SYNDROME 33; JBTS33	 JBTS33
617768	KLEEFSTRA SYNDROME 2; KLEFS2	 KLEFS2
617769	SPINOCEREBELLAR ATAXIA 45; SCA45	 SCA45
617770	SPINOCEREBELLAR ATAXIA 46; SCA46	 SCA46
617771	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	 EIEE57
617772	DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	 DFNA34
617773	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	 MRT61
617780	COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	 CIMAH
617781	RETINITIS PIGMENTOSA 80; RP80	 RP80
617783	NEPHROTIC SYNDROME, TYPE 16; NPHS16	 NPHS16
617784	FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	 FANCW
617787	MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	 MRD50
617788	MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	 MRD51
617796	MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	 MRD52
617798	MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	 MRD53
617799	MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	 MRD54
617800	MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	 MCPH19
617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	 NDMSCA
617804	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	 NEDMIAL
617805	RENAL HYPODYSPLASIA/APLASIA 3; RHDA3	 RHDA3
617810	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	 GPIBD15
617816	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	 GPIBD16
617820	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	 NDHMSR
617821	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	 EDSARTH2
617822	ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	 ALKKUCS
617825	GLUCOCORTICOID DEFICIENCY 5; GCCD5	 GCCD5
617827	IMMUNODEFICIENCY 55; IMD55	 IMD55
617829	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	 IECEE2
617830	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	 EIEE58
617831	MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	 MRD55
617836	DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	 DEDSM
617839	AMYOTROPHIC LATERAL SCLEROSIS 23; ALS23	 ALS23
617865	NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	 NEDMAGA
617866	SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	 SRTD18
617871	RETINITIS PIGMENTOSA 81; RP81	 RP81
617872	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	 COXPD34
617873	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	 COXPD35
617874	POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	 PCLD3
617875	POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	 PCLD4
617877	SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	 SSFSC
617883	FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	 FANCS
617885	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	 BMIQ19
617892	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	 ALS24
617895	SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	 SRTD19
617898	MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	 SYNS4
617900	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	 IIAE8
617903	NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	 NDPLHS
617904	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	 EIEE59
617907	ERYTHROCYTOSIS, FAMILIAL, 5; ECYT5	 ECYT5
617911	DIAMOND-BLACKFAN ANEMIA-LIKE; DBAL	 DBAL
617912	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	 CHTD5
617913	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	 NEDMCR
617914	MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	 MCPH20
617915	HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	 HADDTS
617916	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	 NBIA7
617917	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	 NBIA8
617920	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3	 PLCA3
617921	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25; ALS25	 ALS25
617924	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	 EJM10
617925	SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	 SRTD20
617926	OROFACIODIGITAL SYNDROME XVII; OFD17	 OFD17
617929	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	 EIEE60
617931	SPINOCEREBELLAR ATAXIA 47; SCA47	 SCA47
617933	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	 EIEE61
617935	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	 FFEVF4
617936	BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED	 BCHED
617938	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	 EIEE62
617941	SHWACHMAN-DIAMOND SYNDROME 2; SDS2	 SDS2
617948	ELLIPTOCYTOSIS 3; EL3	 EL3
617950	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	 COXPD36
617951	LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	 HLD15
617952	OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	 OI18
617954	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	 MMDS6
617959	SPERMATOGENIC FAILURE 24; SPGF24	 SPGF24
617960	SPERMATOGENIC FAILURE 25; SPGF25	 SPGF25
617964	LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	 HLD16
617965	SPERMATOGENIC FAILURE 27; SPGF27	 SPGF27
617967	HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	 HYC3
617970	RH-NULL, AMORPH TYPE; RHNA	 RHNA
617974	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	 SEMDDR
617976	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	 EIEE63
617983	MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	 MCPH21
617984	MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	 MCPH22
617985	MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	 MCPH23
617991	DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	 DIDOD
617992	DEAFNESS, CONGENITAL HEART DEFECTS, AND POSTERIOR EMBRYOTOXON; DCHE	 DCHE
617993	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2; HFTC2	 HFTC2
617994	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 3; HFTC3	 HFTC3
617996	OOCYTE MATURATION DEFECT 5; OOMD5	 OOMD5
618000	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	 EDSCLL2
618003	DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	 DFNB57
618005	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	 CDGF1
618006	LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	 HLD17
618007	MOVED TO 613658	
618008	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	 EIEE65
618010	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	 GPIBD17
618012	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	 IECEE3
618013	DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	 DFNB109
618014	PREMATURE OVARIAN FAILURE 14; POF14	 POF14
618015	PROTOPORPHYRIA, ERYTHROPOIETIC, 2; EPP2	 EPP2
618019	PELGER-HUET ANOMALY WITH MILD SKELETAL ANOMALIES; PHASK	 PHASK
618021	TETRAAMELIA SYNDROME 2; TETAMS2	 TETAMS2
618022	HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	 HHRRD
618031	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	 PPCD4
618036	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	 CMT2DD
618049	PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	 PKDYS2
618050	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	 MRD57
618052	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27; CMH27	 CMH27
618056	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	 NEDCAS
618060	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	 IDDECA
618061	POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	 PKD6
618065	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	 PCH1D
618067	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	 EIEE66
618074	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 6; FAME6	 FAME6
618076	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	 NEDSG
618077	INFLAMMATORY BOWEL DISEASE 29; IBD29	 IBD29
618078	OVARIAN DYSGENESIS 6; ODG6	 ODG6
618084	PEELING SKIN SYNDROME 6; PSS6	 PSS6
618086	SPERMATOGENIC FAILURE 28; SPGF28	 SPGF28
618087	SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	 SCA42ND
618092	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	 IDDSFTA
618093	SPINOCEREBELLAR ATAXIA 48; SCA48	 SCA48
618094	DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	 DFNB110
618095	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	 MRT63
618096	PREMATURE OVARIAN FAILURE 15; POF15	 POF15
618097	MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	 MGRISCE2
618098	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	 PEOB5
618103	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	 MRT64
618106	MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	 MRD58
618107	OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	 OPTA3
618108	IMMUNODEFICIENCY 57; IMD57	 IMD57
618112	SPERMATOGENIC FAILURE 31; SPGF31	 SPGF31
618113	ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	 MMERV
618114	LIDDLE SYNDROME 2; LIDLS2	 LIDLS2
618115	SPERMATOGENIC FAILURE 32; SPGF32	 SPGF32
618116	BONE MARROW FAILURE SYNDROME 4; BMFS4	 BMFS4
618117	OVARIAN DYSGENESIS 7; ODG7	 ODG7
618126	LIDDLE SYNDROME 3; LIDLS3	 LIDLS3
618129	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	 LGMDD4
618131	IMMUNODEFICIENCY 58; IMD58	 IMD58
618140	DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	 DFNA74
618149	OROFACIAL CLEFT 8; OFC8	 OFC8
618152	SPERMATOGENIC FAILURE 33; SPGF33	 SPGF33
618153	SPERMATOGENIC FAILURE 34; SPGF34	 SPGF34
618157	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV; IGHD4	 IGHD4
618161	JOUBERT SYNDROME 35; JBTS35	 JBTS35
618170	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	 CONDSIAS
618204	IMMUNODEFICIENCY 15A; IMD15A	 IMD15A
